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Ordinal responses are commonly seen in medical research. Many pathological evalu-
ations and health status outcomes are reported on an ordinal scales. Some examples
of ordinal outcomes include cancer stage (I, II, III and IV), or stage of liver disease
(normal liver, chronic hepatitis, cirrhosis and end of stage liver disease or hepatocel-
lular carcinoma (HCC)).
In recent years, there has been a demand to understanding the pathogenic as-
sociation between ordinal clinical outcomes and molecular characteristics. Genomic
charactersitics are often assayed using a high-dimensional platform where the num-
ber of interrogated sites (P ) exceeds the number of samples (n). Unfortunately,
traditional ordinal response models often do not perform well when the number
of parameter (P ) exceed the number of observations (n). A good solution to this
problem is penalization, for example, least absolute shrinkage and selection operator
(LASSO). Here, we extend a LASSO method, the generalized monotone incremental
viii
forward stagewise algorithm (GMIFS) method, to ordinal response models. Specifi-
cally, this research details the extension of the GMIFS method to probit link ordinal
response models and the stereotype logit model.
Moreover, motivated by the Bayesian LASSO proposed by Park and Casella
(2008), we developed an ordinal response model that incorporates a penalty term
so that both feature selection and outcome prediction are achievable. The ordinal
response model we are focusing on is the cumulative logit model, and the performance
will be compared with the frequentist LASSO cumulative logit model (GMIFS).
In addition to GMIFS and penalized Bayesian cumulative logit model, this re-
search also addresses filtering, which is another dimension reduction method (differ-
ent from penalization). We compare filtering, or univariate feature selection methods,
with penalization methods using grouped survival data.
ix
Chapter 1
Introduction
1.1 Ordinal outcomes and high-dimensional data
Ordinal responses are commonly used in medical research. Many pathological evalu-
ations and health status outcomes are reported on an ordinal scale. Some examples
of ordinal outcomes include cancer stage (stage I, II, III or IV), stage of liver disease
(normal liver, chronic hepatitis, cirrhosis and end of stage liver disease or hepato-
cellular carcinoma (HCC)) or grouped survival outcomes (short, intermediate and
long-term survival). Unlike nominal scales for categorical variables, ordinal variables
have some unique features. For example, there is a clear ordering of the levels, but
the absolute distances among these levels are unknown. For instance, stage II cancer
is more severe than stage I; however, it is hard to quantify the difference between
two levels by a numerical measure [Agresti, 2010]. Because of the distinct nature of
an ordinal response, it is often recommended to use a traditional ordinal response
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model for the analysis of ordinal data. Traditional ordinal response models include
the cumulative link model which has various link functions (logit, probit or com-
plementary loglog link), adjacent category model, and continuation ratio models.
These models have many advantages over a multinomial regression model. They are
usually more parsimonious, have simpler interpretations than multinominal models,
because multinomial models have different sets of slope coefficients for the log-odds
of each response while most ordinal response models assume proportional odds and
therefore only have one set of slope coefficients regardless of response level. Ordi-
nal response models also have greater power for detecting relevant trend effects of
predictors [Agresti, 2010]. In section 1.3, some common ordinal models are briefly
described.
In recent years, as genomic technologies have advanced and the number of genetic
studies have increased, there has been a demand to understand the pathogenic associ-
ation between ordinal clinical outcomes and molecular characteristics. For example,
it may be of interest to identify how methylation of CpG sites or gene/protein expres-
sion values are predictive of an ordinal outcome. Unlike traditional clinical variables,
genomic characteristics are often assayed using a high-dimensional platform where
the number of interrogated sites (P ) exceeds the number of samples (n). For example,
the Illumina HumanMethylation450 Array from Illumina can interrogate methyla-
tion levels of more than 485,000 CpG sites (P = 485, 512)[Bibikova et al., 2011], and
the Reverse phase protein array platform from the MD Anderson Cancer Center can
assess protein levels for more than 135 different antibodies (P ≥ 135) [Tibes et al.,
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2006]. This high-dimensionality often causes problems when fitting models, for ex-
ample, traditional methods for modeling ordinal data do not perform well in the
presence of a high-dimensional covariate space, because traditional methods require
that the number of samples be greater than the number of covariates and assumes
the covariates are independent [Archer et al., 2014b].
Penalized methods have been shown to perform well in linear, logistic regression
and Cox proportional hazards models and have just recently been extended to the
ordinal response setting [Archer et al., 2014b, Archer and Williams, 2012]. In section
1.2, a brief overview of frequentist-based penalized methods for linear and logistic
regression models, as well as a penalized Bayesian approach for the linear model is
provided. Section 1.3 focuses on ordinal response models. In section 1.4, two penal-
ized methods for ordinal response models, glmpath.cr and glmnet.cr, which served
as motivation for expanding penalized ordinal response models are reviewed.
Throughout this thesis, mathematical notation is consistent unless specifically
mentioned. For example, n is always the number of samples and P is always the
number of covariates. For observations i = 1, 2, ...n, Yi is the response for i
th obser-
vation, and xi is the P × 1 covariate vector for observation i.
3
1.2 Penalized methods for continuous and binary
responses
Tibshirani (1996) proposed a widely used method for dimensionality reduction called
the least absolute shrinkage and selection operator (LASSO) [Tibshirani, 1996]. In
linear regression, where Yi is the response variable for the i
th individual, α is the
intercept, xi is the P × 1 covariate vector, β is the P × 1 vector of slope coefficient
and  is the error term that follows a normal distribution with mean 0 and variance
σ2, the model is expressed as
Yi = α + x
T
i β + .
LASSO penalizes the sum of the absolute value of the coefficients (L1-norm)
by introducing a regularization parameter λ which shrinks some coefficients to be
exactly 0. For a dataset with n observations and P covariates, the LASSO solution
can be estimated as
βˆLASSO = argmin
β
( n∑
i=1
(Yi − α−
P∑
j=1
xijβj)
2 + λ
P∑
j=1
|βj|
)
. (1.1)
Another common regularization method is ridge regression [Hoerl and Kennard,
1970]. The ridge solution is chosen to minimize the penalized sum of squares:
n∑
i=1
(Yi − α−
P∑
j=1
xijβj)
2 + λ
P∑
j=1
β2j .
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However, ridge regression does not reduce any coefficients to zero; therefore, it can-
not be used for feature selection.
Since LASSO has been proposed, there have been both frequentist and Bayesian
approaches developed to obtain a LASSO solution. In section 1.2.1, some frequen-
tist approaches, specifically, the incremental forward stagewise (IFS) method for the
linear regression setting and generalized monotone incremental forward stagewise
(GMIFS) for the logistic regression setting, are described. In addition, the coordi-
nate descent algorithm introduced by Park and Hastie (2007) for fitting generalized
linear models and Cox proportional hazard models is described. In section 1.2.2, the
Bayesian LASSO for linear regression is also reviewed.
1.2.1 Frequentist penalized methods
When the outcome variable is continuous, several algorithms can be used to obtain
a LASSO solution based on the likelihood. These includes the incremental forward
stagewise (IFS) and the L1-Regularization path for generalized linear models (glm-
path). First, the IFS method is reviewed given it is the foundation of our penalized
method for ordinal response data. The glmpath algorithm is also reviewed, given we
later compare our penalized ordinal method with glmpath in the analysis of grouped
survival data.
5
IFS method for linear regression
Hastie, Tibshirani & Friedman (2001) observed that the LASSO solution is strikingly
similar to the coefficients estimated by the incremental forward stagewise algorithm
(IFS)[Hastie et al., 2007]. IFS increments the coefficient that is most correlated with
current residual vector (r) by an amount of ± at each step, the sign of  being
determined by the sign of the correlation coefficient between the covariate and the
residual vector. The algorithm is:
1. Standardize all the predictors.
2. Initialize the residuals, r = y−y¯ and for p = 1, ..., P coefficients, let β1, β2, ..., βP =
0.
3. Find the predictor, xj, that is most correlated with r as the predictor to be
updated, j = argmaxp |ρ(r, xp)|.
4. Update βj → βj + δj, where δj = × sign[ρ(r, xj)].
5. Update r → r − δjxj.
6. Repeat steps 3-5 until no predictor has any correlation with r.
 is some very small number, for example, 0.001. Although not specified in the
original publication, we also defined no correlation as the correlation between a
predictor and r is less than a certain threshold, for example, 0.2.
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GMIFS method for logistic regression
Hastie et al. (2007) further extended the IFS method to the logistic regression set-
ting, and called it the generalized monotone incremental forward stagewise algorithm
(GMIFS) [Hastie et al., 2007]. When the response is discrete, minimizing the residual
sum of squares is not reasonable. An alternative procedure was proposed to maximize
the log-likelihood incrementally. For a logistic regression model with log-likelihood
logL(β) =
n∑
i=1
(Yi log pii + (1− Yi) log(1− pii))
where pii =
exp(xTi β)
1+exp(xTi β)
, the algorithm estimates the LASSO solution following the
steps below:
1. Standardize the predictors then expand the covariate matrix X to X˜ = [X :
−X].
2. Initialize the components of βˆ
(s)
at step s=0 to be all 0.
3. Find the predictor xj that minimizes −δlogL/δβp at the current estimate βˆ(s),
j = argminp−δlogL/δβp.
4. Update βˆj
(s+1) → βˆj(s) + .
5. Repeat steps 2 - 4 many times.
In step 5, the original paper did not specify the number of times GMIFS needs
to be updated. We proposed to stop the algorithm when the difference between
two successive logL less than a small threshold, such as 0.0001. The reason for
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expanding the covariate matrix is to simplify computations by mitigating the need
for calculating the second derivative to find the direction of the update. Note because
the positive and negative versions of each covariate are present in the expanded
covariate matrix, the final coefficients are given by βˆp − βˆ2p. Hastie et al. (2007)
proved that the monotone LASSO coefficients β for the expanded covariate matrix
X˜ = [X : −X] and loss function logL(β) is the LASSO solution solved by quadratic
programming.
L1-regularization path algorithm for generalized linear models
Other than GMIFS, Park and Hastie (2007) also provided a penalized method for
generalized linear models, the L1-regularization path algorithm for generalized linear
models (glmpath) [Park and Hastie, 2007]. Their method selects variables based on
the amount of penalization of the L1-term and is less greedy than forward selection-
backward deletion. At any given penalization parameter λ, glmpath calculates the
exact solution for the coefficients and connects these coefficients in a piecewise linear
manner for solutions corresponding to other values of λ.
The algorithm first determines the λmax which penalizes all coefficients except
the intercept to be zero and then alternates between a predictor and a corrector step
as λ decreases by a pre-defined step length. Park and Hastie (2007) introduced the
concept of the “active” set where only selected variables on the iteration are con-
tained. For example, if λ = λmax, the active set only contains the intercept. They
also suggested to use a step length equal to the difference between λk and λk + 1
8
that will change the active set of variables (k stands for kth iteration).
To illustrate further, on the kth iteration, glmpath proceeds according to the
following steps:
1. Determine the step length, δk = λk+1 − λk
2. In the predictor step, linearly approximate the coefficient vector: βˆ
k+
= βˆ
k
+
δk
δβ
δλ
3. In the correction step, find the exact solution for the coefficient vector by mini-
mizing the likelihood of the generalized linear model, by minimizing the partial
likelihood and using βˆ
k+
as the initial value. The optimization is achieved by
using the coordinate descent algorithm.
4. Repeat the above steps until the active set cannot be augmented any further.
Park and Hasite (2007) also extended their method to the Cox proportional haz-
ard model. The main difference between the original glmpath and the glmpath
extended Cox proportional hazard model (Coxpath) is that the algorithm now esti-
mates coefficients by maximizing the partial likelihood of the Cox model.
1.2.2 Bayesian penalized methods
Tibshirani (1996) also suggested that LASSO estimates can be viewed as the modes of
the posterior distribution of β when β have independent and identically distributed
9
Laplace (e.g, double-exponential) priors [Tibshirani, 1996]. Inspired by this connec-
tion, several other authors have proposed using double-exponential (DE) priors to
fit a LASSO model from a Bayesian perspective [Hans, 2009, Lykou and Ntzoufras,
2013, Park and Casella, 2008].
Park and Casella (2008) compared their Bayesian LASSO to the ordinary LASSO
and Ridge regression using diabetes data studied by Efron et al. [2004]. The diabetes
data included 442 diabetes patients (n=442) and 10 baseline covariates (P=10): age,
sex, body mass index, average blood pressure, and six blood serum measurements.
The response was measured as a quantitative measure of disease progression one year
after baseline [Efron et al., 2004].
In their study, they considered a Laplace prior of the form
pi(β|σ2) =
P∏
j=1
λ
2
√
σ2
e−λ|βj |
√
σ2 (1.2)
and because the Laplace distribution can be expressed as a scale mixture of normals
α
2
e−α|z| =
∫ ∞
0
1√
2pis
e
−z2
2s
α2
2
e
−α2s
2 ds, α > 0
the hierarchical Bayesian LASSO model can be represented as
10
Yi|α,xi, σ2 ∼ N(α + xTi β, σ2),
β|σ2, τ 21 , τ 22 , ..., τ 2P ∼ NP (0P , σ2Dτ ),
Dτ = diag(τ
2
1 , ..., τ
2
P ),
σ2, τ 21 , ..., τ
2
P ∼ pi(σ2)dσ2
P∏
j=1
λ2
2
e−λ
2τ2j /2dτ 2j ,
σ2, τ 21 , ..., τ
2
P > 0.
where σ2 has a flat prior, pi(σ2) = 1
σ2
.
After performing Gibbs sampling, the final coefficients and their confidence levels
were estimated using the medians of posterior distributions and 95% credible inter-
vals. The regularization parameter λ was selected by marginal maximum likelihood
using a Monte Carlo Expectation Maximization (EM) algorithm as a complement to
the Gibbs sampler. The Monte Carlo EM algorithm estimates λ from the sample of
the previous iteration. Specifically, at iteration k,
λ(k) =
√
2P∑P
j=1 Eλ(k−1) [τ
2
j |y˜]
The initial value of λ is λ0 = P
√
σˆ2LS/
∑p
j=1 |βˆLSj |, where σˆ2LS and βˆLSj are the
least squares estimates for the variance and regression parameters. Although Park
and Casella (2008) considered a marginal maximum likelihood estimate for λ, they
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also mentioned that λ can be chosen by imposing a gamma prior on λ2 (not λ), where
pi(λ2) =
δr
Γ(r)
(λ2)r−1e−δλ
2
, λ2 > 0 (r > 0, δ > 0).
The prior density for λ2 should have a high probability near the maximum like-
lihood estimate. They further argued that although choosing an improper scale-
invariant prior for λ2 (e.g, r=0, δ = 0) is attractive, it will result in an improper
posterior. In their diabetes data example, they showed that a Gibbs sampler with
λ2 ∼ Gamma(1, 1.78) produced posterior medians for the regression coefficients iden-
tical to those when λ was selected by marginal maximum likelihood [Park and Casella,
2008]. Hans (2001) also considered selecting λ by assigning it an independent gamma
prior distribution, but rather than λ2, Hans (2001) suggested to impose a gamma
prior on λ [Hans, 2009].
In the end, Park and Casella (2008) plotted the LASSO, Bayesian LASSO, and
Ridge estimates against their respective L1 norm fraction ( ‖βˆ‖
max‖βˆ‖). They showed that
the Bayesian LASSO appeared to be a compromise between the ordinary LASSO and
ridge regression. Bayesian LASSO, like ridge estimates, had smoother paths, but the
shape was more like the LASSO path. Moreover, the Bayesian LASSO appeared to
be able to penalize weakly related parameters to 0 more quickly than ridge regres-
sion and the Bayesian posterior medians were very similar to the LASSO estimates
determined by cross-validation.
Lykou and Ntzoufras (2013) proposed a Bayesian LASSO that accomplishes both
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shrinkage and variable selection in the linear regression setting. To enable variable
selection, they utilized binary variable inclusion indicators introduced by George
and McCulloch (1993) and widely used thereafter by Kuo and Mallick (1998) and
Dellaportas et al. (2002). When Y is a dependent variable and X1, X2, ..., XP is the
set of potential predictors, binary variable selection is performed by introducing a
vector of binary variable inclusion indicators γ = (γ1, γ2, ..., γP ), and then model the
jth slope coefficient βj as having come from a mixture of two normal distributions,
where
βj|γj ∼ (1− γj)N(0, τ 2j ) + rjN(0, c2jτ 2j )
and
P (γj = 1) = 1− P (γj = 0) = pij.
George and McCulloch (1993) then set τ 2j to be a very small number and cj to be a
very large number so that when γj = 0, βj ∼ N(0, τ 2j ) is almost 0, and when γj = 1,
βj ∼ N(0, c2jτ 2i ) is estimated as a non-zero slope coefficient. In other words, γj = 1
indicates the jth parameter is included in the model while γj = 0 indicates that the
jth parameter is not included in the model. The method can then be processed using
Gibbs sampling. Those variables with higher probabilities, the variables that more
frequently appear in the Gibbs sample or with higher posterior inclusion probabil-
ity, are then selected. The binary variable inclusion indicator is especially useful
when the number of predictors is large, because most traditional variable selection
methods requires some comparison of model selection criteria (e.g. AIC, BIC or Cp)
for all 2p possible submodels, while this method can avoid calculating the posterior
13
probabilities of all 2p subsets [George and McCulloch, 1993].
Using a prior Bernoulli distribution of γj with hyperparameter pi (γj ∼ Bernoulli(pi)
for j = 1, 2, ..., P ), Lykou and Ntzoufras (2013) express their model as
Yi|α,β,xi, τ,γ ∼ N(α + xTi Dγβ, τ−1),
where Dγ = diag(γ1, ..., γP ),
β|τ ∼ DE(0, 1
τλ
),
γj ∼ Bernoulli(pij),
τ ∼ Gamma(c, d)
where τ = 1
σ2
is the precision of the regression model. The posterior mean of γj is
used to estimate the posterior inclusion probabilities of each covariate. Lykou and
Ntzoufras select a variable if its posterior inclusion probability is greater than 0.5
[Lykou and Ntzoufras, 2013].
1.3 Ordinal response models
In this section, four common ordinal response models are presented. This includes
the cumulative logit model, adjacent category model, forward and backward continu-
ation ratio models. Each model has its own unique characteristics and depending on
the data structure and model interpretation, particular models can perform better
than others. For example, the backward continuation ratio model is preferable when
14
interest lies in estimating the odds of more severe disease compared to less severe
disease, and the forward continuation ratio model is preferable when interest lies in
estimating the odds of having short survival time compared to longer survival time.
In addition to these four commonly used models, an overview of the stereotype logit
model, which can be used when the proportional odds assumption does not hold,
is provided. Moreover, at the end of this chapter, Bayesian inference for ordinal
response data is also briefly described.
For a dataset that contains n observations and P covariates, define Yi as the
response for the ith subject, where Yi can fall into one of K categories (k = 1, 2, ..., K).
Define αj to be a class-specific intercept for the j
th class and β to be the P × 1
coefficient vector associated with covariate vector xi. Let pij(xi) be the probability
that the ith response falls into the jth category. Using these notations, the different
ordinal response models are described in the following subsections.
1.3.1 Cumulative logit model
The cumulative logit model is probably the most frequently used ordinal response
model, expressed as
P (Yi ≤ j|xi) = exp(αj + x
T
i β)
1 + exp(αj + xTi β)
j = 1, ..., K − 1. (1.3)
Class-specific probabilities can be calculated by substracting successive cumulative
logits,
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pij(xi) = P (Yi ≤ j|xi)− P (Yi ≤ j − 1|xi).
Note that the model assumes the α to have a monotonic ordering constraint, −∞ =
α0 < α1 ≤ α2 ≤ ... ≤ αK−1 < αK =∞.
Although the logit link is probably the most popular link for the cumulative link
model, the probit link is also useful in many situations. For example, the probit link
is useful when the outcome is a survey response, because many assume that survey
outcomes will follow an underlying normal distribution [Agresti, 2010]. In chapter 2,
the extension of the GMIFS penalization method for probit link models is described
in detail.
1.3.2 Adjacent category model
The adjacent-category model models the pairs of adjacent categories, and has the
form
log
(
pij(xi)
pij+1(xi)
)
= αj + x
T
i β, j = 1, ..., K − 1. (1.4)
In addition, the adjacent-category model can be expressed as a baseline-category
logit model. For baseline category K, the model is
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log
pij
piK
= log(
pij
pij+1
) + log(
pij+1
pij+2
) + ...+ log(
piK−1
piK
)
= αj + x
T
i β + αj+1 + x
T
i β + ...+ αK−1 + x
T
i β
=
K−1∑
k=j
αk + (K − j)xTi β. (1.5)
1.3.3 Forward and backward continuation ratio models
The backward continuation ratio model using the logit link can be expressed as
logit(P (Y = j|Y ≤ j,x)) = log
(
P (Y = j|Y ≤ j,x)
P (Y < j|Y ≤ j,x)
)
= αj + x
T
i β (1.6)
where j = 2, ..., K. Then the conditional probabilities can be rewritten as
P (Y = j|Y ≤ j,x) = exp(αj + x
T
i β)
1 + exp(αj + xTi β)
.
Whereas the forward formulation models can be expressed as
logit(P (Y = j|Y ≥ j,x)) = log
(
P (Y = j|Y ≥ j,x)
P (Y < j|Y ≥ j,x)
)
= αj + x
T
i β (1.7)
where j = 1, ..., K − 1.
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1.3.4 Stereotype logit model
The cumulative logit, adjacent category, forward and backward continuation ratio
models all assume proportional odds (PO). In other words, covariates will have same
effect on the outcome, regardless of the level of the outcome. Unfortunately, this
assumption does not hold in many situations. For example, we tested the assumption
using a gene expression dataset assayed by Affymetrix HG-U133A GeneChips. The
data contains hippocampal gene expression of 9 control and 22 Alzheimer’s Disease
subjects of varying severity (7 incipient, 8 moderate, and 7 severe). The MAS5
method was used to obtain probe set expression summaries. individual gene probe
set values were treated as missing values if they were > standard deviation from the
group mean and any probe sets that were missing in all 31 samples were removed,
leaving 15,189 probe sets [Blalock et al., 2004]. Score tests indicated that the PO
assumption did not hold for approximately 10% of probe sets. By letting some or
all predictors have non-proportional odds, we can possibly improve the model fit
[Agresti, 2010]. Using a baseline adjacent categories model as an example, if we let
predictors have a different effect on each pair of adjacent categories, the model is
then called a baseline categories model and can be expressed as
log(
pij(xi)
piK(xi)
) = αj + x
T
i βj, j = 1, 2, ...K − 1 (1.8)
Note that this model contains K − 1 slope parameters for each predictor instead
of a single slope parameter in equation (1.4). If model contains too many parameters,
which is most often the case in the high-dimensional data analysis, the model can
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be very complicated.
The stereotype logit model is a compromise between the violation of proportional
odds assumption and model being too complicated. This model was proposed by
Anderson in 1984 [Anderson, 1984]. For baseline-category K , the stereotype logit
model is
log(
pij(xi)
piK(xi)
) = αj + φjx
T
i β, j = 1, ..., K − 1 (1.9)
where φ = (φ1, φ2, ..., φK−1) can be regarded as scores for the outcome categories.
Because the relationship between the linear components and the response is ordinal,
constraints are needed to make the model identifiable. Anderson (1984) recom-
mended the constraint 1 = φ1 ≥ φ2 ≥ ... ≥ φk = 0.
For logit j, the explanatory variable xk now has coefficients φjβk. That is, if
xk increases by 1 unit, the odds of response j instead of K are exp(φjβk) times
greater than the original odds. This model is more parsimonious than the baseline-
category logit model. When the ordinal model contains a large number of predictors
(P is large), this model contains K − 1 pairs of α and φ parameters and P slope
coefficients. This is less than the baseline-category model, which contains K − 1
intercepts, and (K − 1)P slopes [Agresti, 2010].
1.3.5 Bayesian ordinal regression model
Over the last few years, there has been increasing popularity of an alternative ap-
proach for analyzing ordinal response data, the Bayesian approach. Different from
the frequentist approach, the Bayesian approach includes probability distributions
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for parameters as well as for data. It assumes a prior distribution for the parameters
which may reflect our prior beliefs, and these priors are combined with the data likeli-
hood function to generate a posterior distribution for the parameters [Agresti, 2010].
However, in many situations, there is no closed-form expression for the posterior dis-
tribution of the ordinal model parameters. Fortunately, simulation methods can be
used to approximate the posterior distribution. One of these simulation methods is
the Markov Chain Monte Carlo (MCMC) method. MCMC is a stochastic process of
Markov chains designed so that its long-run stationary distribution is the posterior
distribution. Herein, the program Just Another Gibbs Sampler (JAGS) was used to
perform MCMC for the statistical analysis of the Bayesian hierarchical models.
In this section, a Bayesian cumulative logit model is presented as an example of
a Bayesian ordinal response model. It can be challenging to find a sensible prior
when the parameters relate to cumulative logit. One simple approach is taking the
prior distribution to be constant over all possible parameter values, in this way, the
posterior distribution is a constant multiple of the likelihood. In other words, the
posterior is a scaling of the likelihood so that it integrates to 1. The mode of the
posterior distribution is then the ML estimate [Agresti, 2010].
In the Bayesian cumulative logit model, Chipman and Hamada suggested to
use a multivariate normal prior distribution for the slope terms β and a truncated
multivariate normal distribution for the intercept terms α that enable ordering of
the α values [Chipman and Hamada, 1996]. If we assume independent covariates,
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the model can be represented as
P (Yi ≤ K|xi) = exp(αk + x
T
i β)
1 + exp(αk + xTi β)
piK(xi) = P (Yi ≤ K|xi)− P (Yi ≤ K − 1|xi)
Yi ∼ dcat(pi1, ..., piK)
α1 ∼ N(0, σ2a)
αj ∼ N(0, σ2a) αj ∈ (αj−1,∞) j = 2, ..., K − 1
βj ∼ N(0, σ2b ) (1.10)
where σ2a and σ
2
b are very large numbers so that the prior distribution is extremely
diffuse.
1.4 Penalized methods for ordinal response mod-
els
The first penalized ordinal response models were penalized continuation ratio models
estimated using the coordinate descent algorithm and implemented using glmpath
and glmnet [Archer and Williams, 2012]. These two methods have been made avail-
able in the R programming environment in the glmpathcr and glmnetcr Comprehen-
sive R Archive Network packages [Archer et al., 2014a]. Both methods benefit from
the reconstruction of the likelihood function for the continuation ratio model.
In these methods, we again define xi as a P × 1 covariate vector for individual
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i (i = 1, ..., n) and Yi as the ordinal response for the i
th individual that can take on
one of K ordinal levels. Yi can then be re-written as a response matrix containing n
rows and K columns where
yij =
 1 if observation i is class j0 otherwise. (1.11)
In this way, we can represent the likelihood for an ordinal response with K ordinal
levels as
L =
n∏
i=1
K∏
j=1
pij(xi)
yij (1.12)
and the log-likelihood as
logL =
n∑
i=1
K∑
j=1
yij log(pij(xi)) (1.13)
where pij(xi) is the probability that individual i with covariates xi falls into the
jth class. In terms of continuation ratio model, the conditional probability can be
modeled as
δij = δj(xi) = P (Y = j|Y ≤ j,xi) = exp(αj + x
T
i β)
1 + exp(αj + xTi β)
.
The likelihood is then the product of conditionally independent binomial terms,
L(β|y,x) =
n∏
i=1
K∏
j=2
δy
ij
ij (1− δij)
1−
K∑
k=j
yik
,
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such that the likelihood can be factored into K − 1 independent likelihoods, so that
maximization of the independent likelihoods will lead to an overall maximum likeli-
hood. Therefore, a penalized continuation ratio model can be estimated by passing
a restructured dataset to a penalized logistic regression function like glmpath or
glmnet. The resulting L1 penalized continuation ratio models were referred to as
glmpath.cr and glmnet.cr, respectively [Archer et al., 2014a, Archer and Williams,
2012].
Unfortunately, extending glmpath or glmnet to other types ordinal models, for
example, cumulative link, adjacent category, and the stereotype logit models is not
straightforward. As a result, we extend the GMIFS method to ordinal response
models [Archer et al., 2014b]. Specifically, this research details the extension of
the GMIFS method to probit link ordinal response models and the stereotype logit
model. Since the GMIFS algorithm for logit link models and adjacent category model
are similar to the extension to probit link and sterotype logit model, the GMIFS will
not be reviewed here in detail. In chapter 2, the GMIFS algorithm is described
thoroughly with examples when implementing probit link models and the stereotype
logit model.
Although the Bayesian LASSO has been implemented in the linear regression
setting, there is currently no penalized Bayesian ordinal response models. There-
fore, another goal of this dissertation is to implement Bayesian LASSO to ordinal
response models such as cumulative logit, cumulative probit, adjacent category, and
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continuation ratio models.
In the following chapters, our GMIFS extension to both the probit link ordinal
model and the stereotype logit model is reviewed (Chapter 2). In chapter 3, our im-
plementation of the Bayessian LASSO for modeling an ordinal response is described.
In chapter 4, filtering, which is another dimension reduction method (other than
penalization) is addressed, and we compare filtering, or univariate feature selection
methods, with penalization methods using grouped survival data. The last chapter
provides our conclusions and discussion.
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Chapter 2
Penalized Probit models and
Stereotype logit model
2.1 GMIFS ordinal response models
In this chapter, the GMIFS algorithm for three probit link models: cumulative probit
model, forward continuation-ratio model with probit link and backward continuation-
ratio model with probit link, as well as the stereotype logit model, are described. Al-
though GMIFS was originally proposed by Hastie for logistic regression [Hastie et al.,
2007], Archer et al. (2014) extended GMIFS algorithm to the ordinal response set-
ting and developed an R package, ordinalgmifs, to implement the algorithm [Archer
et al., 2014b]. In this section, the GMIFS algorithm for ordinal response model is
reviewed. In section 2.2, we detail the extension of the GMIFS method to probit
link models, specifically, the cumulative probit model, as well as the backward and
25
forward continuation ratio models with a probit link. The computational details nec-
essary for utilizing the GMIFS algorithm are also described. In section 2.3, GMIFS is
extended to the stereotype logit model. The ordinalgmifs package provides functions
that fits both penalized probit models and the stereotype logit model. The function
code is included in Appendix A.
Similar to glmnet.cr and glmpath.cr (section 1.4), the GMIFS algorithm for or-
dinal response models also requires the construction of an ordinal response variable,
Yi and its corresponding likelihood function (equation (1.12), equation (1.13)). The
likelihood and log-likelihood function differs based on the model as shown in next
two sections.
In general, most ordinal response models have K − 1 intercept terms α and P
slope terms, β. The α are essential for an ordinal model that assumes proportional
odds because slope terms, β do not have category specific effects. Therefore, α are
the only parameters that distinguish between the different ordinal levels. GMIFS
produces a series of solutions, each time selecting the slope coefficient which leads
to the maximum decrease in the negative likelihood and updating that slope coeffi-
cient by a small increment, . Then the algorithm calculates Maximum Likelihood
(ML) estimates of α based on the current slope coefficients using a quasi-Newton
or modified quasi-Newton optimization. This iterative process stops until the differ-
ence between two successive log-likelihoods is smaller than a pre-specified tolerance
τ , where a typical τ is 0.0001. Additionally, during each iteration, the AIC or BIC
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can be calculated, which enables model selection based on commonly used criteria.
For K ordinal classes and P predictors, the GMIFS algorithm is as follows:
1. Standardize the predictors then expand covariate matrix X to X˜ = [X : −X].
2. Initialize α based on the specific model being fit (see the following 2.2 and 2.3
sections).
3. Initialize the components of βˆ
(s)
at step s=0 to be all 0.
4. Find m = argminp(−δlogL/δβp) at the current estimate βˆs.
5. Update βˆ
s+1
m → βˆ
s
m + .
6. Consider βˆ
s+1
as fixed, update αs using the maximum likelihood method.
7. Repeat steps 4 - 6 until logL(s+1) − logL(s) < τ .
2.2 Penalized Probit models
For binary or ordinal data, regression models can use link functions other than the
logit, for example, the probit link. The term probit is short for “probability unit”
and was first introduced in the 1930’s by biologists to model data such as the per-
centage of a pest killed by pesticide [Bliss, 1934]. The probit function is the inverse
of the standard normal cumulative distribution function (CDF) denoted by Φ. The
standard normal CDF has similar shape to that of the symmetric S-shape of standard
27
logistic CDF, the difference lies in that the standard normal has a mean of 0 and
a standard deviation of 1, while standard logistic has a mean of 0 and a standard
deviation of pi√
3
≈ 1.81. Because of this similarity, a logistic model and a probit
model tends to fit similarly for the same data.
In section 2.2.1 and 2.2.2, the cumulative probit model and continuation ratio
models with probit link are presented, together with their log-likelihood, gradients,
and initial intercept estimates that are necessary for utilizing GMIFS algorithm. In
addition, an application of the penalized cumulative probit model was demonstrated
to predict depression level in women with breast cancer using methylation dataset
in section 2.2.3.
2.2.1 Cumulative probit model
The cumulative probit models K − 1 probits of the form.
P (Yi ≤ j|xi) = Φ(αj + xTi β) (2.1)
where Φ is the cumulative distribution function (CDF) of the standard normal
distribution, αj denotes the class-specific intercept, and β is a p× 1 vector of
coefficients associated with explanatory variables xi. Note that the class-specific
probabilities can be calculated by subtracting successive cumulative probabilities,
pij(xi) = P (Yi ≤ j|xi)− P (Yi ≤ j − 1|xi)
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Therefore, for any class j, we can express the class-specific probabilities by
pij(xi) = Φ(αj + x
T
i β)− Φ(αj−1 + xTi β)
Similar to the cumulative logit model (equation (1.3)), when we require α0 = −∞
and αK =∞, this expression simplifies to
pi1 = Φ(α1 + x
T
i β)
for j = 1 and
piK = 1− Φ(αK−1 + xTi β)
for j = K.
Therefore, the derivative of the reconstructed log-likelihood (equation (1.13)) with
respect to pth slope term βp is
∂ logL
∂βp
=
∂
n∑
i=1
(
yi1 log(pi1(xi)) +
K−1∑
j=2
yij log(pij(xi)) + yiK log(pik(xi))
)
∂βp
=
n∑
i=1
yi1
∂ log(pi1(xi))
∂βp
+
n∑
i=1
K−1∑
j=2
yij
∂ log(pij(xi))
∂βp
+
n∑
i=1
yiK
∂ log(piK(xi))
∂βp
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Let φ represent the probability density function of the standard normal distribution.
For j = 1,
∂ log(pi1(x))
∂βp
=
∂ log(Φ(α1 + x
Tβ))
∂βp
=
φ(α1 + x
Tβ)
Φ(α1 + xTβ)
xTp .
For j = 2, ..., K − 1,
∂ log(pij(x))
∂βp
=
φ(αj + x
Tβ)− φ(αj−1 + xTβ)
Φ(αj + xTβ)− Φ(αj−1 + xTβ)x
T
p .
For j = K,
∂ log(piK(x))
∂βp
=
−φ(αK−1 + xTβ)
1− Φ(αK−1 + xTβ)x
T
p .
Therefore, we have
∂logL
∂βp
=xTp
(φ(α1 + xTβ)y1
Φ(α1 + xTβ)
+
K−1∑
j=2
(φ(αj + x
Tβ)− φ(αj−1 + xTβ))yj
Φ(αj + xTβ)− Φ(αj−1 + xTβ)
− φ(αK−1 + x
Tβ)yK
1− Φ(αK−1 + xTβ)
) (2.2)
In the GMIFS algorithm, the α terms are initialized considering all slope terms
in equation 2.1 to be 0:
P (Yi ≤ j|xi) = Φ(αj)
αj = Φ
−1(
n∑
i=1
j∑
k=1
yik/n).
Subsequently, α is estimated with the MLE using quasi-Newton optimization
(BFGS method) after each β update. Because the class-specific probabilities are
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obtained by subtracting successive cumulative probabilities, we require
α1 ≤ α2 ≤ ... ≤ αK−1. In the GMIFS extended cumulative probit model, the
solution of the constrained optimization is solved by using an adaptive barrier
method. The adaptive barrier method minimizes the twice continuously
differentiable function logL subject to the linear inequality constraints Aθ − b ≥ 0,
where A is a K − 1 by K matrix,
A =
1 2 3 . . . K − 1 K

−1 1 0 . . . 0 0 1
0 −1 1 . . . 0 0 2
...
...
...
. . .
...
...
...
0 0 0 . . . −1 1 K − 1
,
θ = [α1, α2, α3, ..., αK−1], and b = 0K−1×1. We carried out the constrained
optimization using the package constrOptim in the R programming environment.
Since the derivative of log-likelihood function with respect to α is necessary for
optimization, we derive the partial derivative as described below.
For j = 1,
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∂ logL
∂α1
=
n∑
i=1
(yi1
∂ log(pi1(xi))
∂α1
+ yi2
∂ log(pi2(xi))
∂α2
)
=
n∑
i=1
(
yi1
∂ log Φ(α1 + x
T
i β)
∂α1
− yi2∂ log(Φ(α2 + x
T
i β)− Φ(α1 + xTi β))
∂α2
)
=
n∑
i=1
(
yi1
φ(α1 + x
T
i β)
Φ(α1 + xTi β)
−
yi2
φ(α1 + x
T
i β)
Φ(α2 + xTi β)− Φ(α1 + xTi β)
)
. (2.3)
For j = 2, ..., K − 2,
∂ logL
∂αj
=
n∑
i=1
(yij
∂ log(pij(xi))
∂αj
+ yi(j+1)
∂ log(pij+1(xi))
∂αj
)
=
n∑
i=1
(
yij
φ(αj + x
T
i β)
Φ(αj + xTi β)− Φ(αj−1 + xTi β)
− yi(j+1) φ(αj + x
T
i β)
Φ(αj+1 + xTi β)− Φ(αj + xTi β)
)
. (2.4)
For j = K − 1,
∂ logL
∂αK−1
=
n∑
i=1
(
yi(K−1)
∂ log(piK−1(xi))
∂αK−1
+ yiK
∂ log(piK(xi))
∂αK−1
)
=
n∑
i=1
(yi(K−1)
φ(αK−1 + xTi β)
Φ(αK−1 + xTi β)− Φ(αK−2 + xTi β)
− yiK φ(αK−1 + x
T
i β)
1− Φ(αK−1 + xTi β)
)
. (2.5)
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The code for fitting GMIFS cumulative probit models appears in Appendix A.1.
2.2.2 Continuation ratio models with probit link
Backward continuation ratio model
The backward continuation ratio model with the probit link is similar to the backward
continuation ratio model with the logit link. It models the probit of the j = 2, .., K
conditional probabilities or
Φ−1(P (Yi = j|Yi ≤ j,xi)) = αj + xTi β. (2.6)
The backward formulation can be used when the response variable represents
disease states from none, mild, moderate, and severe and interest is in estimating
the odds of more severe disease compared to less severe disease. Let δij represent
the conditional probabilities,
δij = δj(xi) = P (Yi = j|Yi ≤ j,xi) = Φ(αj + xTi β)
such that for K ordinal classes, there are K − 1 probits. The likelihood can be
expressed using these j = 2, ..., K conditionally independent probabilities:
L(β|Y ,X) =
n∏
i=1
K∏
j=2
δ
yij
ij (1− δij)
1−
K∑
k=j
yik
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which can be seen as the product of K−1 binomial likelihoods. Using this expression,
the log-likelihood is
logL =
n∑
i=1
K∑
j=2
(
yij log(δij) + (1−
K∑
k=j
yik) log(1− δij)
)
Then, the derivative of the log-likelihood with respect to βp for the backward con-
tinuation ratio is given by
∂ logL
∂βp
=
n∑
i=1
K∑
j=2
yij
δij
∂δij
∂βp
+
K∑
k=j
yik − 1
1− δij
∂δij
∂βp
=
K∑
j=2
n∑
i=1
xip
(
yij
φ(αj + x
T
i β)
Φ(αj + xTi β)
+ (
K∑
k=j
yik − 1) φ(αj + x
T
i β)
1− Φ(αj + xTi β)
)
which can be rewritten as the matrix form
∂logL
∂βp
=
K∑
j=2
xTp
(
yj
φ(αj + x
Tβ)
Φ(αj + x
Tβ)
+ (
K∑
k=j
yk − 1)
φ(αj + x
Tβ)
1− Φ(αj + xTβ)
)
. (2.7)
In the GMIFS algorithm, the α terms are initialized considering all slope terms in
equation 2.6 to be 0, where
P (Yi = j|Yi ≤ j,xi) = Φ(αj), such that
αj = Φ
−1(
n∑
i=1
yij
n∑
i=1
j∑
k=1
yik
).
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Forward continuation ratio model
The forward continuation ratio model with the probit link models the probit of the
j = 1, .., K − 1 conditional probabilities or
Φ−1(P (Yi = j|Yi ≥ j,xi)) = αj + xTi β (2.8)
Here we have used the forward formulation, which can be used when the response
variable is grouped survival time, and the goal is to estimate the odds of shorter
survival time compared to longer survival time. As with the backward continuation
ratio model, the likelihood and log-likelihood for the forward continuation ratio model
can be expressed using the K − 1 conditionally independent probabilities,
L(β|Y ,X) =
n∏
i=1
K−1∏
j=1
δijij (1− δij)
K∑
k=j
yik−yij
logL =
n∑
i=1
k−1∑
j=1
yij log(δij) + (
K∑
k=j
yik − yij) log(1− δij)
The partial derivative of the log-likelihood with respect to βp for the forward
continuation ratio model with probit link is given by,
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∂logL
∂βp
=
n∑
i=1
K−1∑
j=1
yij
δij
∂δij
∂βp
+
(yij −
K∑
k=j
yik)
1− δij
∂δij
∂βp
=
K−1∑
j=1
n∑
i=1
xip
(
yij
φ(αj + x
T
i β)
Φ(αj + xTi β)
+ (yij −
K∑
k=j
yik)
φ(αj + x
T
i β)
1− Φ(αj + xTi β)
)
=
K−1∑
j=1
xTp
(
yj
φ(αj + x
Tβ)
Φ(αj + x
Tβ)
+ (yj −
K∑
k=j
yk)
φ(αj + x
Tβ)
1− Φ(αj + xTβ)
)
(2.9)
In the GMIFS algorithm, the α terms are initialized considering all slope terms in
equation 2.8 to be 0, where P (Yi = j|Yi ≥ j,xi) = Φ(αj)
P (Yi = j|Yi ≥ j,xi) = Φ(αj), such that
αj = Φ
−1(
n∑
i=1
yij
n∑
i=1
K∑
k=j
yik
).
The code that fits the penalized continuation ratio models using the probit link
appears in the Appendix A.2.
2.2.3 Example using cumulative probit model
Breast cancer (BC) is the second most common cancer among women. Research
shows that many women with BC experience anxiety, depression, and stress (ADS).
A potential mechanism for the development of ADS is epigenetics, such as methyla-
tion [Zhou et al., 2015]. In this example, we demonstrate the application of our pe-
nalized cumulative probit model to predict severity of psychoneurological symptoms,
specifically, ADS levels, using a methylation data assayed using the Illumina Human
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Methylation 450K assay. The original dataset contains ADS scales and methylation
levels on 485,512 CpG sites. The β-values were defined as the proportion methy-
lated, and CpG sites with all β-values over 0.9 or below 0.1 were filtered out [Zhou
et al., 2015]. For each CpG site, β values were plotted against GC content across all
subjects. Based on the results, CpG sites with a GC content greater than 40% were
also filtered out, left 285,173 CpG sites [Zhou et al., 2015].
Severity of depression and anxiety was measured using the Hospital Anxiety and
Depression Scale (HADS), which is a 14-item questionnaire [Zigmond and Snaith,
1983]. Among the 14-items, 7 assess anxiety and 7 assess depression. Each item is on
a four level ordinal scale, the scale response is calculated such that the ordinal levels
contribute 0-3 points, and the seven items within each scale are summed. Using these
sums, subjects are classified into three ordinal levels: normal (score < 8), borderline
(8− 10), or having clinical anxiety or depression (score > 10) [Lambert et al., 2013].
Stress was measured using the 10-item Perceived Stress Scale (PSS). Ten scores were
summed, with higher total scores of PSS indicating higher overall stress [Cohen and
Williamson, 1988]. Subjects were categorized into four quantiles, where the category
1 has lowest stress, and the category four has highest stress. Based on described cat-
egorization, our ordinal response variables are three ADS categories, where anxiety
has three levels: normal (n=30), borderline (n=25), and anxiety (n=18); depression
has three levels: normal (n=66), borderline (n=4), and depression (n=3); and stress
has four levels: I (n=19), II (n=18), III (n=18), and IV (n=18).
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Since ADS categories are based on survey scores, assumed to have underlying
normal distributions, we used the cumulative probit model to fit the data. Separate
cumulative probit models were fit for each ADS scales (anxiety, depression and stress)
using the ordinal.gmifs function in the ordinalgmifs library. The increment,  for
each update step was set to be 0.01, and all covariates were standardized to reduce
correlations between covariates.
When fitting separate models for each ADS category based on the minimum AIC,
among 285,173 CpG sites, 67 CpG sites were significantly associated with anxiety;
19 CpG sites were significantly associated with depression; and 10 CpG sites were
significantly associated with stress. Significant CpG sites for each ADS scales are
listed in Appendix A.3. We also examined the prediction accuracy of each ADS
model by assessing misclassification rate. Anxiety and depression models have no
misclassifications; however it may be due to the model overfitting (the number of
significant covariates in anxiety and depression models = 67 and 19, respectively).
The stress model had a misclassification rate of 0.34.
To avoid the problem of overfitting, we also examined models attaining the min-
imum BIC. The anxiety model based the minimum BIC only selected 1 significant
CpG site, and is not adequate to predict the response. The depression model based
on the minimum BIC selected seven significant CpG sites and the corresponding mis-
classification rate was 0.10. Stress models based on the the minimum BIC selected
10 significant CpG sites, and the misclassification rate was 0.34. All these significant
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CpG sites are also listed in Appendix A.3. In conclusion, both AIC and BIC selected
anxiety models did not have good prediction accuracy. The BIC selected depression
and stress models have similar prediction accuracy compared to their correspond-
ing AIC models but are more parsimonious. However, misclassfication rates were
estimated using the training dataset, and therefore, are not good indicators for fu-
ture performance. A better approach would be to estimate generalization error (i.e.,
cross-validation error). Since the penalized cumulative probit model took long time
to converge due to the high-dimensionality (P = 285, 173), in the future, we plan to
implement parallel processing to speed up our cross-validation computations. The
code for performing this example appears in Appendix A.1.
2.3 Penalized stereotype logit model
The GMIFS procedure was also extended to the stereotype logit model described in
Chapter 1 (equation (1.9)). The GMIFS procedure for the stereotype logit model
and for probit-link models are similar except that the algorithm for the stereotype
logit model updates not only α but also φ during each iteration.
From the definition of the stereotype logit model (equation 1.6), we can rewrite
the formula in terms of response probabilities:
pij(xi) =
exp(αj + φjx
T
i β)
K∑
k=1
exp(αk + φkxTi β)
(2.10)
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where the intercept terms α and scale parameters φ are both constrained as:
α1 ≤ α2 ≤ ... ≤ αK − 1 ≤ αK
and
φ1 ≥ φ2 ≥ ... ≥ φK
For convenience, we define αK = 0 and φK = 0. Then, the expression simplifies
to
piK(xi) =
exp(0)
K∑
k=1
exp(αk + φkxTi β)
=
1
K−1∑
j=1
exp(αj + φjxTi β)
(2.11)
when j = K.
Again, the GMIFS algorithm requires the log-likelihood for the model and the
partial derivative with respect to βp to find the solution numerically. Based on
equation (1.13), the log-likelihood of the model can be rewritten as a summation of
individual log-likelihoods
logL =
n∑
i=1
(K−1∑
j=1
yij log(pij(xi)) + yiK log(piK(xi))
)
. (2.12)
The first derivative of the log-likelihood with respect to βp is given by
∂logL
∂βp
=
n∑
i=1
(K−1∑
j=1
yij
∂ log(pij(xi
)
)
∂βp
+
n∑
i=1
yiK
∂ log(piK(xi))
∂βp
)
(2.13)
given the simplification from equation (2.11). For j = K, we have
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∂ log(piK(xi
)
)
∂βp
=
∂(log(1)− log(1 +
K−1∑
j=1
exp(αj + φjx
T
i β)))
∂βp
= −xip
K−1∑
j=1
φj exp(αj + φjx
T
i β)
1 +
K−1∑
j=1
exp(αj + φjxTi β)
.
and because of the equation 2.10, for j = 1, ..., K − 1, we have
∂ log(pij(xi
)
)
∂βp
=
αj + φjx
T
i β − log(1 +
K−1∑
j=1
exp(αj + φjx
T
i β)
∂βp
= φjxip −
K−1∑
j=1
φj exp(αj + φjx
T
i β)
1 +
K−1∑
j=1
exp(αj + φjxTi β)
xip
= xip
(
φj −
K−1∑
j=1
φj exp(αj + φjx
T
i β)
1 +
K−1∑
j=1
exp(αj + φjxTi β)
)
.
Substituting the above two equations back into equation 2.13, we have
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∂logL
∂βp
=
n∑
i=1
xip
(
K−1∑
j=1
yij
(
φj −
K−1∑
j=1
φj exp(αj + φjx
T
i β)
1 +
K−1∑
j=1
exp(αj + φjxTi β)
)
− yiK
K−1∑
j=1
exp(αj + φjx
T
i β)
1 +
K−1∑
j=1
exp(αj + φjxTi β)
)
, (2.14)
which can be further rewritten as
∂logL
∂βp
= xTp
(
K−1∑
j=1
yj
(
φj −
K−1∑
j=1
φj exp(αj + φjx
T
i β)
1 +
K−1∑
j=1
exp(αj + φjxTi β)
)
− yK
log(1 +
K−1∑
j=1
exp(αj + φjx
T
i β))
1 + log(1 +
K−1∑
j=1
exp(αj + φjxTi β))
)
. (2.15)
For K ordinal classes and P predictors, the GMIFS algorithm for the stereotype
logit model is
1. Standardize the predictors then expand the covariate matrix X to X˜ = [X :
−X].
2. Initialize α and φ.
3. Initialize the components of βˆ
(s)
at step s=0 to be all 0.
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4. Find m = argminp(−∂logL/∂βp) at the current estimate βˆs.
5. Update βˆ
s+1
m → βˆ
s
m + .
6. Consider βˆ
s+1
as fixed, update αs and φ using maximum likelihood method.
7. Repeat steps 4 - 6 until logL(s+1) − logL(s) < τ .
The α terms are initialized considering all slope terms in equation 1.9 to be 0, or
log(
pij(xi)
piK(xi)
) = Φ(αj),
such that,
αj = log(
n∑
i=1
yij
n∑
i=1
yiK
).
while φ are initialized as φ1 = 1, φ2, ..., φK−1 = 0.1 [Agresti, 2010]. The constraints
on α and φ were insured by box-constraints.
2.3.1 Example of penalized stereotype logit model
Alzheimer’s disease (AD) has been intensely studied during the last 10 years. Ge-
nomic microarray provides new tools in understanding the underlying pathological
mechanism in AD. In this section, we illustrate the utility of the steretype logit
model using a high-throughput genomic dataset. The goal is to predict the sever-
ity of Alzheimer’s disease (AD) using microarray gene expression data assayed by
Affymetrix HG-U133A GeneChips. The full dataset, GSE1297 was downloaded from
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Gene Expression Omnibus [Blalock et al., 2004]. A total of 35 subjects were cat-
egorized into four groups based on the MiniMental Status Examination (MMSE)
criteria: control AD (MMSE > 25), incipient AD (MMSE 20 − 26), moderate AD
(MMSE 14 − 19) and severe AD (MMSE < 14). Four subjects with MMSE < 20
were removed from the study because they were potentially affected by confounding
conditions. The remain 31 subjects fell in the four levels of AD: control (n = 9),
incipient (n = 7), moderate (n = 8) and severe (n = 7). After microarray pre-
processing, probe set level data was summarized using the MAS5 method. Control
probes sets and probe sets absent in all 31 samples were removed, leaving 15,189
probe sets.
Before performing the analysis, we tested the proportional odds assumption using
a score test in a univariate ordered logistic model for each probe set. Since the test
indicated that 9.6% of the probe sets do not have the same slope coefficient across all
levels of the response, modeling the data using the penalized stereotype logit model
is a reasonable approach.
After fitting the GMIFS stereotype logit model, with  = 0.001, the penalized
stereotype logit model selected by the minimum AIC only select three predictors:
203643 at, 206278 at and 212122 at and the misclassification rate was 45%.
The code for fitting GMIFS stereotype logit models and performing Alzheimer’s
disease example appears in Appendix A.4.
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Chapter 3
Penalized Bayesian Cumulative
logit model
Park and Casella (2008) proposed their Bayesian LASSO for linear regression using a
double exponential prior (equation (1.2)). The hyperparameter λ in the density func-
tion of the double exponential prior determines the total amount of shrinkage and
can be selected in several ways. Park and Casella [Park and Casella, 2008], together
with other authors [Hans, 2009, Lykou and Ntzoufras, 2013], considered selecting λ
by assigning it to an independent gamma prior distribution. The shrinkage property
of the LASSO make it a popular variable selection method under the frequentist
framework. Under the Bayesian framework, Park and Casella suggested that the
Bayesian credible intervals could be used to guide variable selection; however, Lykou
and Ntzoufra (2013) argued that the selection based on posterior credible intervals
depends both on the selection of the posterior probability attached to such inter-
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vals and the way that they are constructed, and does not take into account model
uncertainty. Lykou and Ntzoufra (2008) then proposed to use the binary inclusion
indicators method for feature selection [Dellaportas et al., 2002, George and McCul-
loch, 1993, Kuo and Mallick, 1998].
Motivated by these previous developments with respect to the Bayesian LASSO,
here we aimed to extend the Bayesian LASSO to an ordinal regression model, specif-
ically, the cumulative logit model. We present a method for choosing λ by giving
it a hyperprior, and utilize the binary variable inclusion indicator to perform fea-
ture selection. Our method for implementing the Bayesian LASSO cumulative logit
model is described in section 3.1. In sections 3.2 and 3.3, the utility of our method is
illustrated using both simulated data and a high-throughput genomic dataset. In our
simulation study, we compare our penalized ordinal Bayesian model using different
priors to a penalized cumulative logit model using a frequentist approach (gener-
alized monotone incremental forward stage-wise method) in term of their abilities
to predict the ordinal response and to correctly incorporate true predictors from
noise predictors into the model. We will also demonstrate application of our method
to predict stage of liver disease (normal, cirrhotic but without hepatocellular car-
cinoma, hepatocellular carcinoma) using methylation data assayed by the Illumina
GoldenGate Methylation BeadArray Cancer Panel I.
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3.1 Penalized Bayesian LASSO cumulative logit
model
3.1.1 Bayesian cumulative logit model
Let Yi represent the ordinal response for subject i where Yi can fall into one of K
categories (k = 1, 2, ...K). Let xi denote a P × 1 covariate vector for subject i.
Let α1, ..., αK−1 represent the K − 1 intercept terms in the cumulative logit model
where α1 ≤ α2 ≤ ... ≤ αK−1. Let pik(xi) represent the probability that subject i falls
into the kth category. The non-penalized, Bayesian cumulative logit model can be
expressed as
P (Yi ≤ k|xi) = exp(αk + x
T
i β)
1 + exp(αk + xTi β)
pik(xi) = P (Yi ≤ k|xi)− P (Yi ≤ k − 1|xi)
Yi ∼ Cat(pi1, ..., piK)
α1 ∼ N(0, 1000)
αk ∼ N(0, 1000) αk ∈ (αk−1,∞) for k = 2, ..., K − 1
βj ∼ N(0, 1000) for j = 1, ..., P (3.1)
Here, the response variable Yi follows a categorical distribution, which contains a
vector of parameters where each of the K parameters represent the probability an
outcome falls into that response category. The probability mass function (PMF) for
the categorical distribution is P (Yi = i) = pii. To respect the ordering constraint of
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the intercepts, we used a truncated normal prior distribution for α, where the kth
intercept αk will have a lower boundary αk−1. To reflect a lack of prior information,
the intercepts have a mean of 0 and a large, diffuse standard deviation of 1000. We
have a similar prior setting for slope coefficients, where the jth slope βj (j = 1, 2, ...P )
has a normal prior with a mean of 0, and a standard deviation of 1000. Since both
intercepts and slopes have non-informative priors, theoretically, we would expect the
mode/mean/median of the posterior distribution to be similar to the ML estimates.
Other than assuming the normal distribution for the K − 1 intercepts, we could also
use a gamma distribution for the difference between two adjacent intercepts.
3.1.2 Bayesian LASSO cumulative logit model
In this section, we modify Equation 3.1 to construct our penalized Bayesian cu-
mulative logit model. Inspired by Park and Casella’s Bayesian LASSO for linear
regression, here we impose shrinkage by giving a double exponential prior to each of
the slope coefficients βj (j = 1, 2, ...P ):
pi(βj|σ2) = λ
2τ
e−λτ
−1|βj |,
where λ controls the amount of shrinkage and τ is the standard deviation of the
response variable. In our method, the prior for τ is taken to be relatively diffuse,
non-informative gamma distribution with a shape of 0.001, and a scale of 0.001.
There are many ways to select λ, here we chose λ by giving it a gamma hyperprior,
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λ ∼ Gamma(a, b) with a mean a/b and a variance a/b2. Although it is attractive to
assign a and b small values so the prior is non-informative, in reality, λ cannot be
too large or too small. Lykou and Ntzoufra (2013) argued that a large λ can force
the posterior distributions of the coefficients to be close to 0; therefore, the data (in
comparison to the prior) are not strong enough to provide evidence for a significant
coefficient. They further argued that when the λ is too small, the posterior coefficient
shrinks back to zero instead of the MLE estimates due the Lindley-Barlett paradox
(Lindley-Barlett paradox states that small values of λ lead to posterior model odds
that fully support the most parsimonious model which shrink coefficients to zero)
[Lykou and Ntzoufras, 2013]. Therefore, as a reasonable start, we assign λ with a
Gamma(1, 1) prior distribution. The sensitivity analysis will be conducted in the
second simulation study in section 3.2, where we compare models with different λ
priors in term of their feature selection accuracy.
Although Tibshirani suggested that LASSO estimates can be interpreted as pos-
terior mode estimates when the regression parameters have independent and iden-
tical Laplace priors [Tibshirani, 1996], under the Bayesian framework, we often use
the posterior means and medians as points estimates. Since the Bayesian posterior
mean/medians lose the ability to shrink coefficients to exactly zero as the frequen-
tist LASSO estimates or the posterior modes, we then utilize the binary variable
inclusion indicator method first proposed by George and McCulloch [George and
McCulloch, 1993] to enable feature selection. Specifically, for every βj, we introduce
a Bernoulli indicator γj, where γj = 1 indicates the j
th covariate is selected into the
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model and γj = 0 otherwise. George and McCulloch (1993) suggested a Bernoulli
prior distribution for γj with success probability of 0.5 (psucc = 0.5). This can be in-
terpreted as one half of the features will be selected into the model without knowing
any data and therefore, can be considered as a non-informative prior. Combining βj
and γj together, now our slope coefficient will be denoted as β
(γ)
j = βjγj for the j
th
covariate. Similar to equation (3.1), the intercept terms α in the penalized Bayesian
logit cumulative model follow truncated normal distributions. For a non-informative
prior, the normal distribution can have a very large standard deviation, for example,
1000. Additionally, since it would be strange for an ordinal class to have less than
0.1% of the observations, we further assume the α terms follow a truncated normal
with a lower bound of logit(0.001) = −6.9 and upper bound of logit(0.999) = 6.9.
This alleviates obtaining really wildly large values for α terms, speeds up the MCMC
convergence, but is still non-informative.
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Our penalized Bayesian cumulative logit model is
P (Yi ≤ k|xi) = exp(αk + x
T
i β
(γ))
1 + exp(αk + xTi β
(γ))
pik(xi) = P (Yi ≤ k|xi)− P (Yi ≤ k − 1|xi)
Yi ∼ Cat(pi1, ..., piK)
α1 ∼ N(0, 1000) α1 ∈ (−6.9, 6.9)
αk ∼ N(0, 1000) αk ∈ (αk−1, 6.9) for k = 2, ..., K − 1
β(γ) = (β
(γ)
1 , β
(γ)
2 , ..., β
(γ)
P )
β
(γ)
j = γjβj
For j = 1, 2, ..., P., βj ∼ DE(0, 1
τλ
)
γj ∼ Bernoulli(psucc)
λ ∼ Gamma(a, b)
τ ∼ Gamma(0.001, 0.001). (3.2)
Although we have used non-informative truncated normal priors for intercept
terms, α, we could also consider more informative priors. Agresti (2010) stated
that when there are many parameters, the posterior mode need not then necessarily
be close to the ML estimate, and Markov chains may converge slowly. Therefore,
it is usually more sensible to construct a prior distribution that represents careful
expression of our prior beliefs about the parameter values. For example, instead of
using a very large standard deviation for a normal prior distribution, use a mean and
standard deviation such that the range within three standard deviations of the mean
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contains all plausible values the parameter could take[Agresti, 2010]. In our penalized
Bayesian cumulative logit model, we can also assign α with more informative priors,
where
α1 ∼ N(a0,1, 1000) α1 ∈ (−6.9, 6.9)
αk − αk−1 ∼ Gamma(a0,k − a0,k−1, 1) for k = 2, ..., K. (3.3)
a0,1, a0,k, and a0,k−1 can be any reasonable numbers for means of the intercepts. For
example, they can be initial values for the 1st, kth and (k − 1)th intercepts, respec-
tively, in the GMIFS method. In the GMIFS method, we set the initial values of the
intercepts to aj = logit(
∑n
i=1
∑j
k=1 yik/n), for the cumulative logit model, which is
equivalent to the intercepts in a null cumulative logit model. These priors reflect a
belief that the sizes of the effects are not extremely strong and the difference between
two adjacent intercepts has a mean of a0,k − a0,k−1, and a variance of a0,k − a0,k−1.
We compare our penalized Bayesian cumulative logit model using both informative
priors (equation 3.3) and non-informative priors (equation 3.2) to a penalized cumu-
lative logit model using our GMIFS method in terms of their ability to accurately
select features in simulation study II, section 3.3.
Due to the complexity of double exponential priors, it is less straightforward to
find the closed-form expression for the posterior distribution [Lykou and Ntzoufras,
2013]. Therefore, we approximate the posterior distribution using Markov Chain
Monte Carlo (MCMC), specifically, Gibbs sampling. Gibbs sampling was carried
52
out using the R package R2jags. After Gibbs sampling, the slope coefficients were
estimated using the posterior means of β(r), and the intercepts were estimated using
the posterior means of α. The posterior means of γ can be interpreted as the poste-
rior inclusion probabilities. The covariates with high posterior inclusion probabilities
will then be selected and the ones with low or zero posterior inclusion probabilities
can be ignored. In the simulation study of Kykou and Ntzoufras (2013), Kykou and
Ntzoufras selected important predictors as those for which the posterior inclusion
probabilities were greater than 0.5. However, in a real genomic data set the sample
size is often quite small compared to the number of predictors, such that there may
be no high posterior means of γ [George and McCulloch, 1993].
The MCMC convergence will be confirmed visually via traceplot when the number
of parameters is small and examined statistically by the Gelman-Rubin test. The
Gelman-Rubin test calculates within-chain and between-chain variance, and then
estimates the variance of the parameter as a weighted sum of the within-chain and
between-chain variance. After that, it calculates the potential scale reduction factor
Rˆ, which indicates non-convergence when Rˆ is greater than 1.1. To illustrate the
test with formulas, suppose we have m parallel chains (m ≥ 2) and each chain has a
length n. sij is the parameter of interest at the i
th iteration for the jth chain. Then
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Rˆ can be calculated using the following equations:
B =
n
m
m∑
j=1
(s¯.j − s¯..)2
where, s¯.j =
1
n
n∑
i=1
sij and s¯.. =
1
m
s¯.j
W =
1
m
m∑
j=1
s2j where, s
2
j =
1
n− 1
n∑
i=1
(sij − s¯.j)2
ˆvar+ =
n− 1
n
W +
1
n
B
Rˆ =
√
ˆvar+/W
In our method, we used three Markov chains, and we considered MCMC to have
converged when Rˆ ≤ 1.1.
3.1.3 Prediction
In Bayesian analysis, predictions of future observations are based on the posterior
predictive distributions. When future observations are Y˜ , and the posterior distri-
bution for the modeling parameters θ is pi(θ|Y ), the posterior predictive distribution
is
f(Y˜ ) =
∫
f(Y˜ |θ)pi(θ|Y )δθ.
A merit of Bayesian analysis using MCMC is that future observations Y˜ can be
viewed as additional parameters under estimation, and therefore, estimated directly
from an MCMC sampler. In fact, to predict ordinal responses using the same data
used for training the model, one can simply generate replicated responses, Y rep = Y˜
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from the posterior predictive distribution by adding a single step within any MCMC
sampler using the likelihood function f(Y rep|θ(t)) evaluated at parameter values θ(t)
of the current stage of the algorithm [Ntzoufras, 2008]. In our penalized Bayesian
model, we can generate the predicted values by adding the below step
Y repi ∼ Cat(pi1, ..., piK).
If we want to generate a predicted response Yn+1 from a vector of new data xn+1,
then the below steps can be added to a cumulative logit model.
P (Yn+1 ≤ k|xn+1) = exp(αk + x
T
n+1β)
1 + exp(αk + xTn+1β)
pik(xn+1) = P (Yi ≤ k|xn+1)− P (Yi ≤ k − 1|xn+1)
Yn+1 ∼ Cat(pi1, ..., piK)
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Thus, a penalized Bayesian cumulative logit model with prediction embedded is
P (Yi ≤ k|xi) = exp(αk + x
T
i β)
1 + exp(αk + xTi β)
pik(xi) = P (Yi ≤ k|xi)− P (Yi ≤ k − 1|xi)
Yi ∼ Cat(pi1, ..., piK)
α1 ∼ N(0, 1000)
αk ∼ trunN (0, 1000) αk ∈ (αk−1,∞) for k = 2, ..., K − 1
βj ∼ DE(0, 1
τλ
) for j = 1, ..., P
τ ∼ Gamma(a, b)
λ ∼ Gamma(0.001, 0.001)
P (Yn+1 ≤ k|xn+1) = exp(αk + x
T
n+1β)
1 + exp(αk + xTn+1β)
pik(xn+1) = P (Yi ≤ k|xn+1)− P (Yi ≤ k − 1|xn+1)
Yn+1 ∼ Cat(pi1, ..., piK). (3.4)
Note that the above model uses non-informative prior distributions for the α terms,
though they can be changed to informative priors to speed up the MCMC process. In
addition, when the number of covariates is relatively small, β can be assigned diffuse
normal priors. In this way, we will have a non-penalized regular cumulative logit
model for prediction. In section 3.3, we demonstrate how our method can be used
to predict stage of liver disease using features from a high-throughput methylation
array.
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3.2 Simulation Study
In this section, we present results from two simulation studies. In subsection 3.2.1,
we demonstrate our Bayesian cumulative logit model using a simulated non-high
dimensional dataset. The estimated coefficients will be compared to a penalized
cumulative logit model using a frequentist approach (GMIFS) and a non-penalized
cumulative logit model. In subsection 3.2.2, we compare our penalized Bayesian
cumulative logit model using different priors to GMIFS in terms of their abilities
to predict the ordinal response and to correctly incorporate true predictors from
noise predictors into the model when feature space is high-dimensional. The code for
performing these two simulation studies appears in Appendix B.1. The model files
that are necessary for running JAGS appear in Appendix B.3.
3.2.1 Simulation study I
The main objective of this simulation study is to illustrate our method and compare it
to existing methods. Ordinal responses were simulated according to the cumulative
logit model. Five covariates (P = 5) were generated from independent standard
normal distributions. We then generated a three level ordinal response variable
(K = 3) for 200 individuals (n = 200). The values for the α terms and β terms
were chosen by trial and error to ensure approximately equal outcome frequencies in
the individual categories. The simulation was performed according to the following
steps:
1. Randomly generate 5 variables, x1,x2, ...,x5, each follows a standard normal
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distribution.
2. Let the first two predictors, x1 and x2 be associated with the outcome so
that x1 and x2 are important covariates while the rest of the covariates are
non-important.
3. Assign α1 = −1, α2 = 2, β1 = 3, β2 = 1.
4. Generate P (Yi ≤ 1) and P (Yi ≤ 2) according to the cumulative logit model,
Specifically, let
P (Yi ≤ 1) = α1 + β1xi1 + β2xi2 and
P (Yi ≤ 2) = α2 + β1xi1 + β2xi2.
5. Randomly generate a variable T where T ∼ Unif (0, 1).
6. If T ≤ P (Yi ≤ 1), then assign Yi = 1; if P (Yi ≤ 1) < T ≤ P (Yi ≤ 2), then
assign Yi = 2; otherwise, assign Yi = 3.
7. Repeat steps 4-6 for the remaining n− 1 observations.
Here, we present the coefficients estimated by three different cumulative logit
models. The regular non-penalized cumulative logit model (VGLM) was fit using
the vglm function in the VGAM package. The LASSO estimates were obtained
by the generalized monotone incremental forward stage-wise (GMIFS) method us-
ing the ordinal.gmifs function in the ordinalgmifs R package and the final model
was selected based on the minimum AIC. For the Bayesian analysis, we used non-
informative truncated normal prior distributions for the two intercepts, α1 and α2
(equation (3.2)).
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The analysis was implemented using the Bayesian software JAGS using an in-
terface through R, implemented in the R2jags package. The posterior estimation
results were based on three MCMC chains each using 10,000 iterations followed by
5000 iterations auto-updating until the model converged. The first 10,000 iterations
were discarded as burn-in and the last 2500 iterations from the updating step were
saved with a thinning rate of 2 (number of iterations saved = number of iterations /
thinning rate). The initial values for the three chains are shown in the Table 3.1.
Table 3.1: Bayesian initiation table
α1 α2 β
Chain 1 logit(
∑n
i=1 yi1/n) logit(
∑n
i=1
∑2
j=1 yij/n) 0
Chain 2 -1 1 ∼ N(0, 0.012)
Chain 3 -2 2 ∼ N(0, 0.0012)
The Trace Plot of the last 2500 iterations versus sampled values for each param-
eter was used to assess convergence. Based on the plots, the three chains mixed well
and converged to their stationary distributions (figs. 3.1 to 3.3). The Gelman-Rubin
tests supported this conclusion as Rˆ ranged from 1 to 1.03 for all parameters.
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Figure 3.1: Traceplot of the two α terms. The trajectory of our chains is consistent over
time, with a relatively constant mean and variance indicating good convergence.
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Figure 3.2: Traceplot of the five β terms. β1 and β2 have a relatively constant mean and
variance indicating good convergence. β3, β4, and β5 have means at 0, the high variances
are due to random error.
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Figure 3.3: Traceplot of the five γβ terms. β1γ1 and β2γ2 have a relatively constant
mean and variance indicating good convergence. β3γ3, β4γ4, and β5γ5 have means at 0,
the high variances are due to random error.
Table 3.2 shows the results from the three different cumulative logit models
(VGLM, LASSO, and Bayesian LASSO). In terms of parameter estimation (α1, α2,
β1 and β2), the three analyses produced similar estimates and were close to the true
underlying values. Although the penalized Bayesian cumulative logit model was not
able to shrink some of the non-important covariates to be exactly zero, like GMIFS
algorithm, the model was able to assign important covariates with much higher pos-
terior inclusion probabilities. For example, the posterior inclusion probabilities for
x1 and x2 were both 1; on the contrary, the posterior inclusion probabilities for x3,
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x4, and x5 were 0.09, 0.101 and 0.09, respectively (Table 3.2).
Table 3.2: Simulation results from three different cumulative logit models
True
parameters
VGLM
coefficient estimates
GMIFS
coefficient estimates
Bayesian LASSO
coefficient estimates
Bayesian LASSO
Posterior inclusion
probability
α1 -1 -1 -1 -1 -
α2 2 2.3 2.3 2.3 -
β1 3 3.2 3.1 3.2 1
β2 1 1.1 1 1.1 1
β3 - -0.02 0 -0.001 0.09
β4 - 0.09 0.07 0.008 0.101
β5 - 0.023 0 0.002 0.09
The last column is the inclusion probabilities obtained from Bayesian LASSO cumulative logit model which are not
directly comparable to the slope estimates (columns 1 to 4)
3.2.2 Simulation II
The goal of simulation study II is to examine the ability of our method to correctly
incorporate true predictors from noise predictors into the model when the feature
space is high-dimensional. To start the simulation, 90 ordinal responses were pre-
defined (n = 90): 30 of them belong to category 1 (Y1 = ... = Y30 = 1), 30 belong
to category 2 (Y31 = ... = Y60 = 2), and the remaining 30 belong to category 3
(Y61 = ... = Y90 = 3). We then designed our covariate matrix to consist of 100
covariates (P = 100) and 90 observations. Among these 100 covariates, we let the
first five covariates be the important predictors, which are truly associated with the
response, and we let the remaining 95 be non-important covariates, which are not as-
sociated with the response. Our covariate matrix X was generated as a combination
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of four submatrices,
X =

Xa
(30×5) Xd
(90×95)Xb(30×5)
Xc
30×5
 ,
where the elements in the submatrices were simulated as follow:
• elements in Xa were randomly generated from ∼ N(0, 0.16);
• elements in Xb were randomly generated from ∼ N(1, 0.16);
• elements in Xc were randomly generated from ∼ N(2, 0.16); and
• elements in Xd were randomly generated from ∼ N(0, 0.16).
In this way, [Xa,Xb,Xc]
T is the matrix of true predictors; while, Xd is the
matrix of non-important predictors. Note that we used 0.16 as the variance for the
normal distributions, because ordinarily the level of gene expression ( on log base
2 scale ) follows a normal distribution with a variance of approximately 0.16. We
simulated the data in this way 100 times, so that in the end, we could examine feature
selection performance by counting the number of true predictors that were identified
and the number of non-important predictors that were identified. We evaluated our
method by two measurements: true positives and false positives. True positives
were measured by the median number and the range of correctly identified non-zero
predictors over 100 simulations. False positives were measured by the median number
and the range of incorrectly identified non-zero predictors over 100 simulations. Here,
we compared four models:
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1. A penalized cumulative logit model using a frequentist approach (GMIFS);
2. A penalized Bayesian cumulative logit model using a hyperprior λ ∼ Gamma(1, 1)
(equation (3.2));
3. A penalized Bayesian cumulative logit model using a hyperprior λ ∼ Gamma(0.025, 0.05)
(equation (3.2)); and
4. A penalized Bayesian cumulative logit model with informative α priors (equa-
tion (3.3)).
The reason we used a hyperprior λ ∼ Gamma(0.025, 0.05) was because if we
treated our response as a continuous outcome and used least angle regression as
implemented in the R package lars, the λ selected by CV had a mean of 0.5. There-
fore, based on this prior information, we used a hyperprior λ ∼ Gamma(0.025, 0.05),
where the distribution has a mean of 0.025/0.05 = 0.5 and a relatively larger variance
of 0.025/0.05/0.05 = 10. The fourth model used informative priors for the α terms,
where a0,1 = logit(
∑n
i=1 yi1/n) ≈ −0.7, and a0,k − a0,k−1 = logit(
∑n
i=1
∑2
j=1 yij/n)−
logit(
∑n
i=1 yi1/n) = 1.4. Therefore, α1 ∼ N(−0.7, 1000) α1 ∈ (−6.9, 6.9) and
α2 − α1 ∼ Gamma(1.4, 1).
Table 3.3 show the results of the second simulation study. The median number of
correctly identified true covariates using all four methods is 5 (range=5,5), indicating
all methods perform well in identifying the true predictors. The median number of
incorrectly identified non-zero coefficients using all four methods is 1 for all methods,
with slightly different ranges. GMIFS had a slightly larger range compared to the
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rest, but all methods had a small number of false positives. Using a different gamma
hyperprior for λ did not change the results indicating that feature selection is ro-
bust for different gamma hyperpriors. Also, the Bayesian penalized cumulative logit
model using informative priors for α had similar results when compared to the other
methods, but the chains converged faster than when using non-informative priors.
Table 3.3: Simulation II results
Median (Range) GMIFS
Bayesian LASSO
λ ∼ gamma(1, 1)
Bayesian LASSO
λ ∼ gamma(0.025, 0.05)
Bayesian LASSO
λ ∼ gamma(1, 1)
αk − αk−1 ∼ gamma(1.4, 1)
True Positive 5(5,5) 5(5,5) 5(5,5) 5(5,5)
False Positive 1(0,7) 1(0,5) 1(0,4) 1(0,4)
3.3 Application
The penalized Bayesian cumulative logit model was applied to a methylation dataset
assayed using the Illumina GoldenGate Methylation Bead Array Cancer Panel I. The
data set was downloaded from GEOquery (GSE18081) and was filtered by Archer et
al. (2014). The response variable was liver hepatocellular carcinoma (HCC) status:
Normal (N=20), cirrhotic but not having HCC (N=16), and HCC (N=20). Cirrho-
sis is considered as the middle level, because the cirrhotic liver is often described
as being a pre-malignant condition of more severe liver disease such as HCC. In
this study, All 20 HCC patients had cirrhosis due to HCV infection. 16 independent
HCV-cirrhotic tissue from patients without HCC were collected from liver transplant
patients [Archer et al., 2010]. Covariates are methylation levels on 1469 CpG sites
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[Archer et al., 2014b], since interest is in predicting stage of liver disease using DNA
methylation levels on different CpG sites. Traditional non-penalized methods such as
ML estimation carried out by functions in the VGAM package can not be estimated
due to the fact that the number of covariates (P = 1469) exceeds the number of
samples (n = 56).
Previous to the Bayesian analysis, all covariates were standardized to reduce the
correlations between explanatory variables. For the Bayesian analysis, we used non-
informative normal priors for the α terms. The initial values for all three chains are
shown below in Table 3.4.
Table 3.4: Bayesian initiation table for Liver data
α1 α2 − α1 β
Chain 1 logit(
∑n
i=1 yi1/n) logit(
∑n
i=1
∑2
j=1 yij/n)− logit(
∑n
i=1 yi1/n) 0
Chain 2 -1 2 ∼ N(0, 0.012)
Chain 3 -2 4 ∼ N(0, 0.0012)
The Bayesian estimates were based on three MCMC chains using 100,000 itera-
tions (first 50,000 are treated as burn-in). Since the number of sampled parameters
is too high for graphical evaluation, we determined the convergence solely by the
values of Rˆ.
Unfortunately, due to the large predictor space (P = 1469) and the sparsity of
the model, most of CpG sites have very low posterior inclusion probabilities. And
the posterior inclusion probabilities for all covariates did not have a bi-peak distri-
bution to clearly distinguish the important features from the non-important features
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like in simulation I, where 2 features had extremely high posterior inclusion proba-
bilities (posterior inclusion probabilities for x1 and x2 were both 1), and the remain-
ing features had extremely low posterior inclusion probabilities (posterior inclusion
probabilities for x3, x4 and x5 were 0.09, 0.101 and 0.09, respectively). Instead,
the posterior inclusion probabilities for the liver disease data followed a relatively
normal distribution with a mean of 0.5 and a SD of 0.008 (Figure 3.4). Note that the
distribution also had a long right tail. Therefore, we proposed to select features that
have posterior inclusion probabilities greater than mean + 3× SD. After using this
selection criterion, 9 out of 1,469 features were selected. The selected CpG sites are
related to the following genes: ABL1, CDKN2B, DDIT3, GML, HOXA5, MMP7,
PADI4, PLSCR3, and S100A2. Note that among these selected features, CDKN2B,
DDIT3, GML, PADI4 were also selected by using the generalized monotone incre-
mental forward stage-wise method [Archer et al., 2014b]. Table 3.5 shows the genes
that were selected and related literature that has previously linked these genes to
liver disease.
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Figure 3.4: Distribution of posterior inclusion probabilities for all covariates.
Table 3.5: Genes identified as Liver disease related by penalized Bayesian cumulative
logit model
PROBE ID GENE NAME (SYMBOL) RELEVANT PUBLICATION
ABL1 P53 F ABL proto-oncogene 1 (ABL1) HCC[Rana et al., 2013]
Hepatitis infection [Yamauchi et al., 2015]
CDKN2B seq 50 S294 F Cyclin-dependent kinase inhibitor 2B isoform 1
(CDKN2B)
DDIT3 P1313 R DNA damage inducible transcript 3 (DDIT3) Acute liver failure [Rao et al., 2015]
GML E144 F GPI anchored molecule like protein (GML)
HOXA5 E187 F Homeobox A5 (HOXA5) HCC [Kanai et al., 2010]
MMP7 E59 F Matrix metallopeptidase 7 (MMP7) HCC [Chen et al., 2013]
PADI4 P1158 R Peptidyl arginine deiminase, type IV (PADI4) HCC [Zhang et al., 2013]
PLSCR3 P751 R Phospholipid scramblase 3 (PLSCR3)
S100A2 E36 R S100 calcium binding protein A2 (S100A2) cholangiocarcinoma [Sato et al., 2013]
HCC (mouse model) [Wang et al., 2001]
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To predict ordinal responses, we proposed to fit predictive models using only
the selected features. We compared four Bayesian predictive models by examining
two types of errors: re-substitution error and leave-one-out cross validation error
(CV error). Lower error rates indicate better prediction power. The four predictive
models are
1. Penalized Bayesian cumulative logit model with non-informative priors for α
terms ( βj ∼ DE(0, 1τλ) for j = 1, ..., P and α1 ∼ N(0, 1000), α1 ∈ (−6.9, 6.9),
αk ∼ N(0, 1000), αk ∈ (αk−1, inf) for k = 1, ..., K − 1);
2. Penalized Bayesian cumulative logit model with informative priors for α terms
( βj ∼ DE(0, 1τλ) for j = 1, ..., P and α1 ∼ N(−0.6, 1000), α1 ∈ (−6.9, 6.9),
αk − αk−1 ∼ Gamma(1.2, 1) for k = 1, ..., K − 1);
3. Non-penalized Bayesian cumulative logit model with non-informative priors
for α terms ( βj ∼ N(0, 1000) for j = 1, ..., P and α1 ∼ N(0, 1000), α1 ∈
(−6.9, 6.9), αK ∼ N(0, 1000),αk ∈ (αk−1, 6.9) for k = 1, ..., K − 1); and
4. Non-penalized Bayesian cumulative logit model with informative priors for α
terms ( βj ∼ N(0, 1τλ) for j = 1, ..., P and α1 ∼ N(−0.6, 1000), α1 ∈ (−6.9, 6.9),
αk − αk−1 ∼ Gamma(1.2, 1) for k = 1, ..., K − 1).
The results are displayed in the Table 3.6. All four predictive models provided
good predictions (small misclassification rates and CV errors). In conclusion, our
penalized Bayesian cumulative logit model performs accurate feature selection and is
helpful in predicting an ordinal response when applied to a high-dimensional dataset.
Extensions of this approach for other ordinal response models will be investigated in
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the near future. The code for performing this application appears in Appendix B.2.
The model files that are necessary for running JAGS appear in Appendix B.3.
Table 3.6: Error rates from four penalized Bayesian cumulative response models.
βk ∼ DE
αk ∼ trunN (0, 1000)
βj ∼ DE
αk − αk−1
∼ gamma(1.2, 1)
βk ∼ N(0, 1000)
αk ∼ trunN (0, 1000)
βk ∼ N(0, 1000)
αk − αk−1
∼ gamma(1.2, 1)
Misclassification
rate
0.107 0.107 0.107 0.09
Leave-one-out
CV error
0.161 0.178 0.179 0.23
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Chapter 4
Univariate feature selection
method
This chapter is supplemental to the previous three chapters. The first three chapters
focused on penalized models that perform automatic feature selection, so the model
building step is not necessary. The frequentist LASSO ordinal models using the
GMIFS method in Chapter 2 can shrink coefficients corresponding to non-important
covariates to be exactly zero, and therefore, leave only important features in the
model. In chapter 3, the Bayesian LASSO is not able to shrink coefficients to ex-
actly zero, but it is able to give the important covariates high posterior inclusion
probabilities, so that feature selection is achievable. In this chapter, we describe a
competing method for feature selection other than frequentist or Bayesian penaliza-
tion. We assume that many of the features are irrelevant to predicting overall survival
and thus can be removed by some feature selection methods before fitting a multi-
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variable model. This is a univariate feature selection or filtering method. In section
4.1, we introduce the survival dataset that inspired us to examine filtering methods,
we then examine the performance of filtering methods in comparison to penalization
methods. The survival dataset contains clinical variables and proteomic measure-
ments for 187 subjects with acute myeloid leukemia (AML). The goal is to predict
survival using both proteomic expression and other covariates. In section 4.2, four
univariate feature selection methods are described, together with two penalization
approaches for comparison purposes. We also describe our error assessment process.
The results of filtering and penalization when applied to high-dimensional protein
expression data are presented in section 4.3.
4.1 Introduction
Acute myeloid leukemia (AML) is a cancer of the blood and the bone marrow. Muta-
tions in the myeloid line of blood stem cells lead to the formation of aberrant myeloid
blasts and white blood cells. If a treatment fails to destroy all the neoplastic cells,
the rapid or delayed regrowth of blasts can eventually lead to death [Kornblau et al.,
2013]. It was estimated that in 2014, there were 18,860 new cases of AML in the
United States, and the estimated number of deaths reached 10,460 [Society, 2014].
As AML progress rapidly, only about one fourth of the patients diagnosed with AML
survive beyond 5 years. Therefore, there is an urgency in finding better treatments
for AML [York et al., 2012].
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One difficulty in treating AML is that the cancer is heterogeneous. It is a collec-
tion of diseases that often share a similar clinical presentation, for example, weight
loss, fatigue, fever or low white blood cell counts; however, these diseases can arise
from diverse mutations and genetic events [Mardis et al., 2009]. As a consequence,
AML patients treated with similar therapies often respond differently. For exam-
ple, AML associated with cytogenic abnormalities t(8;21), t(15,17) or inv(16) are
predicted to survive longer (5-year survival =70%), whereas patients with cytogenic
abnormalities -5, -7, del(5q) or abnormal 3q are predicted to survive a shorter time
(5-year survival=15%) [Grimwade et al., 1998]. Currently, protein expression has
become more important in affecting AML treatment [Kornblau et al., 2009]. For
example, it has been shown that patients with low or high Friend leukemia virus in-
tegration 1(FLI1) expression had shorter overall survival (22.6 and 30.3 versus 51.1
weeks, respectively) [Kornblau et al., 2011]. In another study, Kornbalu (2009) sepa-
rated patients into seven protein signature groups using principle component analysis
and showed that these signature groups were associated with overall survival [Korn-
blau et al., 2009].
In this chapter, we sought to determine a statistical model that is able to predict
overall survival of AML patients using their protein expression profiles assayed by
Reverse phase protein array (RPPA). RPPA is able to assess the total proteins and
their corresponding phosphoprotein of an given pathway, and has been shown to
have a high precision and reproduciblility in printing, detecting, amplificating, and
staining arrays [Tibes et al., 2006].
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However, overall survival time is not immediately predictable. The argument has
been that point prediction of survival has poor accuracy [Henderson et al., 2001].
Henderson (2001) showed that Cox, Weibull, log-normal and Aalen models all have
poor predictive capabilities with practical parameter values [Henderson et al., 2001].
As a consequence, the interest may lie in seeking an alternative method of predicting
actual survival time. In this study, the goal is to predict grouped survival time, where
overall survival was categorized into several intervals, specifically, short, intermediate
and long-term survival.
Another main challenge in predicting survival using protein expression profiles
is the high-dimensionality of the covariate space. In our study, 231 proteomic mea-
surements (proteins and phosphoprotein expression levels) and 18 clinical/baseline
demographic, cytogenic and blood tests results were measured on 187 AML patients.
Most traditional predictive models cannot be estimated when the number of pa-
rameters exceeds the sample size. One approach to overcome this issue is to use a
penalization method, such as the generalized monotone incremental forward stage-
wise regression method (GMIFS) described in Chapter 1 and 2. Archer et al. (2014)
extended the GMIFS algorithm to several ordinal response models, including the
forward continuation ratio model with a complementary log-log link (FCR-cloglog).
This model can be used to describe the hazard function for grouped survival data
[Ferber and Archer, 2015] and has the advantage of being equivalent to the propor-
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tional hazards model of the form:
log[− log(1− ωj(x))] = αj + βTx
where ωj(x) = P (Y = j|Y ≥ j) for j = 1, ..., K − 1. K is the level of the grouped
survival, αj denotes the class-specific intercept and the β vector represents the co-
efficients associated with the covariate matrix x in this study [Agresti, 2010]. Al-
though the GMIFS extended FCR-cloglog model (GMIFS-FCR) is helpful in predict-
ing grouped survival time, currently there is no study in comparing its performance
to other feature selection methods or to other existing penalized survival models, such
as a penalized Cox model. Tibshirani (1997) proposed a version of the LASSO for
the Cox model [Tibshirani, 1996]. Park and Hastie (2007) developed a path follow-
ing method for the Cox PH model that uses the predictor-corrector method called
L1-regularization path algorithm for the Cox model (Coxpath) [Park and Hastie,
2007]. The details of the GMIFS extended FCR model and Coxpath are described
in section 4.2.2.
Another traditional method to overcome the issue of high-dimensionality is to
assume that many of the features are irrelevant to predicting overall survival and thus
can be removed by some feature selection method before fitting a multivariable model.
Here, we describe competing methods for feature selection. These four methods
are univariate Cox proportional hazards (PH) model, Spearman’s rank correlation
test, and two additional methods that are based on the categorization of continuous
feature data (for example, low, intermediate and high-protein expression) referred to
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as Importance Scores Ic and Id. The difference between the two importance scores
is that Ic is based on continuous survival time and Id is based on discretized survival
(grouped survival). These two importance scores are inspired by Multigene profile
association method (MPAS) proposed by Yan and Zheng [Yan and Zheng, 2008], and
can identify important genes for capturing the difference in survival time between
expression categories. We describe the four filtering methods in section 4.2.1. In
the last section (4.3), we will investigate the performance of all previously mentioned
methods to determine if any method yields superior prediction accuracy when applied
to our high-dimensional AML dataset.
4.2 Univariate feature selection and penalization
methods
This section contains four subsections. In the first two subsections, the four uni-
variate feature selection methods and the two penalized methods: GMIFS extended
forward continuation ratio model with a complementary log-log link (GMIFS-FCR)
and the L1-regularization path algorithm for the Cox model (Coxpath), are described.
After that, we illustrate how these methods can be used in predicting our ordinal
response when the dataset is high-dimensional (Section 4.2.3) and how well their
prediction can be measured (Error assessment) (section 4.2.4).
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4.2.1 Univariate feature selection methods
In this study, we first focused on selecting features based on the importance of individ-
ual features. The first feature selection method uses p-values from fitting univariate
Cox proportional hazards (PH) models. The Cox PH model has long been used as
a statistical technique to explore the relationship between survival time and patient
features. Herein, Cox PH models were fit to each of 249 features (18 clinical/demo-
graphic and 231 proteomic measurements) and features having an observed p-value
less than 0.1 were retained for multivariable model building.
A common way to test association between two continuous variables is correla-
tion. Because survival time may not follow a Gaussian distribution, non-parametric
Spearman’s rank correlation test was performed to estimate the strength of the re-
lationship between survival and each feature. The significance level was again set
at 0.1. We note, however, that Spearman’s rank correlation does not take censoring
into account.
The remaining two feature selection methods were inspired by methods developed
by Yan and Zheng [Yan and Zheng, 2008], where they discretized protein expression
into three levels: high, normal, or low using K-means clustering. They argued that
discretization can simplify the data and make the analysis more resistant to outliers
or extreme values [Yan and Zheng, 2008]. In their first feature selection method,
after discretization, they created a multigene profile association score (MAPS) for a
given gene among P genes and this score measures the importance of each gene in
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terms of its association with a binary outcome, given the current genes. Based on
the MAPS, they selected important genes through a backward elimination for class
prediction [Yan and Zheng, 2008]. Here, we propose two methods. The first is de-
signed to capture differences in continuous survival time between discretized protein
expression categories (Ic), while the second is designed to capture the association
between discretized protein expression levels and grouped survival (Id)
The importance score based on continuous overall survival (Ic) is defined for each
feature as
Ic(xp) =
K∑
k=1
n2k(Y¯k − Y¯ )2
n∑
i=1
(Yi − Y¯ )2
where K represents the number of discrete levels of the feature. The continuous
features were discretized into K = 3 groups using K-means clustering independently.
K-mean clustering is an algorithm that partitions data points into a pre-specified
number of clusters, K. In our study, for each continuous feature, the 187 observa-
tions were clustered into one of K groups so that the within cluster variance was
minimized [Hastie et al., 2001]. n represents the total number of observations; nk
represents the number of observations at level k; Y¯k represents the average overall
survival at level k; Y¯ represents the global average of overall survival and Yi rep-
resents the observed overall survival for observation i. Because Ic is a complicated
statistic without a well-defined distribution, a bootstrap technique was used to per-
form hypothesis testing. In our study, the null hypothesis is that a feature is not
associated with overall survival while the alternative hypothesis (Ha) is that a fea-
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ture is associated with overall survival. Ic is defined such that the more the data are
consistent with alternative hypothesis, the greater Ic tends to be.
The bootstrap resampling method for the pth feature was performed according to
the following steps
1. Combine observations for a feature from different discrete levels together, define
the number of observations in level 1 = n1, number of observations in level 2
= n2, etc.
2. Draw a random sample with replacement (bootstrap sample) where the first n1
observations are taken to represent group 1, the second set of n2 observations
are taken to represent group 2, etc.
3. Recalculate the importance scores using that bootstrap samples, denoted as
I∗c (xp).
4. Repeat steps 1 through 3, B=1000 times.
Thus p-values for testing H0 for Ic were defined as
p-valueIc(xp) =
B∑
b=1
I
(
I∗c (xp) ≥ Iobsc (xp)
)
B
where Iobsc (xp) is the observed test statistic for the p
th feature.
We developed importance score Id based on categorized survival to leverage the
ordinal nature of grouped survival. The continuous features were again discretized
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by applying K-means clustering (K = 3). Let Fk(g) represent the proportion of
samples characterized by an outcome less than or equal to g within cluster k, then
for each variable, the importance score, Id, is defined as
Id(xp) =
K∑
k=1
G∑
g=1
Fk(g)(1− Fk(g))
where g = 1, 2 or 3. Note Id is the summation of ordinal impurity functions based
on nominal-ordinal association proposed by Piccarreta (2001) over K clusters. The
ordinal impurity function for J classes ordinal response is
ios(t) =
G∑
g=1
F (g)(1− F (g))
where F (g) represent the proportion of samples characterized by an outcome less
than or equal to g [Archer, 2010, Piccarreta, 2001, 2008].
We also used a bootstrap technique to perform hypothesis testing. Id is defined
such that the more the data are consistent with the alternative, the smaller Id tends
to be. Therefore, p-values for testing of the H0 for Id were defined as
p-valueId(xp) =
B∑
b=1
I
(
I∗d(xp) ≤ Iobsd (xp)
)
B
Where Iobsd (xp) and I
∗
d(xp) are the observed and bootstrapped test statistics for the
pth feature. For both Ic and Id, features with a p-value less than 0.1 were retained
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for multivariable modeling.
4.2.2 Penalization approach
Two penalized approaches were examined for feature selection: GMIFS-FCR and
Coxpath.
Ferber and Archer (2015) implemented the GMIFS algorithm for the forward
continuation ratio model, which was implemented in the ordinalgmifs R package
[Archer et al., 2014b] and is often used when interest lies in estimating the odds of
shorter survival compared to longer survival. Park and Hastie (2007) proposed the
L1-regularization path algorithm for the Cox model (Coxpath). Coxpath implements
the predictor-corrector method to calculate the coefficient estimates iteratively as the
tuning parameter λ varies. The algorithm first determines the λmax which penalizes
all coefficients except the intercept to be zero and then alternates between a predictor
and a corrector step as λ decreases by a pre-defined step length. Park and Hastie
(2007) introduced the concept of the “active” set where only selected variables on the
iteration are contained. For example, if λ = λmax, the active set only contains the
intercept. They also suggested to use a step length equal to the difference between λk
and λk + 1 that will change the active set of variables (k stands for k
th iteration). To
illustrate further, on the kth iteration, Coxpath linearly approximates the coefficient
vector, called βˆ
k+
in the predictor step and in the corrector step, it finds the exact
coefficient solution βˆ
k+1
by minimizing the partial likelihood of Cox PH model and
using βˆ
k+
as the initial value. The iterative process continues until the active set
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cannot be augmented any further [Park and Hastie, 2007].
4.2.3 Prediction
After selecting features using four different methods (Univariate Cox PH model,
Spearman’s rank correlation test, Ic and Id), both FCR-cloglog and Cox PH models
were fit to predict grouped survival using the more parsimonious set of features as
predictors. FCR-cloglog produced the fitted conditional probabilities that can be
used to estimate the class specific probability piik for i
th subject and kth class. The
predicted class ωˆ for observation i can be determined by
ωˆi = arg max(piik).
GMIFS-FCR and Coxpath were also applied to the dataset with no filtering. For
GMIFS-FCR, the above approach was applied for prediction.
Predicting grouped survival for the Cox PH model and Coxpath model is more
complicated because the Cox model is not designed for predicting discrete survival
time. In this study, we proposed to predict grouped survival by estimating the class
specific probability from the predicted survival curve. To be more specific, after
fitting a Cox PH model or a Coxpath model, the baseline hazards were estimated
using the extension of the Nelson-Aalen estimate proposed by Cox and Oakes (1984).
In our study, there were n individuals with observed survival or censored times,
t1, t2, ..., tn and r distinct failure times. Arranging these failure times in ascending
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order t(1) < t(2), ..., < t(r), then t(i) is the i
th failure time. Let di denote the number of
failures at time t(i); Ri represent the risk set at t(i); and xj represent a p×1 covariate
vector for individual j (j = 1, ..., n). The baseline hazard at distinct failure time t(i)
is estimated as
λˆi =
di∑
j∈Ri e
xTj β
.
The baseline hazards at censored times are zero. Therefore, the cumulative baseline
hazard function at time t is estimated as
Λˆ0(t) =
∑
i:t(i)<t
λˆi
and the cumulative hazard and the predicted survival for the jth individual at time
t are estimated as
Λˆj(t) = Λˆ0(t)e
xTj β Sˆj(t) = −eΛˆj(t).
After that, the difference in the range of the estimated survival probability was
used for estimating class specific probability for class k. To describe using a formula,
for the jth subject, define ∆Sjk as the difference in the range of Sˆj(t) when t ≤ 52,
52 < t ≤ 104, t ≥ 104, respectively, for class k (k=1, 2 or 3). Then, the class-specific
probability pijk for the j
th subject and kth class can be estimated as
pˆiik = ∆Sjk.
The class with highest probability is taken to be the predicted class.
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4.2.4 Error assessment
We investigated the accuracy of all proposed methods by examining two types of
errors: re-substitution error and leave-one-out cross validation error (CV error).
Lower error indicates better performance.
4.3 Application
In this section, we applied the two existing penalized methods as well as the four
feature selection methods to the AML data. We compared the results to determine if
any methods yielded consistently superior predictions. Statistical methods used are
displayed in Figure 4.1. The two penalization methods are displayed in yellow blocks
while the feature selection methods followed by multivariable models are displayed
in blue blocks. All statistical analyses were performed using the R programming
environment (version 3.0.2). Cox PH models were fit using the survival library;
forward continuation ratio models were fit using the vglm function in the VGAM
library; GMIFS-FCR were fit using the ordinal.gmifs function in the ordinalgmifs
library; and Coxpath was fit using coxpath the function in the glmpath library.
The code for performing four univariate feature selection followed by multivariable
predictive model appears in Appendix C.1. The code for applying two existing
penalized methods appears in Appendix C.2.
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Figure 4.1: Methods flowchat
The training data for 187 AML patients was provided by M.D. Anderson Cancer
Center. The data consisted of 18 covariates measuring baseline demographics (sex
and age), medical histories (whether a patient has been diagnosed with a prior cancer,
infection or had a prior chemotherapy, radiation therapy), cytogenetics and results
from standard blood tests (counts of white blood cells, myeloid blast cells, hemoglobin
and platelets together with Albumin, Bilirubin, and Creatinine levels measured in
blood; myeloid blast cells, moncytes and promegakaryocytes counts in bone marrow).
Although the original data contained 16 categories of AML cytogenetic abnormal-
ities (“-5”, “-5,-7”, “-5,-7,+8”, “-7”, “-7,+8”, “11q23”, “21”, “8”, “diploid”, “IM”,
“inv6”, “inv9”, “Misc”, “t6;9”, “t8;21” and “t9;22”), we dichotomized these 16 cyto-
genic abnormalities to “diploid” and “non-diploid” and labeled them as “abnormal”
and “no cytogenetic abnormality” due to the low frequencies in the individual cat-
egories. The resulting abnormal group contained 86 subjects (46% of total sample
size). All missing covariates were imputed using mean-imputation.
In addition, the data included proteomic measurements probed by Reverse phase
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protein array (RPPA) using 231 antibodies. The process started with preparing
leukemia enriched whole cell lysates from blood and bone marrow of newly diagnosed,
untreated AML patients. After probed with primary and secondary antibodies, the
slides coated lysate were scanned. The final data were analyzed by Microvigene R©
software (Vigene Tech, Carlisle, MA) and normalized by “variable slopes” and “to-
pographical” using SuperCurve software.
Overall survival and censoring times were classified into G = 3 groups: 1) 52
weeks or less, 2) more than 52 weeks but less than or equal to 104 weeks or 3) more
than 104 weeks to create grouped survival data. These groups were developed to
represent short, intermediate and long-term survival.
After applying different feature selection methods, univariate Cox PH model,
Spearman’s rank correlation test, Ic and Id methods selected 55, 76, 46 and 41 fea-
tures, respectively (Table 4.1). Ic and Id methods selected a smaller number of
features relative to the other methods; while Spearman’s rank correlation test se-
lected the most. Although Ic and Id methods produced similar numbers of features,
only 21 features overlapped (Figure 4.2). Figure 4.2 is a Venn diagram illustrating
the relationship between the features selected by the four feature selection methods.
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Table 4.1: Significant features selected using four feature selection methods.
Methods Selected features
Cox proportional hazards model Age, PRIOR.MAL, PRIOR.CHEMO, PRIOR.XRT, cyto.cat, WBC,
BM.BLAST, HGB, ALBUMIN, ACTB, ARC, BAD.pS136, BCL2L1,
BECN1, BIRC2, CASP7.cl198, CCND3, CD74, EGFR.pY992, EIF2AK2,
EIF2S1, EIF4E, ERG, Fli1, FN1, FOXO3.S318 321, GSKA B,
H3histon,H3K27Me3,HNRNPK, HSP90AA1 B1, HSPA1A L,HSPB1,
INPPL1, ITGA2, LCK, MAPT, NCL, NRP1, PA2G4, PA2G4.pS65,
PA2G4.pT37 46, PA2G4.pT70, PIK3CA, PRKCD.pT507, SMAD2.pS245,
SMAD4, SRC.pY416, STAT1.pY701, STAT3, STMN1, TP53, TRIM62,
TSC2, YAP1p
Spearman’s rank correlation test Age, PRIOR.XRT, Infection, cyto.cat, WBC, ABS.BLST, BM.BLAST,
HGB, ALBUMIN, ACTB, AKT1 2 3.pT308, ARC, ASH2L, BAD.pS136,
BCL2L1, BECN1, BIRC2, CASP7.cl198, CASP8, CBL, CCND3, CD74,
CDK4, CDKN1A, CDKN2A, EGFR.pY992, EIF2AK2, EIF2S1, EIF4E, Fli1,
FN1, FOXO3.S318 321, GSKA B, GSKA B.pS21 9, H3histon, H3K27Me3,
HDAC1, HIF1A, HNRNPK, HSP90AA1 B1, HSPA1A L, HSPB1, INPPL1,
IRS1.pS1101, ITGA2, ITGB3, KDR, LCK, LEF1, MAPT, NCL,
NOTCH1.cl1744, NPM1.3542, NR4A1, PA2G4, PA2G4.pS65, PA2G4.pT70,
PIK3CA, PPP2R2A B C D, PRKCD.pS664, PRKCD.pT507, RAC1 2 3,
SMAD3, SMAD4, SPP1, SRC.pY416, STAT3, STAT3.pS727, STK11,
STMN1,TAZ, TP53, TRIM24, TRIM62, TSC2, YAP1p
Ic PRIOR.MAL, PRIOR.CHEMO, cyto.cat, Age, WBC HGB,
AKT1 2 3.pT308, ARC, BAD.pS136, BCL2L1, CASP7.cl198, CASP8,
CAV1, CCNB1, CD74, CDKN2A, DIABLO, EIF2AK2, EIF4E, ERG,
GSKA B, H3K27Me3, H3K4Me3, HNRNPK, HSP90AA1 B1, HSPA1A L,
HSPB1, INPPL1, ITGA2, KDR, MAPK1 3.pT202Y204, MAPK9, NR4A1,
NRP1, PA2G4.pT70, PIK3CA, PPARA, PPP2R2A B C D, PRKCB.I,
PTK2, SMAD1, SMAD4, SPP1, STAT5A B.pY694, TRIM62, YAP1p
Id PRIOR.MAL, PRIOR.CHEMO, PRIOR.XRT, Infection, cyto.cat, Age,
HGB, ALBUMIN, CREATININE, ARC, BAD.pS112, BECN1, CASP8,
CCND3, DIABLO, EGFR.pY992, EIF2S1, EIF2S1.pS51, EIF4E, H3histon,
H3K27Me3, HNRNPK, HSP90AA1 B1, HSPA1A L, INPPL1, ITGA2,
KDR, MAPK9, MAPT, MET.pY1230 1234 1235, NPM1, PA2G4.pS65,
PA2G4.pT70, PRKCD.pT507, PTK2, STAT5A B, TP53, TRIM62, TSC2,
YAP1p, YWHAZ 88
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Figure 4.2: Venn diagram
After fitting GMIFS-FCR, Coxpath and FCR-cloglog/ Cox PH model for each
of the four univariate feature selection methods, the re-substitution error and cross
validation error associated with each method are shown in Table 4.2 and Table 4.3.
The graphic presentation of error rates are shown in Figure 4.3 and Figure 4.4. Note
that the Spearman’s rank correlation test has lowest resubstitution error but the
highest CV error because Spearman’s rank correlation test selected most number of
features which resulted in a complicated predictive model. However, when applied
to a future data, a complicated model do not necessary provide a good prediction.
In general, the FCR-cloglog model had smaller re-substitution errors in compar-
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ison to the same feature selection method followed by the Cox PH model. Although
CV errors were similar regardless of the feature selection method, FCR generally had
a slightly lower CV error than Cox PH.
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Figure 4.3: Resubstitution misclassification error rates for each filtering and modeling
method.
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Figure 4.4: Cross-validated misclassification error rates for each filtering and modeling
method.
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Table 4.2: Re-substitution errors.
Univariate feature selection method Multivariable model Re-substitution error
Cox PH Cox PH 0.321
Spearman Cox PH 0.257
Ic Cox PH 0.326
Id Cox PH 0.310
Cox PH FCR 0.262
Spearman FCR 0.230
Ic FCR 0.278
Id FCR 0.273
GMIFS-FCR 0.283
Coxpath 0.01
* Cox PH = Cox proportional hazards model, Spearman = Spearman’s rank correlation
test, FCR = Forward continuation ratio model; GMIFS-FCR = GMIFS extended forward
continuation-ratio model; Coxpath = L1-regularization path algorithm for the Cox model.
93
Table 4.3: Cross-validation errors.
Univariate feature selection method Multivariable model Cross-validation error
Cox PH Cox PH 0.439
Spearman Cox PH 0.476
Ic Cox PH 0.433
Id Cox PH 0.417
Cox PH FCR 0.433
Spearman FCR 0.465
Ic FCR 0.406
Id FCR 0.422
GMIFS-FCR 0.439
Coxpath 0.465
* Cox PH = Cox proportional hazards model, Spearman = Spearman’s rank correlation
test, FCR = Forward continuation ratio model; GMIFS-FCR = GMIFS extended forward
continuation-ratio model; Coxpath = L1-regularization path algorithm for the Cox model.
4.3.1 Discussion
Unfortunately, other than univariate Cox proportional hazards model, the other three
feature selection methods cannot handle censored data. Although both penalization
methods (GMIFS-FCR and Coxpath) can incorporate censoring information, regular
FCR-cloglog cannot. It would be beneficial to extend FCR-cloglog to censored data.
Ic and Id methods had similar performance in term of cross-validation error and
94
number of features selected. However, Id has advantage of analyzing grouped survival
data; therefore, if only grouped data are available, the Id method is recommended.
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Chapter 5
Conclusions and Future Work
5.1 Conclusion
Ordinal responses are commonly collected in biomedical studies. There has been
increasing emphasis in medical research on the relationship between clinical phe-
notypes and high-dimensional genomic information. Many clinical phenotypes are
on an ordinal scale and thus are recommended to be analyzed using ordinal re-
sponse models. Traditional methods for modeling ordinal data do not perform well
in the presence of a high-dimensional covariate space, because traditional methods
require that the number of samples is greater than the number of covariates and
assumes covariate independence. A good solution to this problem is penalization,
for example, LASSO [Tibshirani, 1996]. In chapter 1, we first reviewed the LASSO
method under both a frequentist and a Bayesian framework. Under the frequentist
framework, the incremental forward stagewise algorithm (IFS) for linear regression,
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generalized monotone incremental forward stagewise algorithm (GMIFS) for logis-
tic regression, and L1-regularization path for generalized linear models (i.e., Cox
regression) were described. Under the Bayesian framework, the Bayesian LASSO
which uses i.i.d LaPlace priors to enable penalization was described. Next, we re-
viewed the six classical ordinal response models: cumulative logit model, adjacent
category model, forward and backward continuation ratio models, stereotype logit
models and Bayesian cumulative logit model. We also reviewed two LASSO ordinal
response models, glmnet.cr and glmpath.cr were reviewed.
GMIFS was recently adapted to fit cumulative logit, adjacent category, and con-
tinuation ratio models, and were shown to be capable of deriving a parsimonious
classifier [Archer et al., 2014b]. However, the GMIFS method had not been adapted
to fit ordinal response models with the probit link or the stereotype logit model. In
chapter 2, the GMIFS method was extended to the cumulative probit model, forward
continuation-ratio model with probit link and the backward continuation-ratio model
with probit link. The GMIFS extended cumulative probit link model was applied
to a methylation dataset to identify methylation patterns that are associated with
anxiety, depression and stress. After fitting separate GMIFS extended cumulative
probit models, a large number of CpG sites were found to be associated with anxi-
ety and depression based on the AIC selected model (67 CpG sites were associated
with anxiety; 19 CpG sites were associated with depression; and 10 CpG sites were
associated with stress). BIC selected model can be used to avoid overfitting.
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The GMIFS method was also extended to the stereotype logit model to cope with
situations when the proportional odds assumption does not hold. The method was
applied to a gene expression dataset to predict the severity of Alzheimer’s disease
(AD), and the resulting misclassification rate based on the AIC selected model was
45%. The poor performance for AIC is probably due to the fact that our AD dataset
only included 31 subjects.
Chapter 3 focused on the penalized Bayesian cumulative logit model. We de-
veloped an innovative Bayesian ordinal response model that incorporates a penalty
term so that a sparse model is obtained. Our Bayesian method includes the like-
lihood of the cumulative logit model combined with a LaPlace prior. The feature
selection property is achieved by utilizing the binary variable inclusion indicator
method. The proposed model was first examined using two simulation studies. It
was shown that, when the data are not high-dimensional (Simulation study I), the
penalized Bayesian cumulative logit model produced similar estimates to other exist-
ing methods and were close to the true underlying values. The proposed model was
also able to perform feature selection by assigning important covariates with much
higher posterior inclusion probabilities. If the data are high-dimensional (Simula-
tion study II), the proposed model performs accurate feature selection, since it has
good ability to correctly incorporate true predictors from noise predictors. We also
applied our proposed model to a methylation dataset to demonstrate its usage in
analysis of a real high-dimensional dataset. The penalized Bayesian cumulative logit
model was first fit to perform feature selection. To predict ordinal responses, we
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proposed to fit predictive models using only the selected features. The performance
of this two step prediction method was assessed using both misclassification rate and
cross-validation error. In conclusion, our proposed model provided good prediction
(small misclassification rates and CV errors).
In chapter 4, filtering, a competing feature selection method that differs from
penalization was addressed. We first stated the question of interest, that is, which
methods can predict grouped survival more accurately using the high-dimensional
acute myeloid leukemia (AML) dataset. We described our proposed methods: four
filtering methods (univariate Cox proportional hazards model, Spearman’s s rank cor-
relation test, Ic and Id) and two penalization methods (Coxpath and GMIFS-FCR).
After fitting all these competing methods, results were presented and compared. In
conclusion, penalized methods and filtering methods have similar performance in
terms of prediction accuracy.
5.2 Future work
5.2.1 Assessing generalization errors for GMIFS extended
probit model and stereotype logit model
Prediction performance of the GMIFS extended cumulative probit model and stereo-
type logit model were examined by assessing the misclassification rates in section
2.2.3 and section 2.3.1; however, misclassification rate cannot be used to evaluate
the model performance when applying to the future data. A better way of estimat-
ing generalization error should be introduced. In section 2.2.3, we can assess the
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cross-validation error. Although cross-validation procedure is straightforward, the
GMIFS algorithm needs a long time to fit a model due to the fact that the dataset
contains 285,173 covariates. One way to speed up the process is by parallel compu-
tation. In the stereotype logit model example in section 2.3.1, since the dataset is
too small for a cross-validation, we need to find an independent testing dataset to
assess the generalization error. Unfortunately, finding an independent dataset can
be challenging, because the response variable in the testing dataset also needs to
be the severity of Alzheimer’s disease categorized based on the MiniMental Status
Examination criteria. Moreover, the gene expression levels in the new testing dataset
also need to be assayed by Affymetrix HG-U133A. One challenge in genomic data
analysis is that since the techniques advanced rapidly, one platform may soon be
out of date, it is difficult to find an independent testing dataset assayed by the same
platform.
5.2.2 Selecting optimal priors for λ and α
In Chapter 3, we assigned the shrinkage parameter λ with a Gamma(a, b) prior distri-
bution, where a = 1, and b = 1. Here, inspired by Huang et al (2013), we proposed to
obtain the optimal values of hyperparameters a and b with cross-validation by three
steps. In the first step, we examined a = b = 0.01, 1, and 2, and a pair (a1, b1) cor-
responding to the smallest cross-validation error was obtain. In the second step, we
treated b as fixed at b1, and examined a = −0.5,−0.3,−0.1,−0.01, 0.01, 0.05, 0.1, 0.5,
and 1, and kept an a2 corresponding to the smallest cross-validation error. In the
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third step, a was fixed at a2, and b was chosen from the set [0.01, 0.1, 0, 1, 2, 3, 4, 5],
which yielded our optimal b2 [Huang et al., 2013]. Note that this process can result
in a long computation time, we propose to introduce parallel computing to speed up
the MCMC convergence.
Additionally, we can check the results of the Bayesian LASSO when an improper
flat prior is used for intercepts.
5.2.3 Bayesian variable selection with consideration of the
correlations between features
In our proposed penalized Bayesian cumulative logit model, we made a strong as-
sumption that all covariates are independent and we imposed i.i.d Bernoulli priors
to each of the binary indicate variables, γi. However, the independence assumption
is almost always violated when we have a high-dimensional data, especially, genomic
data. For example, in section 3.3, we demonstrated the application of our proposed
Bayesian method using a methylation data assayed by the Illumina GoldenGate Can-
cer Panel I (Illumina, San Diego, CA). This platform interrogates 1,505 CpG sites,
selected from 807 genes. As a consequence, many of the CpG sites are correlated
since they are located on the same gene. For instance, 463 genes are represented on
the assay by two CpG sites, and 114 genes are represented on the assay by more than
three CpG sites. Not only are CpG sites located on the same gene are correlated,
many genes are correlated, too. For example, among these 807 interrogated genes,
the OCT, NBC, MDR1, ABCG5, and ABCB4 genes are presented on the same Bile
secretion pathway [Klaassen and Aleksunes, 2010]. The highly correlated nature
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of genomic data has deleterious effects on the performance of our methods [Clarke
et al., 2008]. Although normalization during data filtering process and standardiza-
tion before statistical analysis can remove correlation, the normalization itself can
make different results [Qiu et al., 2005].
When there is a known biological structure among the predictor spaces, the
Bayesian framework provides a very natural setting for incorporating pre-existing
correlation structures in the covariate matrix. Li and Zhang (2010) proposed theo-
retical and computational schemes to incorporating prior structural information in
linear regression setting. They proposed to give general Ising prior for γ and present
Gibbs Sampling scheme of f(γ|Y ). The feature selection are then performed based
on the posterior inclusion probabilities of γ.
5.2.4 Extensions of Bayesian LASSO to other cumulative
logit models
In the near future, we also propose to investigate the extensions of the Bayesian
LASSO for other ordinal response models. For example, probit link models, adjacent
category model, forward and backward continuation-ratio models.
5.2.5 Inclusion of unpenalized predictors
It is sometimes desirable to include relevant predictors based on the prior knowledge.
For example, methylation is known to be age-related; therefore, the predictive model
including age as a non-penalized covariate can adjust for confounding. In the future,
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we would include no penalty subset for predictors, such as age in our Bayesian LASSO
framework.
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Appendix A
Chapter 2 appendix
A.1 GMIFS cumulative probit model with exam-
ple code
1 ############################----------------------------------
2 The code for fitting GMIFS cumulative probit models code in ordinal.
gmifs function
3 ############################-----------------------------------
4 cumprobit.likelihood<-function (par, xmatrix, y)
5 {
6 k <- length(unique(y))
7 levels <- sort(unique(y))
8 Ymat <- matrix(0, nrow = length(y), ncol = k)
9 for (i in levels) {
112
10 Ymat[which(y == i), which(levels == i)] <- 1
11 }
12 alpha <- numeric()
13 alpha[1] <- -Inf
14 alpha[k + 1] <- 400 ###change to 100 to match Jiayi
15 alpha[2:k] <- par[1:(k-1)]
16 beta<- par[k:length(par)]
17 Xb <- xmatrix %*% beta
18 G.mat <- matrix(0, nrow = length(y), ncol = k+1)
19 G.mat[,1]<-0
20 G.mat[,k+1]<-1
21 for (i in 2:k) { G.mat[,i]<-pnorm(alpha[i]+Xb) }
22 pi <- matrix(0, nrow = length(y), ncol = k)
23 for (i in 2:(k + 1)) {
24 pi[, i - 1] <- G.mat[,i] - G.mat[,i-1]
25 }
26 pi <- apply(pi * Ymat, 1, sum)
27 loglik <- sum(log(pi))
28 -loglik
29 }
30
31 cumprobit.stepwise<-function (x, y, epsilon = 0.0001, tol = 1e-05,
scale = FALSE)
113
32 {
33 levels <- sort(unique(y))
34 k <- length(unique(y))
35 x <- as.matrix(x)
36 vars <- dim(x)[2]
37 oldx <- x
38 if (scale) {
39 x <- scale(x, center = TRUE, scale = TRUE)
40 }
41 x <- cbind(x, -1 * x)
42 Ymat <- matrix(0, nrow = length(y), ncol = k)
43 for (i in levels) {
44 Ymat[which(y == i), which(levels == i)] <- 1
45 }
46
47 # initiating alpha
48 pi.0 <- table(y)/length(y)
49 alpha <- qnorm(cumsum(pi.0))[1:(k - 1)]
50 beta <- rep(0, dim(x)[2])
51 names(beta) <- dimnames(x)[[2]]
52 step <- 0
53 Estimates<-matrix(0,ncol=dim(oldx)[[2]])
54 alpha.update <- matrix(alpha, ncol = k-1)
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55 Likelihood<-numeric()
56 AIC<-numeric()
57
58 ui<-matrix(0,nr=length(alpha)-1,nc=length(alpha)) #constrain matrix
59 for (i in 1:dim(ui)[1]){
60 ui[i,i]<- -1
61 ui[i,i+1]<- 1
62 }
63
64 ci<-rep(0,dim(ui)[1])
65 repeat {
66 z <- matrix(ncol = k - 1, nrow = length(y))
67 for (i in 1:(k - 1)) {
68 z[, i] <- alpha[i] + x %*% beta
69 }
70
71
72 u1<-matrix(nr=dim(x)[1],nc=k)
73 for (j in 1:k){
74 if (j==1){
75 u1[,j]<-Ymat[,1]*dnorm(z[,1])/pnorm(z[,1])
76 }
77 else if (j <= k-1 ){
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78 u1[,j]<-Ymat[,j]*(dnorm(z[,j])-dnorm(z[,j-1]))/(pnorm(z[,j])-pnorm(
z[,j-1]))
79 }
80 else if (j == k) {
81 u1[,j]<- -Ymat[,k]*dnorm(z[,k-1])/(1-pnorm(z[,k-1])+1e-16)
82 }
83 }
84
85 u<- -t(x) %*% apply(u1,1,sum)
86
87
88
89 update.value <- min(u)
90 update.j <- which.min(u)
91 if (update.value < 0) {
92 beta[update.j] <- beta[update.j] + epsilon
93 }
94 Estimates<-rbind(Estimates,beta[1:vars]-beta[(vars+1):length(
beta)])
95
96
97 out<-constrOptim(alpha.update[step+1,],fn.cumprobit,grad=gr.
probit, ui=ui,ci=ci,x=x[,1:vars], y=y,
116
98 beta=beta[1:vars]-beta[(vars+1):length(beta)],method="BFGS")
99 #out<-optim(alpha.update[step+1,], fn.cumprobit, x=x[,1:vars], y=
y, beta=beta[1:vars]-beta[(vars+1):length(beta)], method="
BFGS")
100 alpha.update <- rbind(alpha.update, out$par)
101 alpha <- out$par
102 p <- sum(Estimates[step+2,]!=0) + length(alpha)
103
104 Likelihood[step+1]<- LL1<- -out$value
105 AIC[step+1]<-2*p-2*Likelihood[step+1]
106 print(step)
107
108 #cat("update.value=",update.value,"\n")
109
110 if (step >= 1 && LL1 - LL0 < tol) {
111 break
112 }
113 LL0 <- LL1
114 step <- 1 + step
115 }
116 beta <- Estimates[-1,]
117 alpha<-alpha.update[-1,]
118 model.select<-which.min(AIC)
117
119 list(beta = beta, alpha = alpha, x=oldx, y=y, scale=scale,
Likelihood=Likelihood, AIC=AIC, model.select=model.select)
120 }
121
122 fn.cumprobit<-function (par,beta,x, y)
123 {
124 k <- length(unique(y))
125 levels <- sort(unique(y))
126 Ymat <- matrix(0, nrow = length(y), ncol = k)
127 for (i in levels) {
128 Ymat[which(y == i), which(levels == i)] <- 1
129 }
130 alpha <- numeric()
131 alpha[1] <- -Inf
132 alpha[k + 1] <- 400 ###change to 100 to match Jiayi
133 alpha[2:k] <- par
134 xmatrix<-as.matrix(x)
135 Xb <- xmatrix %*% beta
136 G.mat <- matrix(0, nrow = length(y), ncol = k+1)
137 G.mat[,1]<-0
138 G.mat[,k+1]<-1
139 for (i in 2:k) { G.mat[,i]<-pnorm(alpha[i]+Xb) }
140 pi <- matrix(0, nrow = length(y), ncol = k)
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141 for (i in 2:(k + 1)) {
142 pi[, i - 1] <- G.mat[,i] - G.mat[,i-1]
143 }
144 pi <- apply(pi * Ymat, 1, sum)
145 loglik <- sum(log(pi))
146 #cat(par,"\n")
147 -loglik
148
149 }
150
151 #gradient function that used in constrOptim function
152 gr.probit<-function(par,beta,x, y){
153 k <- length(unique(y))
154 levels <- sort(unique(y))
155 Ymat <- matrix(0, nrow = length(y), ncol = k)
156 for (i in levels) {
157 Ymat[which(y == i), which(levels == i)] <- 1
158 }
159
160 alpha <- par
161 xmatrix<-as.matrix(x)
162 Xb <- xmatrix %*% beta
163 z <- matrix(ncol = k - 1, nrow = length(y))
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164 for (i in 1:(k - 1)) {
165 z[, i] <- alpha[i] + Xb
166 }
167
168 grad<-matrix(nr=dim(xmatrix)[1],nc=k-1)
169 for (j in 1:(k-1)){
170 if (j==1){
171 grad[,j]<-Ymat[,1]*dnorm(z[,1])/pnorm(z[,1])- Ymat[,2]*(dnorm(z
[,1])/(pnorm(z[,2])-pnorm(z[,1])))
172
173 }
174 else if (j < k-1 ){
175 grad[,j]<-Ymat[,j]*(dnorm(z[,j])/(pnorm(z[,j])-pnorm(z[,j-1])))-
Ymat[,j+1]*(dnorm(z[,j])/(pnorm(z[,j+1])-pnorm(z[,j])))
176 }
177 else if (j == k-1) {
178 grad[,j]<- Ymat[,k-1]*(dnorm(z[,k-1])/(pnorm(z[,k-1])-pnorm(z[,k
-2])))-Ymat[,k]*dnorm(z[,k-1])/(1-pnorm(z[,k-1]))
179 }
180 }
181
182 c(-apply(grad,2,sum))
183 }
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184
185
186
187 # Predict outcome for a given vector of fit=c(beta,alpha) estimates
188 predict.forward.cumprobit<-function(fit,newx,scale=TRUE,model.select=
NA) {
189 y<-fit$y
190 x<-fit$x
191 if (is.na(model.select)) model.select=dim(fit$beta)[1]
192 beta<-fit$beta[model.select,]
193 alpha<-fit$alpha[model.select,]
194 k<-length(unique(y))
195 if (identical(newx,x)) {
196 if (scale) {
197 newx<-scale(newx,center=TRUE,scale=TRUE)
198 }
199 } else if (scale) {
200 newx<-rbind(x,newx)
201 newx<-scale(newx,center=TRUE,scale=TRUE)
202 newx<-matrix(newx[-(1:dim(x)[1]),],ncol=dim(x)[2])
203 }
204 levels<-sort(unique(y))
205 z<-matrix(ncol=k-1,nrow=dim(newx)[1])
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206 for (i in 1:(k-1)) {
207 z[,i]<-alpha[i]+newx%*%beta
208 }
209 pi.z<-matrix(ncol=k,nrow=dim(newx)[1])
210 for (i in 1:k) {
211 if (i==1) {
212 pi.z[,i]<-pnorm(z[,i])
213 } else if (i <= k-1) {
214 pi.z[,i]<-pnorm(z[,i]) - pnorm(z[,i-1])
215 } else if (i==k) {
216 pi.z[,i]<-1 - pnorm(z[,i-1])
217 }
218 }
219 class<-levels[apply(pi.z,1,which.max)]
220 class}
221
222
223 #
#-------------------------------------------------------------------------
224 Code for performing example in chapter 2.2.3
225 #
#-------------------------------------------------------------------------
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226 ##09/15/2014###
227 rm(list=ls())
228 load("phenoinfo.RData") #pheno info for baseline data
229 load("qz_bcworkspace.RData") # geno info for baseline data
230 #library(gtools)
231 #library(reshape2)
232 #library(lme4)
233 library(ordinalgmifs)
234
235 #get rid of duplicated rows
236 pheno.info2<-pheno.info[!duplicated(pheno.info$Sid),] #I keep pheno.
info2 for numeric outcomes
237 dim(pheno.info2)
238
239 pheno.info3<-transform(pheno.info2, Stress =quantcut(pheno.info2$
TotalPSS, q=seq(0,1,by=0.25),labels=FALSE,na.rm=TRUE),
240 Anxiety=ifelse(pheno.info2$HadsAxiety<=7,1,ifelse(pheno.info2$
HadsAxiety <=10 ,2,3)),Depress=ifelse(pheno.info2$HadsDepress
<=7,1,ifelse(pheno.info2$HadsDepress <=10 ,2,3))
241 )
242
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243 #Filtering process
-----------------------------------------------------------------------------------------------------------------
244 #filtering out CpG sites that fully methylated (beta > 0.9) and not
methylated(beta <0.1) for all samples
245 ind.full_unmethy<-numeric()
246 for (i in 1:dim(beta.corrected)[1]){
247 ind.full_unmethy[i]<-ifelse(sum(beta.corrected[i,]<=0.1 | beta.
corrected[i,]>=0.9)==73,1,0)
248 }
249 table(ind.full_unmethy)
250 beta.filtered<-beta.corrected[ind.full_unmethy==0,]
251 #methy.M<-log(beta.filtered/(1-beta.filtered))
252 methy.M<-beta.filtered
253 dim(methy.M)
254
255 x.genes<-t(methy.M)
256
257 #Seperated model
------------------------------------------------------------------------------------------------------------------------------------------------
258 Anxiety.model<-ordinal.gmifs(Anxiety ~1,x=x.genes,data=pheno.info3,
epsilon=0.01,probability.model="Cumulative",link="probit",scale=
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TRUE)
259 Depress.model<-ordinal.gmifs(Depress ~1,x=x.genes,data=pheno.info3,
epsilon=0.01,probability.model="Cumulative",link="probit",scale=
TRUE)
260 Stress.model<-ordinal.gmifs(Stress ~1,x=x.genes,data=pheno.info3,
epsilon=0.01,probability.model="Cumulative",link="probit",scale=
TRUE)
261
262 save.image("ADS_gmifs1.RData")
263 #-------------------------------------------------
264 load("ADS_gmifs1.RData")
265 ls()
266 library(ordinalgmifs)
267 #AIC model misclassification--------------------
268 pred.an<-predict(Anxiety.model)
269 table(pheno.info3$Anxiety, pred.an$class)
270 pred.dep<-predict(Depress.model)
271 table(pheno.info3$Depress, pred.dep$class)
272 pred.st<-predict(Stress.model)
273 out<-table(pheno.info3$Stress, pred.st$class)
274 (sum(out)-sum(diag(out)))/sum(out)
275
276 #obtain BIC models--------------------------------------------------
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277 an.b<-coef(Anxiety.model, model.select=which.min(Anxiety.model$BIC))
278 dep.b<-coef(Depress.model, model.select=which.min(Depress.model$BIC))
279 st.b<-coef(Stress.model, model.select=which.min(Stress.model$BIC))
280
281 pred.an.bic<-predict(Anxiety.model,model.select=which.min(Anxiety.
model$BIC))
282 out<-table(pheno.info3$Anxiety, pred.an.bic$class)
283 out
284 pred.dep.bic<-predict(Depress.model,model.select=which.min(Depress.
model$BIC))
285 out<-table(pheno.info3$Depress, pred.dep.bic$class)
286 out
287 pred.st.bic<-predict(Stress.model,model.select=which.min(Stress.model
$BIC))
288 out<-table(pheno.info3$Stress, pred.st.bic$class)
289 out
290 (sum(out)-sum(diag(out)))/sum(out)
291
292 Sig.B<-list(Anxiety.BIC=an.b[an.b!=0][-c(1:2)],Depress.BIC=dep.b[dep.
b!=0][-c(1,2)],Stress.BIC=st.b[st.b!=0][-c(1,2,3)])
293 savehistory(file = "Probit analysis.Rhistory")
A.2 GMIFS continuation ratio model code
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1 ####----------------------------------------------------
2 Penalized forward continuation ratio model using probit link code
3 ####----------------------------------------------------
4 FCR_probit.fn<-function(par, x, y, beta) {
5 x<-as.matrix(x)
6 k <- length(unique(y))
7 levels <- sort(unique(y))
8 Ymat <- matrix(0, nrow = length(y), ncol = k)
9 for (i in levels) {
10 Ymat[which(y == i), which(levels == i)] <- 1
11 }
12 Xb<-x%*%beta
13 G.mat <- matrix(0, nrow = length(y), ncol = k)
14 G.mat[,1]<-pnorm(par[1]+Xb)
15 G.mat[,2]<-pnorm(par[2]+Xb)*(1-G.mat[,1])
16 if (k>3) {
17 for (i in 3:(k-1)) {
18 G.mat[,i]<-pnorm(par[i]+Xb)*(1-matrix(apply(G.mat[,1:(i-1)],1,
sum),nrow=nrow(G.mat),byrow=T))
19 }
20 }
21 G.mat[,k]<-1-matrix(apply(G.mat[,1:(k-1)],1,sum),nrow=nrow(G.mat),
byrow=T)
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22 pi <- Ymat*G.mat
23 pi <- apply(pi,1,sum)
24 loglik <- sum(log(pi))
25 -loglik
26 }
27
28
29 ### Forward Continuation Ratio GMIFS function ###
30 fcr_probit.stepwise<-
31 function(x,y,tol=1e-5, epsilon=0.0001, scale=FALSE, step=TRUE) {
32 levels<-sort(unique(y))
33 k<-length(unique(y))
34 x<-as.matrix(x)
35 vars<-dim(x)[2]
36 oldx<-x
37 if (scale) {
38 x<-scale(x,center=TRUE,scale=TRUE)
39 }
40 x<-cbind(x,-1*x)
41 Ymat<-matrix(0,nrow=length(y),ncol=k)
42 for (i in levels){
43 Ymat[which(y==i),which(levels==i)]<-1
44 }
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45 beta <- rep(0, dim(x)[2])
46 names(beta) <- dimnames(x)[[2]]
47
48 alpha<-numeric()
49 tab<-table(y)
50
51 Cum.Ymat<-matrix(0,nrow=nrow(Ymat),ncol=k-1)
52 for(i in 1:(k-1)) {
53 alpha[i]<- dnorm(tab[i]/sum(tab[i:k]))
54 Cum.Ymat[,i]<-apply(matrix(Ymat[,i:k],nrow=dim(Ymat)[1]),1,sum)
55 }
56 names(alpha)<-paste("alpha",1:(k-1),sep=".")
57 step<-0
58 Estimates<-matrix(0,ncol=dim(oldx)[[2]])
59 alpha.update <- matrix(alpha, ncol = k-1)
60 Likelihood<-numeric()
61 AIC<-numeric()
62 repeat {
63 u <- rep(0,dim(x)[[2]])
64 Xb<-x%*%beta
65 eta<-matrix(0,ncol=k-1,nrow=dim(x)[1])
66 for (i in 1:(k-1)) {
67 eta[,i]<-alpha[i] + Xb
129
68 }
69 z1<- dnorm(eta)/pnorm(eta)*Ymat[,1:(k-1)] + dnorm(eta)/(1-
pnorm(eta))*(Ymat[,1:(k-1)]-Cum.Ymat)
70 u<- -apply(t(x)%*%z1,1,sum)
71 update.value<-min(u)
72 if (update.value<0) {
73 beta[which.min(u)]<- beta[which.min(u)]+epsilon
74 }
75 Estimates<-rbind(Estimates,beta[1:vars]-beta[(vars+1):length(
beta)])
76 out<-optim(fn=FCR_probit.fn, par=alpha.update[step+1,], x=x
[,1:vars], y=y, beta=beta[1:vars]-beta[(vars+1):length(beta
)], method="BFGS")
77 alpha.update <- rbind(alpha.update, out$par)
78 alpha <- out$par
79 p <- sum(Estimates[step+2,]!=0) + length(alpha)
80 Likelihood[step+1]<- LL1<- -out$value
81 AIC[step+1]<-2*p-2*Likelihood[step+1]
82 if (step){
83 print(step)}
84 if ( (step>=1 && LL1-LL0<tol) ) {
85 break
86 }
130
87 LL0<-LL1
88 step<-1+step
89 }
90 beta<-Estimates[-1,]
91 alpha<-alpha.update[-1,]
92 model.select<-which.min(AIC)
93 list(beta = beta, alpha = alpha, x=oldx, y=y, scale=scale,
Likelihood=Likelihood, AIC=AIC, model.select=model.select)
94 }
95
96
97 ### Function to predict class ###
98 predict.FCR_probit<-function(fit,newx,model.select=NA) {
99 x<-fit$x
100 y<-fit$y
101 if (is.na(model.select)) model.select=dim(fit$beta)[1]
102 beta<-fit$beta[model.select,]
103 alpha<-fit$alpha[model.select,]
104 k<-length(unique(y))
105 newx<-as.matrix(newx)
106 if (identical(newx,x)) {
107 if (fit$scale) {
108 newx<-scale(newx,center=TRUE,scale=TRUE)
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109 }
110 } else if (fit$scale) {
111 newx<-rbind(x,newx)
112 newx<-scale(newx,center=TRUE,scale=TRUE)
113 newx<-matrix(newx[-(1:dim(x)[1]),],ncol=dim(x)[2])
114 }
115 levels<-sort(unique(y))
116 Xb<-newx%*%beta
117 pi <- matrix(0, nrow = dim(newx)[1], ncol = k)
118 pi[,1]<-pnorm(alpha[1]+Xb)
119 pi[,2]<-pnorm(alpha[2]+Xb)*(1-pi[,1])
120 if (k>3) {
121 for (i in 3:(k-1)) {
122 pi[,i]<-pnorm(alpha[i]+Xb)*(1-matrix(apply(pi[,1:(i-1)],1,sum),
nrow=nrow(pi),byrow=T))
123 }
124 }
125 pi[,k]<-1-matrix(apply(pi[,1:(k-1)],1,sum),nrow=nrow(pi),byrow=T)
126 class<-levels[apply(pi,1,which.max)]
127 list(predicted=pi,class=class)
128 }
129
130 ####----------------------------------------------------
132
131 Penalized back continuation ratio model using probit link code
132 ####----------------------------------------------------
133 backcr_probit.stepwise<-
134 function(x,y,tol=1e-5, epsilon=0.0001, scale=FALSE,step=TRUE) {
135 levels<-sort(unique(y))
136 k<-length(unique(y))
137 x<-as.matrix(x)
138 vars<-dim(x)[2]
139 oldx<-x
140 if (scale) {
141 x<-scale(x,center=TRUE,scale=TRUE)
142 }
143 x<-cbind(x,-1*x)
144 Ymat<-matrix(0,nrow=length(y),ncol=k)
145 for (i in levels){
146 Ymat[which(y==i),which(levels==i)]<-1
147 }
148 beta <- rep(0, dim(x)[2])
149 names(beta) <- dimnames(x)[[2]]
150
151 alpha<-numeric()
152 tab<-table(y)
153
133
154 Cum.Ymat<-matrix(0,nrow=nrow(Ymat),ncol=k-1)
155 for(i in 1:(k-1)) {
156 alpha[i]<- dnorm(tab[i+1]/sum(tab[1:(i+1)]))
157 Cum.Ymat[,i]<-apply(matrix(Ymat[,(i+1):k],nrow=dim(Ymat)[1]),1,sum
)
158 }
159 names(alpha)<-paste("alpha",1:(k-1),sep=".")
160 step<-0
161 Estimates<-matrix(0,ncol=dim(oldx)[[2]])
162 alpha.update <- matrix(alpha, ncol = k-1)
163 Likelihood<-numeric()
164 AIC<-numeric()
165 repeat {
166 u <- rep(0,dim(x)[[2]])
167 Xb<-x%*%beta
168 eta<-matrix(0,ncol=k-1,nrow=dim(x)[1])
169 for (i in 1:(k-1)) {
170 eta[,i]<-alpha[i] + Xb
171 }
172 z1<- dnorm(eta)/pnorm(eta)*Ymat[,2:k] + dnorm(eta)/(1-
pnorm(eta))*(Cum.Ymat-1)
173 u<- -apply(t(x)%*%z1,1,sum)
174 update.value<-min(u)
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175 if (update.value<0) {
176 beta[which.min(u)]<- beta[which.min(u)]+epsilon
177 }
178 Estimates<-rbind(Estimates,beta[1:vars]-beta[(vars+1):length(
beta)])
179 out<-optim(fn=BackCR_probit.fn, par=alpha.update[step+1,], x=x
[,1:vars], y=y, beta=beta[1:vars]-beta[(vars+1):length(beta
)],method="BFGS")
180 alpha.update <- rbind(alpha.update, out$par)
181 alpha <- out$par
182 p <- sum(Estimates[step+2,]!=0) + length(alpha)
183 Likelihood[step+1]<- LL1<- -out$value
184 AIC[step+1]<-2*p-2*Likelihood[step+1]
185 if (step){
186 print(step)}
187 if ( (step>=1 && LL1-LL0<tol) ) {
188 break
189 }
190 LL0<-LL1
191 step<-1+step
192 }
193 beta<-Estimates[-1,]
194 alpha<-alpha.update[-1,]
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195 model.select<-which.min(AIC)
196 list(beta = beta, alpha = alpha, x=oldx, y=y, scale=scale,
Likelihood=Likelihood, AIC=AIC, model.select=model.select)
197 }
198
199
200 ### Function to update alpha ###
201 BackCR_probit.fn<-function(par, x, y, beta) {
202 x<-as.matrix(x)
203 k <- length(unique(y))
204 levels <- sort(unique(y))
205 Ymat <- matrix(0, nrow = length(y), ncol = k)
206 for (i in levels) {
207 Ymat[which(y == i), which(levels == i)] <- 1
208 }
209 Xb<-x%*%beta
210 G.mat <- matrix(0, nrow = length(y), ncol = k)
211 G.mat[,k]<-pnorm(par[k-1]+Xb)
212 G.mat[,k-1]<-pnorm(par[k-2]+Xb)*(1-G.mat[,k])
213 if (k>3) {
214 for (i in (k-2):2) {
215 G.mat[,i]<-pnorm(par[i-1]+Xb)*(1-matrix(apply(G.mat[,k:(i+1)],1,
sum),nrow=nrow(G.mat),byrow=T))
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216 }
217 }
218 G.mat[,1]<-1-matrix(apply(G.mat[,k:2],1,sum),nrow=nrow(G.mat),byrow
=T)
219 pi <- Ymat*G.mat
220 pi <- apply(pi,1,sum)
221 loglik <- sum(log(pi))
222 -loglik
223 }
224
225
226
227 ### Function to predict class ###
228 predict.backCR_probit<-function(fit,newx,model.select=NA) {
229 x<-fit$x
230 y<-fit$y
231 if (is.na(model.select)) model.select=dim(fit$beta)[1]
232 beta<-fit$beta[model.select,]
233 alpha<-fit$alpha[model.select,]
234 k<-length(unique(y))
235 newx<-as.matrix(newx)
236 if (identical(newx,x)) {
237 if (fit$scale) {
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238 newx<-scale(newx,center=TRUE,scale=TRUE)
239 }
240 } else if (fit$scale) {
241 newx<-rbind(x,newx)
242 newx<-scale(newx,center=TRUE,scale=TRUE)
243 newx<-matrix(newx[-(1:dim(x)[1]),],ncol=dim(x)[2])
244 }
245 levels<-sort(unique(y))
246 Xb<-newx%*%beta
247 pi <- matrix(0, nrow = dim(newx)[1], ncol = k)
248 pi[,k]<-pnorm(alpha[k-1]+Xb)
249 pi[,k-1]<-pnorm(alpha[k-2]+Xb)*(1-pi[,k])
250 if (k>3) {
251 for (i in (k-2):2) {
252 pi[,i]<-pnorm(alpha[i-1]+Xb)*(1-matrix(apply(pi[,k:(i+1)],1,sum)
,nrow=nrow(pi),byrow=T))
253 }
254 }
255 pi[,1]<-1-matrix(apply(pi[,k:2],1,sum),nrow=nrow(pi),byrow=T)
256 class<-levels[apply(pi,1,which.max)]
257 list(predicted=pi,class=class)
258 }
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AIC model : CpG sites that were significantly associated with Anxiety (Illumina
loci ID) : cg22417589 cg07424927 cg17129821 cg10313047 cg15060599 cg18005693
cg20449692 cg03827835 cg13619597 cg22056094 cg26630791 cg15262505 cg13679303
cg27615378 cg27332938 cg02072400 cg16094511 cg12485185 cg00049664 cg09955084
cg08900396 cg15250633 cg08888354 cg09759458 cg17399362 cg01943289 cg00375105
cg01044189 cg11152528 cg18412777 cg21471515 cg25832529 cg07501029 cg16298457
cg17443007 cg01267068 cg02058002 cg16277214 cg17336044 cg22532079 cg05350396
cg05237015 cg02734955 cg19685567 cg23169584 cg23684218 cg05483021 cg05738743
cg17795240 cg19049724 cg13717350 cg14090916 cg14223966 cg12566078 cg16871435
cg23260525 cg06730161 cg15001406 cg06722407 cg17809365 cg26657240 cg14556515
cg20985587 cg03234186 cg03832839 cg18917378 cg00192046
CpG sites that were significantly associated with Depression (Illumina loci ID) :
cg00378717 cg00147788 cg20399616 cg24394624 cg10043663 cg17336044 cg03049125
cg03091070 cg19748937 cg18873166 cg05453820 cg13781956 cg19683821 cg25542438
cg20418308 cg14516632 cg06771839 cg04932840 cg19913465
CpG sites that were significantly associated with Stress (Illumina loci ID) :
cg21566642 cg22040631 cg13619597 cg22307444 cg10758057 cg10174864 cg00324161
cg21121843 cg19755435 cg26889118
BIC model : CpG sites that were significantly associated with Anxiety (Illumina
loci ID) : cg15060599
CpG sites that were significantly associated with Depression (Illumina loci ID) :
cg24394624 cg03091070 cg13781956 cg19683821 cg25542438 cg20418308 cg19913465
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CpG sites that were significantly associated with Stress (Illumina loci ID) :
cg21566642 cg22040631 cg13619597 cg22307444 cg10758057 cg10174864 cg00324161
cg21121843 cg19755435 cg26889118
A.3 GMIFS stereotype logit model with example
code
1 ### sterotype model with fixed beta
2 stereo.fn<-function (par, xmatrix, y,beta)
3 {
4 k <- length(unique(y)) # there are k levels
5 levels <- sort(unique(y))
6 Ymat <- matrix(0, nrow = length(y), ncol = k) # create a matrix of
i * k, yi1=1 if control else 0, yi2=1 if incipient else 0...
7 for (i in levels) {
8 Ymat[which(y == i), which(levels == i)] <- 1
9 }
10 Xb<-xmatrix%*%beta
11 eta<-matrix(0,ncol=k-1,nrow=dim(xmatrix)[1])
12 eta[,1] <- exp(par[1] + Xb)
13 for (i in 2:(k-1)) {
14 eta[,i]<- exp(par[i] + par[i+k-2]*Xb)
15 }
140
16 pik<- 1- apply(eta,1,sum)/(1+apply(eta,1,sum))
17
18
19 pi<-matrix(0,ncol=k,nrow=dim(xmatrix)[1])
20 pi[,k]<- pik
21 pi[,1:(k-1)]<-eta*pik
22 loglik<-sum(apply(Ymat*log(pi),1,sum))
23 -loglik
24 }
25
26 stereo.stepwise<-function(xmatrix,y,tol=1e-5,epsilon=0.001, scale=
FALSE) {
27 levels<-sort(unique(y))
28 k<-length(unique(y))
29 x<-as.matrix(xmatrix)
30 vars<-dim(x)[2]
31 oldx<-x
32 if (scale) {
33 x<-scale(x,center=TRUE,scale=TRUE)
34 }
35 x<-cbind(x,-1*x)
36 Ymat<-matrix(0,nrow=length(y),ncol=k)
37 for (i in levels){
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38 Ymat[which(y==i),which(levels==i)]<-1
39 }
40
41 #initialize beta
42 beta <- rep(0, dim(x)[2])
43 names(beta) <- dimnames(x)[[2]]
44
45 #initialize alpha
46 alpha<-numeric()
47 pi.0 <- table(y)/length(y)
48 for(i in 1:(k-1)) {
49 alpha[i]<- log(pi.0[i]/pi.0[k])
50 }
51 names(alpha)<-paste("alpha",1:(k-1),sep=".")
52
53 #initialize phi
54 phi <- c(1,rep(0.1,k-2))
55 names(phi) <- paste("phi",1:(k-1),sep=".")
56
57 step<-0
58 Estimates<-matrix(0,ncol=dim(oldx)[[2]])
59 alpha.update <- matrix(alpha, ncol = k-1) # 1*3 matrix for updated
alpha
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60 phi.update <- matrix(phi,ncol=k-1)
61
62 Likelihood<-numeric()
63 AIC<-numeric()
64 repeat {
65 u <- rep(0,dim(x)[[2]])
66 Xb<-x%*%beta
67
68 eta<-matrix(0,ncol=k-1,nrow=dim(x)[1])
69 for (i in 1:(k-1)) {
70 eta[,i]<- exp(alpha[i] + phi[i]*Xb)
71 }
72 denom<- 1+apply(eta,1,sum)
73 numer<-matrix(0,ncol=k-1,nrow=dim(x)[1])
74 for (i in 1:(k-1)){
75 numer[,i]<-eta[,i]*phi[i]
76 }
77 numer2<- -apply(numer,1,sum)*Ymat[,k]/denom #contribution to
log-like for class K
78 numer1<-matrix(0,ncol=k-1,nrow=dim(x)[1]) # contribution to
log-like for classes 1 to K-1
79 for (i in 1:(k-1)){
80 numer1[,i]<-Ymat[,i]*(phi[i]-apply(numer,1,sum)/denom)
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81 }
82 numer1f<- apply(numer1,1,sum)
83 dll<-x*(numer1f + numer2)
84 u<-apply(-dll,2,sum) # u is a 2p*1 vector of -dlogL/dbeta
85 update.value<-min(u)
86 if (update.value<0) {
87 beta[which.min(u)]<- beta[which.min(u)]+epsilon
88 }
89 Estimates<-rbind(Estimates,beta[1:vars]-beta[(vars+1):length(
beta)]) #?
90 #out<-optim(par=c(alpha.update[step+1,],phi.update[step+1,2:
dim(phi.update)[2]]), stereo.fn, x=x[,1:vars], y=y, beta=
beta[1:vars]-beta[(vars+1):length(beta)], method="BFGS")
91 out<-optim(par=c(alpha.update[step+1,],phi.update[step+1,2:
dim(phi.update)[2]]), stereo.fn, x=x[,1:vars], y=y, beta=
beta[1:vars]-beta[(vars+1):length(beta)],
92 method="L-BFGS-B",upper=c(rep(Inf,k-1),rep(1,k-2)),lower=c(rep
(-Inf,k-1),rep(0,k-2)))
93 alpha.update <- rbind(alpha.update, (out$par)[1:k-1])
94 phi.update <- rbind(phi.update, c(1,out$par[k:length(out$par)]))
95 alpha <- out$par[1:k-1]
96 phi <- c(1,out$par[k:length(out$par)])
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97 p <- sum(Estimates[step+2,]!=0) + length(alpha) + length(phi)
# ?
98 Likelihood[step+1]<- LL1<- -out$value
99 AIC[step+1]<-2*p-2*Likelihood[step+1]
100 print(step)
101 if (step >= 1 && LL1 - LL0 < tol) {
102 break
103 }
104 LL0<-LL1
105 step<-1+step
106 }
107 beta<-Estimates[-1,]
108 alpha<-alpha.update[-1,]
109 phi<-phi.update[-1,]
110 model.select<-which.min(AIC)
111 list(beta = beta, alpha = alpha, phi = phi, x=oldx, y=y, scale=
scale, Likelihood=Likelihood, AIC=AIC, model.select=model.
select)
112 }
113
114
115
116 ### Function to predict class ###
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117 predict.stereo<-function(fit,newx,model.select=NA) {
118 x<-fit$x
119 y<-fit$y
120 if (is.na(model.select)) model.select=dim(fit$beta)[1] # if no
model.select, using the last iteration
121 beta<-fit$beta[model.select,]
122 alpha<-fit$alpha[model.select,]
123 phi<-fit$phi[model.select,]
124 k<-length(unique(y))
125 newx<-as.matrix(newx)
126 if (identical(newx,x)) {
127 if (fit$scale) {
128 newx<-scale(newx,center=TRUE,scale=TRUE)
129 }
130 } else if (fit$scale) {
131 newx<-rbind(x,newx)
132 newx<-scale(newx,center=TRUE,scale=TRUE)
133 newx<-matrix(newx[-(1:dim(x)[1]),],ncol=dim(x)[2])
134 }
135 levels<-sort(unique(y))
136 eta<-matrix(0,ncol=k-1,nrow=dim(newx)[1])
137 Xb <- newx%*%beta
138 for (i in 1:(k-1)) {
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139 eta[,i]<-exp(alpha[i] + phi[i]*Xb)
140 }
141
142 pik<- 1- apply(eta,1,sum)/(1+apply(eta,1,sum))
143
144
145 pi<-matrix(0,ncol=k,nrow=dim(newx)[1])
146 pi[,k]<- pik
147 pi[,1:(k-1)]<-eta*pik
148
149 class<-levels[apply(pi,1,which.max)]
150 list(predicted=pi,class=class)
151 }
152
153
154 load("GSE1297.RData")
155 class<-sorted.pheno$y
156 x<-log(x,2)
157 x<-scale(x,center=TRUE,scale=TRUE)
158
159
160 Alz.stereo<-stereo.stepwise(xmatrix=x,y=class)
147
161 fit.class<-predict.stereo(Alz.stereo,newx=x,model.select=Alz.stereo$
model.select)
162 table(fit.class$class,class)
163 full.class<-predict.stereo(Alz.stereo,newx=x,model.select=dim(Alz.
stereo$beta)[1])
164 table(full.class$class,class)
165 save.image("stereo1297.RData")
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Appendix B
Chapter 3 appendix
B.1 Simulation code
1 #-----------------------------------------
2 #Simulation 1 code------------------------
3 #-----------------------------------------
4 n.sim<-200
5 set.seed(125)
6 x.var<-matrix(nr=n.sim,ncol=5)
7 for (i in 1:5){
8 x.var[,i]<-rnorm(n.sim,0,1)
9 }
10
11
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12 alpha1=-1
13 alpha2=2
14
15 beta1<-3
16 beta2<-1
17
18 logit1<-alpha1+beta1*x.var[,1]+beta2*x.var[,2]
19 logit2<-alpha2+beta1*x.var[,1]+beta2*x.var[,2]
20
21 G<-function(z){
22 exp(z)/(1+exp(z))
23 }
24
25 p1<-G(logit1)
26 p2<-G(logit2)
27
28 tmp <- runif(n.sim)
29 y <- 4-((tmp < p1) + (tmp < p2) + (tmp<1))
30 y
31 table(y)
32
33 simu.x<-scale(x.var,center=TRUE,scale=TRUE)
34 simu.y<-y
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35
36 ##vglm
37 library(VGAM)
38 vglm.simu<-vglm(simu.y~ simu.x[,1]+simu.x[,2] + simu.x[,3]+simu.x[,4]
+ simu.x[,5], family=cumulative(parallel=T,reverse=F))
39 vglm.pi<-predict(vglm.simu,type="response")
40 vglm.class<-apply(vglm.pi,1,which.max)
41 out<-table(simu.y, vglm.class)
42 1-sum(diag(out))/sum(out)
43 summary(vglm.simu)
44
45 #ordinalgmifs
46 library(ordinalgmifs)
47 penal.ord.simu<-ordinal.gmifs(simu.y~1, x=simu.x, data=data.frame(
simu.x))
48 summary(penal.ord.simu)
49
50
51 #Bayesian
52 library(rjags)
53 library(R2jags)
54 k<-length(unique(simu.y))
55 pi.0 <- table(simu.y)/length(simu.y)
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56 alpha.0 <- log(cumsum(pi.0)/(1 - cumsum(pi.0)))[1:(k - 1)]
57 simu.inits1<-list(tau=alpha.0,beta=c(rep(0,5)))
58 simu.inits2<-list(tau=c(-1,1),beta=c(rnorm(5,0,0.01)))
59 simu.inits3<-list(tau=c(-2,2),beta=c(rnorm(5,0,0.001)))
60 simu.inits<-list(simu.inits1,simu.inits2,simu.inits3)
61 simu.data<-list(Y=simu.y,X=as.matrix(simu.x),N=length(simu.y),nb=5,k=
k)
62 simu.params<-c("tau","beta","gamma","lambda","bgamma")
63
64 simujags <- jags(data=simu.data, inits=simu.inits, simu.params,
65 n.iter=10000, model.file="Non_info_model.txt",n.chains=3,n.thin=2)
66 simujags.upd <-autojags(simujags,n.thin=2,n.iter=5000,Rhat=1.1,n.
update=4)
67 print(simujags.upd)
68 range(simujags.upd$BUGSoutput$summary[,"Rhat"])
69
70
71 #####traceplot#####
72
73 traceplot.qz<-function(x,param,v.name){
74 x <- x$BUGSoutput
75 n.chain <- x$n.chains
76 n.keep <- x$n.keep
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77 bugs.array <- x$sims.array
78 range.x <- c(1, n.keep)
79
80 range.y <- range(bugs.array[, , param])
81 plot(range.x, range.y, type = "n", main = v.name, xlab = "iteration",
ylab = v.name, xaxt = "n",
82 xaxs = "i")
83
84 col = rainbow(x$n.chains)
85 for (i in 1:n.chain) {
86 x.cord <- 1:n.keep
87 y.cord <- bugs.array[, i, param]
88 lines(x.cord, y.cord, col = col[i], lty = 1,
89 lwd = 1)
90 }
91 abline(h=x$summary[param,"mean"],lwd=2)
92 mtext(paste("Mean=",round(x$summary[param,"mean"],2)),side=4,at=x$
summary[param,"mean"],line=0.5)
93 axis(1, at = seq(0, n.keep, n.keep * 0.1), tick = TRUE)
94 }
95
96
97 par(mfrow=c(2,1))
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98 traceplot.qz(x=simujags.upd,param="tau[1]",v.name=expression(alpha
[1]))
99 traceplot.qz(x=simujags.upd,param="tau[2]",v.name=expression(alpha
[2]))
100
101
102 par(mfrow=c(3,2))
103 traceplot.qz(x=simujags.upd,param="beta[1]",v.name=expression(beta
[1]))
104 traceplot.qz(x=simujags.upd,param="beta[2]",v.name=expression(beta
[2]))
105 traceplot.qz(x=simujags.upd,param="beta[3]",v.name=expression(beta
[3]))
106 traceplot.qz(x=simujags.upd,param="beta[4]",v.name=expression(beta
[4]))
107 traceplot.qz(x=simujags.upd,param="beta[5]",v.name=expression(beta
[5]))
108
109 par(mfrow=c(3,2))
110 traceplot.qz(x=simujags.upd,param="bgamma[1]",v.name=expression(gamma
[1]*beta[1]))
111 traceplot.qz(x=simujags.upd,param="bgamma[2]",v.name=expression(gamma
[2]*beta[2]))
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112 traceplot.qz(x=simujags.upd,param="bgamma[3]",v.name=expression(gamma
[3]*beta[3]))
113 traceplot.qz(x=simujags.upd,param="bgamma[4]",v.name=expression(gamma
[4]*beta[4]))
114 traceplot.qz(x=simujags.upd,param="bgamma[5]",v.name=expression(gamma
[5]*beta[5]))
115
116
117
118
119 rm(list=ls())
120
121 #--------------------------------------------------
122 #Simulation 2 codes--------------------------------
123 #--------------------------------------------------
124
125 #Simulation for frequentist GMIFS
--------------------------------------
126 library(ordinalgmifs)
127 n.sim<-90
128 p.sim<-100
129
130 gmifs.coef<-list()
155
131 seed.se<-seq(1234,123456,by=120)
132 for (j in 1:100){
133 set.seed(seed.se[[j]])
134 x.var<-matrix(nr=n.sim,ncol=p.sim)
135 for (i in 1:5){
136 x.var[,i]<-c(rnorm(30,0,0.4),rnorm(30,1,0.4),rnorm(30,2,0.4))}
137
138
139 for (i in 6:p.sim){
140 x.var[,i]<-rnorm(n.sim,0,0.4)
141 }
142
143
144 colnames(x.var)<-paste0("x",seq(1,p.sim))
145
146
147 simu.x<-scale(x.var,center=TRUE,scale=TRUE)
148 simu.y<-c(rep(1,30),rep(2,30),rep(3,30))
149 table(simu.y)
150 head(simu.x)
151
152 penal.ord.simu<-ordinal.gmifs(simu.y~1, x=simu.x, data=data.frame(
simu.x),
156
153 epsilon = 0.001,verbose=TRUE)
154 summary(penal.ord.simu)
155 coefficients<-coef(penal.ord.simu)
156 gmifs.coef[[j]]<-coefficients[coefficients!=0]
157 }
158
159 save.image("gmifs100_01132016.RData")
160
161 #Simulation for Bayesian with non-info \alpha -----------------------
162 library(rjags)
163 library(R2jags)
164 n.sim<-90
165 p.sim<-100
166 num<-100
167 simujags.upd<-list()
168 seed.se<-seq(1234,123456,by=120)
169 for (j in 1:100){
170 set.seed(seed.se[j])
171 x.var<-matrix(nr=n.sim,ncol=p.sim)
172 for (i in 1:5){
173 x.var[,i]<-c(rnorm(30,0,0.4),rnorm(30,1,0.4),rnorm(30,2,0.4))}
174
175
157
176 for (i in 6:p.sim){
177 x.var[,i]<-rnorm(n.sim,0,0.4)
178 }
179
180
181 colnames(x.var)<-paste0("x",seq(1,p.sim))
182
183
184 simu.x<-scale(x.var,center=TRUE,scale=TRUE)
185 simu.y<-c(rep(1,30),rep(2,30),rep(3,30))
186 table(simu.y)
187 head(simu.x)
188
189 k<-length(unique(simu.y))
190 pi.0 <- table(simu.y)/length(simu.y)
191 alpha.0 <- log(cumsum(pi.0)/(1 - cumsum(pi.0)))[1:(k - 1)]
192 simu.inits1<-list(tau=alpha.0,beta=c(rep(0,num)))
193 simu.inits2<-list(tau=c(-1,1),beta=c(rep(0,num)))
194 simu.inits<-list(simu.inits1,simu.inits2)
195 simu.data<-list(Y=simu.y,X=as.matrix(simu.x),N=length(simu.y),nb=num,
k=k)
196 simu.params<-c("tau","beta","gamma")
197
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198 simujags <- jags(data=simu.data, inits=simu.inits, simu.params,
199 n.iter=10000, model.file="Non_info_model.txt",n.chains=2,n.thin=16)
200 simujags.upd[[j]] <-autojags(simujags,n.thin=16,n.iter=5000,Rhat=1,n.
update=4)$BUGSoutput$summary
201
202 }
203
204 save.image("bayes100_flat.RData")
205
206
207 #Simulation with shrink \lambda, non-info \alpha
--------------------------------------------
208 library(rjags)
209 library(R2jags)
210 n.sim<-90
211 p.sim<-100
212 num<-100
213 simujags.upd<-list()
214 seed.se<-seq(1234,123456,by=120)
215 for (j in 1:100){
216 set.seed(seed.se[j])
217 x.var<-matrix(nr=n.sim,ncol=p.sim)
218 for (i in 1:5){
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219 x.var[,i]<-c(rnorm(30,0,0.4),rnorm(30,1,0.4),rnorm(30,2,0.4))}
220
221
222 for (i in 6:p.sim){
223 x.var[,i]<-rnorm(n.sim,0,0.4)
224 }
225
226
227 colnames(x.var)<-paste0("x",seq(1,p.sim))
228
229
230 simu.x<-scale(x.var,center=TRUE,scale=TRUE)
231 simu.y<-c(rep(1,30),rep(2,30),rep(3,30))
232 table(simu.y)
233 head(simu.x)
234
235 k<-length(unique(simu.y))
236 pi.0 <- table(simu.y)/length(simu.y)
237 alpha.0 <- log(cumsum(pi.0)/(1 - cumsum(pi.0)))[1:(k - 1)]
238 simu.inits1<-list(tau=alpha.0,beta=c(rep(0,num)))
239 simu.inits2<-list(tau=c(-1,1),beta=c(rep(0,num)))
240 simu.inits<-list(simu.inits1,simu.inits2)
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241 simu.data<-list(Y=simu.y,X=as.matrix(simu.x),N=length(simu.y),nb=num,
k=k)
242 simu.params<-c("tau","beta","gamma")
243
244 simujags <- jags(data=simu.data, inits=simu.inits, simu.params,
245 n.iter=10000, model.file="Non_info_model2.txt",n.chains=2,n.thin=16)
246 simujags.upd[[j]] <-autojags(simujags,n.thin=16,n.iter=5000,Rhat=1,n.
update=4)$BUGSoutput$summary
247
248 }
249
250 save.image("bayes100_shrink.RData")
251
252 #Simulation with informative \alphas ----------------------
253 library(rjags)
254 library(R2jags)
255 n.sim<-90
256 p.sim<-100
257 num<-100
258 simujags.upd<-list()
259 seed.se<-seq(1234,123456,by=120)
260 for (j in 1:100){
261 set.seed(seed.se[j])
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262 x.var<-matrix(nr=n.sim,ncol=p.sim)
263 for (i in 1:5){
264 x.var[,i]<-c(rnorm(30,0,0.4),rnorm(30,1,0.4),rnorm(30,2,0.4))}
265
266
267 for (i in 6:p.sim){
268 x.var[,i]<-rnorm(n.sim,0,0.4)
269 }
270
271
272 colnames(x.var)<-paste0("x",seq(1,p.sim))
273
274
275 simu.x<-scale(x.var,center=TRUE,scale=TRUE)
276 simu.y<-c(rep(1,30),rep(2,30),rep(3,30))
277 table(simu.y)
278 head(simu.x)
279
280 k<-length(unique(simu.y))
281 pi.0 <- table(simu.y)/length(simu.y)
282 alpha.0 <- log(cumsum(pi.0)/(1 - cumsum(pi.0)))[1:(k - 1)]
283
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284 simu.inits1<-list(tau1=alpha.0[1],beta=c(rep(0,100)),Diff=alpha.0[2]-
alpha.0[1])
285 simu.inits2<-list(tau1=-1,beta=c(rep(0,100)),Diff=2)
286 simu.inits3<-list(tau1=-2,beta=c(rep(0,100)),Diff=4)
287 simu.inits<-list(simu.inits1,simu.inits2,simu.inits3)
288 simu.data<-list(Y=simu.y,X=as.matrix(simu.x),N=length(simu.y),nb=num,
k=k,a=alpha.0[1])
289 simu.params<-c("tau1","Diff","beta","gamma")
290
291
292 simujags <- jags(data=simu.data, inits=simu.inits, simu.params,
293 n.iter=5000, model.file="Info_model.txt",n.chains=3,n.thin=16)
294 simujags.upd[[j]] <-autojags(simujags,n.thin=16,n.iter=2000,Rhat=1,n.
update=4)$BUGSoutput$summary
295
296 }
297
298 save.image("bayes100_info.RData")
299
300
301 #Data loading--------------------------------------
302 #load bayesian model with noninformative alpha prior and gamma (1,1)
lambda prior
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303 load("bayes100_flat.RData")
304 post.flat<-simujags.upd
305 rm(list=ls()[ls()!="post.flat"])
306
307 #load bayesian model with informative alpha prior and gamma (1,1)
lambda prior
308 load("bayes100_info.RData")
309 post.info<-simujags.upd
310 rm(list=ls()[!ls()%in%c("post.flat","post.info")])
311
312 #load bayesian model with flat alpha prior but different gamma
(0.025,0.05) lambda prior
313 load("bayes100_shrink.RData")
314 post.shrink<-simujags.upd
315 rm(list=ls()[!ls()%in%c("post.flat","post.info","post.shrink")])
316
317 #load gmifs model
318 load("gmifs100_01132016.RData")
319 rm(list=ls()[!ls()%in%c("post.flat","post.info","post.shrink","gmifs.
coef")])
320
321
322 #analysis--------------------------------------
164
323 select.threshold<-0.5
324 freq.alpha<-matrix(0,nc=2,nr=100)
325 freq.beta<-matrix(0,nc=100,nr=100)
326 freq.table<-matrix(0,nc=100,nr=100)
327
328
329 flat.alpha<-matrix(nr=100,nc=2)
330 flat.beta<-matrix(nr=100,nc=100)
331 flat.table<-matrix(0,nr=100,nc=100)
332
333 info.alpha<-matrix(nr=100,nc=2)
334 info.beta<-matrix(nr=100,nc=100)
335 info.table<-matrix(0,nr=100,nc=100)
336
337 shrink.alpha<-matrix(nr=100,nc=2)
338 shrink.beta<-matrix(nr=100,nc=100)
339 shrink.table<-matrix(0,nr=100,nc=100)
340
341
342 alpha.ind<-grep("tau",names(post.flat[[1]][,"mean"]))
343 beta.ind<-grep("beta",names(post.flat[[1]][,"mean"]))
344 gamma.ind<-grep("gamma",names(post.flat[[1]][,"mean"]))
345
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346 alpha.ind2<-c(grep("Diff",names(post.info[[1]][,"mean"])),grep("tau1"
,names(post.info[[1]][,"mean"])))
347 beta.ind2<-grep("beta",names(post.info[[1]][,"mean"]))
348 gamma.ind2<-grep("gamma",names(post.info[[1]][,"mean"]))
349
350
351 for(i in 1:100){
352 flat.alpha[i,]<-post.flat[[i]][,"mean"][alpha.ind]
353 flat.beta[i,]<-post.flat[[i]][,"mean"][beta.ind]
354 flat.table[i,which(post.flat[[i]][,"mean"][gamma.ind]>=select.
threshold)]<-1
355
356 shrink.alpha[i,]<-post.shrink[[i]][,"mean"][alpha.ind]
357 shrink.beta[i,]<-post.shrink[[i]][,"mean"][beta.ind]
358 shrink.table[i,which(post.shrink[[i]][,"mean"][gamma.ind]>=select.
threshold)]<-1
359
360 info.alpha[i,]<-post.info[[i]][,"mean"][alpha.ind2]
361 info.beta[i,]<-post.info[[i]][,"mean"][beta.ind2]
362 info.table[i,which(post.info[[i]][,"mean"][gamma.ind2]>=select.
threshold)]<-1
363
364 freq.alpha[i,]<-gmifs.coef[[i]][1:2]
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365 freq.beta.ind<-paste("x",seq(1:100),sep="") %in% names(gmifs.coef[[i
]][-(1:2)])
366 freq.beta[i,freq.beta.ind]<- gmifs.coef[[i]][-c(1:2)]
367 freq.table[i,freq.beta.ind]<-1
368 }
369
370 flat.true<-apply(flat.table[,c(1,2,3,4,5)],1,sum)
371 info.true<-apply(info.table[,c(1,2,3,4,5)],1,sum)
372 shrink.true<-apply(shrink.table[,c(1,2,3,4,5)],1,sum)
373 freq.true<-apply(freq.table[,c(1,2,3,4,5)],1,sum)
374 summary(flat.true)
375 summary(info.true)
376 summary(shrink.true)
377 summary(freq.true)
378
379 flat.false<-apply(flat.table[,-c(1,2,3,4,5)],1,sum)
380 info.false<-apply(info.table[,-c(1,2,3,4,5)],1,sum)
381 shrink.false<-apply(shrink.table[,-c(1,2,3,4,5)],1,sum)
382 freq.false<-apply(freq.table[,-c(1,2,3,4,5)],1,sum)
383 summary(flat.false)
384 summary(info.false)
385 summary(shrink.false)
386 summary(freq.false)
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B.2 Application code
1 #-------------------------------------------------------
2 #HCC data-----------------------------------------------
3 #-------------------------------------------------------
4 load("hccCancerPanel.RData")
5 library(rjags)
6 library(R2jags)
7
8 k<-length(unique(hccCancerPanel$Tissue))
9 pi.0 <- table(hccCancerPanel$Tissue)/length(hccCancerPanel$Tissue)
10 alpha.0 <- log(cumsum(pi.0)/(1 - cumsum(pi.0)))[1:(k - 1)]
11 hcc.inits1<-list(tau=alpha.0,beta=c(rnorm(1469,0.01)))
12 hcc.inits2<-list(tau=c(-1,1),beta=c(rnorm(1469,0.0001)))
13 hcc.inits3<-list(tau=c(-2,2),beta=c(rnorm(1469,0.1)))
14 hcc.inits<-list(hcc.inits1,hcc.inits2,hcc.inits3)
15 hcc.params<-c("tau","beta","gamma")
16 hcc.data<-list(Y=hccCancerPanel$Tissue,X=scale(as.matrix(
hccCancerPanel[,-1]),center=TRUE,scale=TRUE),N=length(
hccCancerPanel$Tissue),nb=1469,k=k)
17 hcc.jags <- jags(data=hcc.data, inits=hcc.inits, hcc.params,
18 n.iter=100000, model.file="Non_info_model.txt",n.chains=3)
19 hcc.upd <- autojags(hcc.jags,n.iter=10000)
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20
21 save.image("hcc_bay0_5_03232016.RData")
22
23 load("hcc_bay0_5_03232016.RData")
24 result<-hcc.jags$BUGSoutput$summary
25
26 #Obtain posterior slopes
27 beta.ind<-grep("bgamma",names(result[,"mean"]))
28 beta.value<-result[,"mean"][beta.ind]
29
30 beta.ind2<-grep("beta",names(result[,"mean"]))
31 beta.value2<-result[,"mean"][beta.ind2]
32
33 #Obtain posterior binary indicator
34 gamma.ind0<-grep("gamma",names(result[,"mean"]))
35 gamma.ind<-gamma.ind0[gamma.ind0%in%beta.ind==FALSE]
36 gamma.value<-result[,"mean"][gamma.ind]
37 hist(gamma.value,breaks=100, xlab=expression(paste(gamma, " value")),
main=expression(paste("Histogram of ", gamma, " value")))
38
39 #Obtain posterior intercepts
40 alpha.ind<-grep("tau1",names(result[,"mean"]))
41 diff.ind<-grep("Diff",names(result[,"mean"]))
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42 alpha.value<-c(result[,"50%"][alpha.ind],result[,"50%"][alpha.ind]+
result[,"50%"][diff.ind])
43
44
45 genename<-colnames(hccCancerPanel[,-1])
46 threshold<-mean(result[,"mean"][gamma.ind])+3*sd(result[,"mean"][
gamma.ind])
47 sig.ind<-which(result[,"mean"][gamma.ind]>=threshold)
48
49
50 slope.coef<-beta.value[sig.ind]
51 names(slope.coef)<-genename[sig.ind]
52
53 freq.sig<-c("CDKN2B_seq_50_S294_F","DDIT3_P1313_R","ERN1_P809_R","GML
_E144_F","HDAC9_P137_R","HLA.DPA1_P205_R","HOXB2_P488_R","IL16_
P226_F",
54 "IL16_P93_R","IL8_P83_F","MPO_E302_R","MPO_P883_R","PADI4_P1158_R","
SOX17_P287_R","TJP2_P518_F")
55 table(genename[sig.ind]%in%freq.sig)
56
57 #Prediction for misclassification error
---------------------------------------
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58 #refit a non-penalized cumulative logit model with only selected
features
59 x.select<-scale(as.matrix(hccCancerPanel[,-1]),center=TRUE,scale=TRUE
)[,sig.ind]
60
61 library(rjags)
62 library(R2jags)
63 #with non-informative priors
64 k<-length(unique(hccCancerPanel$Tissue))
65 pi.0 <- table(hccCancerPanel$Tissue)/length(hccCancerPanel$Tissue)
66 alpha.0 <- log(cumsum(pi.0)/(1 - cumsum(pi.0)))[1:(k - 1)]
67 pred.inits1<-list(tau=alpha.0,beta=c(rep(0,dim(x.select)[2])))
68 pred.inits2<-list(tau=c(-1,1),beta=c(rnorm(dim(x.select)[2],0,0.001))
)
69 pred.inits3<-list(tau=c(-2,2),beta=c(rnorm(dim(x.select)[2],0,0.01)))
70 pred.inits<-list(pred.inits1,pred.inits2,pred.inits3)
71 pred.params<-c("tau","beta","Y.pred")
72 pred.data<-list(Y=hccCancerPanel$Tissue,X=x.select,N=length(
hccCancerPanel$Tissue),nb=dim(x.select)[2],k=k)
73 pred.jags <- jags(data=pred.data, inits=pred.inits, pred.params,
74 n.iter=2000, model.file="Reg_pred.txt",n.chains=3)
75 pred.upd <- autojags(pred.jags)$BUGSoutput$summary
76
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77 y.ind<-grep("Y.pred",names(pred.upd[,"50%"]))
78 y.pred<-pred.upd[y.ind,"50%"]
79 out<-table(hccCancerPanel$Tissue,y.pred)
80 1-sum(diag(out))/sum(out)
81
82 #with informative priors
83 rm(list=ls()[ls()=="out"])
84 info.inits1<-list(tau1=alpha.0[1],beta=c(rep(0,dim(x.select)[2])),
Diff=alpha.0[2]-alpha.0[1])
85 info.inits2<-list(tau1=-1,beta=c(rnorm(dim(x.select)[2],0,0.01)),Diff
=2)
86 info.inits3<-list(tau1=-2,beta=c(rnorm(dim(x.select)[2],0,0.001)),
Diff=4)
87 info.inits<-list(info.inits1,info.inits2,info.inits3)
88 info.data<-list(Y=hccCancerPanel$Tissue,X=x.select,N=length(
hccCancerPanel$Tissue),nb=dim(x.select)[2],k=k,a=alpha.0[1])
89 info.params<-c("tau1","Diff","beta","Y.pred")
90 info.jags <- jags(data=info.data, inits=info.inits, info.params,
91 n.iter=2000, model.file="Reg_pred_info.txt",n.chains=3)
92 info.upd <- autojags(info.jags)
93 y.ind<-grep("Y.pred",names(info.upd$BUGSoutput$summary[,"50%"]))
94 y.pred<-info.upd$BUGSoutput$summary[y.ind,"50%"]
95 out<-table(hccCancerPanel$Tissue,y.pred)
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96 1-sum(diag(out))/sum(out)
97
98
99 #refit a penalized cumulative logit model with only selected features
-------------------------------
100 x.select<-scale(as.matrix(hccCancerPanel[,-1]),center=TRUE,scale=TRUE
)[,sig.ind]
101
102 library(rjags)
103 library(R2jags)
104 #non-informative priors
105 k<-length(unique(hccCancerPanel$Tissue))
106 pi.0 <- table(hccCancerPanel$Tissue)/length(hccCancerPanel$Tissue)
107 alpha.0 <- log(cumsum(pi.0)/(1 - cumsum(pi.0)))[1:(k - 1)]
108 pred.inits1<-list(tau=alpha.0,beta=c(rep(0,dim(x.select)[2])))
109 pred.inits2<-list(tau=c(-1,1),beta=c(rnorm(dim(x.select)[2],0,0.001))
)
110 pred.inits3<-list(tau=c(-2,2),beta=c(rnorm(dim(x.select)[2],0,0.01)))
111 pred.inits<-list(pred.inits1,pred.inits2,pred.inits3)
112 pred.params<-c("tau","beta","Y.pred")
113 pred.data<-list(Y=hccCancerPanel$Tissue,X=x.select,N=length(
hccCancerPanel$Tissue),nb=dim(x.select)[2],k=k)
114 pred.jags <- jags(data=pred.data, inits=pred.inits, pred.params,
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115 n.iter=2000, model.file="DE_pred.txt",n.chains=3)
116 pred.upd <- autojags(pred.jags)$BUGSoutput$summary
117
118 y.ind<-grep("Y.pred",names(pred.upd[,"50%"]))
119 y.pred<-pred.upd[y.ind,"50%"]
120 out<-table(hccCancerPanel$Tissue,y.pred)
121 1-sum(diag(out))/sum(out)
122
123 #informative priors
124 rm(list=ls()[ls()=="out"])
125 info.inits1<-list(tau1=alpha.0[1],beta=c(rep(0,dim(x.select)[2])),
Diff=alpha.0[2]-alpha.0[1])
126 info.inits2<-list(tau1=-1,beta=c(rnorm(dim(x.select)[2],0,0.01)),Diff
=2)
127 info.inits3<-list(tau1=-2,beta=c(rnorm(dim(x.select)[2],0,0.001)),
Diff=4)
128 info.inits<-list(info.inits1,info.inits2,info.inits3)
129 info.data<-list(Y=hccCancerPanel$Tissue,X=x.select,N=length(
hccCancerPanel$Tissue),nb=dim(x.select)[2],k=k,a=alpha.0[1])
130 info.params<-c("tau1","Diff","beta","Y.pred")
131 info.jags <- jags(data=info.data, inits=info.inits, info.params,
132 n.iter=2000, model.file="DE_pred_info.txt",n.chains=3)
133 info.upd <- autojags(info.jags)
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134 y.ind<-grep("Y.pred",names(info.upd$BUGSoutput$summary[,"50%"]))
135 y.pred<-info.upd$BUGSoutput$summary[y.ind,"50%"]
136 out<-table(hccCancerPanel$Tissue,y.pred)
137 1-sum(diag(out))/sum(out)
138
139
140 #Cross-validation
---------------------------------------------------------
141 #noninf0
142 pred.noninfo<- function(x, y, nit,penal){
143 k<-length(unique(y[!is.na(y)]))
144 p<-dim(x)[2]
145 pi.0 <- table(y[!is.na(y)])/length(y[!is.na(y)])
146 alpha.0 <- log(cumsum(pi.0)/(1 - cumsum(pi.0)))[1:(k - 1)]
147 inits1<-list(tau=alpha.0,beta=c(rep(0,p)))
148 inits2<-list(tau=c(-1,1),beta=c(rnorm(p,0,0.001)))
149 inits3<-list(tau=c(-2,2),beta=c(rnorm(p,0,0.01)))
150 inits<-list(inits1,inits2,inits3)
151 params<-c("tau","beta","Y.pred","Y")
152 pred.data<-list(Y=y,X=x,N=length(y),nb=p,k=k)
153 pred.jags <- jags(data=pred.data, inits=inits, params,
154 n.iter=nit, model.file=penal,n.chains=3)
155 pred.upd <- autojags(pred.jags)$BUGSoutput$summary
175
156 return(pred.upd)
157 }
158
159 y.cv<-numeric()
160 for (i in 1:56){
161 x<-x.select
162 y<-hccCancerPanel$Tissue
163 y[i]<-NA
164 pred.upd<-pred.noninfo(x=x.select,y=y,nit=1000,penal="DE_pred.txt") #
change to Reg_red to let beta ~ N
165 y.cv[i]<-pred.upd[i,"50%"]
166 }
167 out<-table(hccCancerPanel$Tissue,y.cv)
168 1-sum(diag(out))/sum(out)
169 rm(list=ls()[ls()=="out"])
170 rm(list=ls()[ls()=="y.cv"])
171 #Cross-validation
---------------------------------------------------------
172 #inf0
173 pred.info<- function(x, y, nit,penal){
174 k<-length(unique(y[!is.na(y)]))
175 p<-dim(x)[2]
176 pi.0 <- table(y[!is.na(y)])/length(y[!is.na(y)])
176
177 alpha.0 <- log(cumsum(pi.0)/(1 - cumsum(pi.0)))[1:(k - 1)]
178 inits1<-list(tau1=alpha.0[1],beta=c(rep(0,p)),Diff=alpha.0[2]-alpha
.0[1])
179 inits2<-list(tau1=-1,beta=c(rnorm(p,0,0.01)),Diff=2)
180 inits3<-list(tau1=-2,beta=c(rnorm(p,0,0.001)),Diff=4)
181 inits<-list(inits1,inits2,inits3)
182 info.data<-list(Y=y,X=x,N=length(y),nb=p,k=k,a=alpha.0[1])
183 params<-c("tau1","Diff","beta","Y.pred","Y")
184 info.jags <- jags(data=info.data, inits=inits, params,
185 n.iter=nit, model.file=penal,n.chains=3)
186 info.upd <- autojags(info.jags)$BUGSoutput$summary
187 return(info.upd)
188 }
189
190 y.cv<-numeric()
191 for (i in 1:56){
192 x<-x.select
193 y<-hccCancerPanel$Tissue
194 y[i]<-NA
195 pred.upd<-pred.info(x=x.select,y=y,nit=1000,penal="DE_pred_info.txt")
#change to Reg_pred_info to let beta ~ N
196 y.cv[i]<-pred.upd[i+1,"50%"]
197 }
177
198 out<-table(hccCancerPanel$Tissue,y.cv)
199 1-sum(diag(out))/sum(out)
B.3 Bayesian model files
Penalized Bayesian cumulative logit model with non-informative priors,
corresponding to equation (3.2) (Non info model.txt)
1 model{
2 for(i in 1:N){
3 mu[i] <- inprod(X[i,],bgamma[])
4 logit(Q[i,1]) <- tau[1]+mu[i]
5 p[i,1] <- Q[i,1]
6 for(j in 2:(k-1)){
7 logit(Q[i,j]) <- tau[j]+mu[i]
8 p[i,j] <- Q[i,j] - Q[i,j-1]
9 }
10 p[i,k] <- 1 - Q[i,(k-1)]
11 Y[i] ~ dcat(p[i,1:k])
12 }
13 tt <- lambda * v
14 for (b in 1:nb){
15 beta[b] ~ ddexp(0,tt)}
16 lambda ~ dgamma(1,1)
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17 v ~ dgamma (0.0001,0.0001)
18 for (j in 1:nb){
19 bgamma[j] <- beta[j] * gamma[j]
20 gamma[j] ~ dbern(0.5)
21 }
22 tau[1] ~ dnorm(0,0.001)T(-6.9,6.9)
23 tau[2] ~ dnorm(0,0.001)T(tau[1],6.9)
24 }
Non info model2.txt
1 model{
2
3 for(i in 1:N){
4 mu[i] <- inprod(X[i,],bgamma[])
5 logit(Q[i,1]) <- tau[1]+mu[i]
6 p[i,1] <- Q[i,1]
7 for(j in 2:(k-1)){
8 logit(Q[i,j]) <- tau[j]+mu[i]
9 p[i,j] <- Q[i,j] - Q[i,j-1]
10 }
11
12 p[i,k] <- 1 - Q[i,(k-1)]
13
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14 Y[i] ~ dcat(p[i,1:k])
15 }
16
17
18 tt <- lambda * v
19 for (b in 1:nb){
20 beta[b] ~ ddexp(0,tt)}
21
22 lambda ~ dgamma(0.025,0.05)
23 v ~ dgamma (0.0001,0.0001)
24
25 for (j in 1:nb){
26
27 bgamma[j] <- beta[j] * gamma[j]
28 gamma[j] ~ dbern(0.5)
29 }
30
31 tau[1] ~ dnorm(0,0.001)T(-6.9,6.9)
32 tau[2] ~ dnorm(0,0.001)T(tau[1],6.9)
33
34
35 }
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Penalized Bayesian cumulative logit model with informative priors, cor-
responding to equation (3.3) (info model.txt)
1 model{
2
3 for(i in 1:N){
4 mu[i] <- inprod(X[i,],bgamma[])
5 logit(Q[i,1]) <- tau1+mu[i]
6 p[i,1] <- Q[i,1]
7 for(j in 2:(k-1)){
8 logit(Q[i,j]) <- tau2+mu[i]
9 p[i,j] <- Q[i,j] - Q[i,j-1]
10 }
11
12 p[i,k] <- 1 - Q[i,(k-1)]
13
14 Y[i] ~ dcat(p[i,1:k])
15 }
16
17 tt <- lambda * v
18 for (b in 1:nb){
19 beta[b] ~ ddexp(0,tt)}
20
21 lambda ~ dgamma(1,1)
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22 v ~ dgamma (0.0001,0.0001)
23
24 for (j in 1:nb){
25
26 bgamma[j] <- beta[j] * gamma[j]
27 gamma[j] ~ dbern(0.5)
28
29 }
30
31 tau1 ~ dnorm(a,0.001)T(-6.9,6.9)
32 Diff ~ dgamma(1.4,1)
33 tau2 <- tau1 + Diff
34
35
36 }
Penalized Bayesian cumulative logit model with non-informative priors(DE pred.txt)
1 model{
2
3 for(i in 1:N){
4
5 mu[i] <- inprod(X[i,],beta[])
6
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7 logit(Q[i,1]) <- tau[1]+mu[i]
8 p[i,1] <- Q[i,1]
9 for(j in 2:(k-1)){
10 logit(Q[i,j]) <- tau[j]+mu[i]
11 p[i,j] <- Q[i,j] - Q[i,j-1]
12 }
13
14 p[i,k] <- 1 - Q[i,(k-1)]
15
16 Y[i] ~ dcat(p[i,1:k])
17 Y.pred[i] ~ dcat(p[i,1:k])
18 }
19
20 tt <- lambda * v
21 for (b in 1:nb){
22 beta[b] ~ ddexp(0,tt)}
23
24 lambda ~ dgamma(1,1)
25 v ~ dgamma (0.0001,0.0001)
26
27 tau[1] ~ dnorm(0,0.001)T(-6.9,6.9)
28 tau[2] ~ dnorm(0,0.001)T(tau[1],6.9)
29
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30
31 }
Penalized Bayesian cumulative logit model with informative priors (DE pred info.txt)
1 model{
2
3 for(i in 1:N){
4
5 mu[i] <- inprod(X[i,],beta[])
6
7
8 logit(Q[i,1]) <- tau1+mu[i]
9 p[i,1] <- Q[i,1]
10 for(j in 2:(k-1)){
11 logit(Q[i,j]) <- tau2+mu[i]
12 p[i,j] <- Q[i,j] - Q[i,j-1]
13 }
14
15 p[i,k] <- 1 - Q[i,(k-1)]
16
17 Y[i] ~ dcat(p[i,1:k])
18 Y.pred[i] ~ dcat(p[i,1:k])
19 }
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20
21
22 tt <- lambda * v
23 for (b in 1:nb){
24 beta[b] ~ ddexp(0,tt)}
25
26 lambda ~ dgamma(1,1)
27 v ~ dgamma (0.0001,0.0001)
28
29
30 tau1 ~ dnorm(a,0.001)T(-6.9,6.9)
31 Diff ~ dgamma(1.2,1)
32 tau2 <- tau1 + Diff
33
34
35 }
Non-penalized Bayesian cumulative logit model with non-informative pri-
ors(Reg pred.txt)
1 model{
2 for(i in 1:N){
3 mu[i] <- inprod(X[i,],beta[])
4 logit(Q[i,1]) <- tau[1]+mu[i]
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5 p[i,1] <- Q[i,1]
6 for(j in 2:(k-1)){
7 logit(Q[i,j]) <- tau[j]+mu[i]
8 p[i,j] <- Q[i,j] - Q[i,j-1]
9 }
10
11 p[i,k] <- 1 - Q[i,(k-1)]
12
13 Y[i] ~ dcat(p[i,1:k])
14 Y.pred[i] ~ dcat(p[i,1:k])
15 }
16
17 for (b in 1:nb){
18 beta[b] ~ dnorm(0,0.001)}
19
20 tau[1] ~ dnorm(0,0.001)T(-6.9,6.9)
21 tau[2] ~ dnorm(0,0.001)T(tau[1],6.9)
22
23 }
Non-penalized Bayesian cumulative logit model with informative priors(Reg pred info.txt)
1 model{
2 for(i in 1:N){
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3 mu[i] <- inprod(X[i,],beta[])
4 logit(Q[i,1]) <- tau1+mu[i]
5 p[i,1] <- Q[i,1]
6 for(j in 2:(k-1)){
7 logit(Q[i,j]) <- tau2+mu[i]
8 p[i,j] <- Q[i,j] - Q[i,j-1]
9 }
10
11 p[i,k] <- 1 - Q[i,(k-1)]
12
13 Y[i] ~ dcat(p[i,1:k])
14 Y.pred[i] ~ dcat(p[i,1:k])
15 }
16
17
18 for (b in 1:nb){
19 beta[b] ~ dnorm(0,0.001)}
20
21 tau1 ~ dnorm(a,0.001)T(-6.9,6.9)
22 Diff ~ dgamma(1.2,1)
23 tau2 <- tau1 + Diff
24
25 }
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Appendix C
Chapter 3 appendix
C.1 Filtering code
1 #############----------------
2 #Four univariate feature selection methods
3 #############----------------
4 library("survival")
5 library(bootstrap)
6 library(VGAM)
7 AML<-read.csv("AMLdata.csv")
8 attach(AML)
9 censor<-ifelse(vital.status=="A",1,0)
10 AML.feature<-AML[,4:252]
11 delta<-1-censor
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12
13
14 #Cox PH-------------------------------------------------
15 AML.feature<-AML[,4:252]
16 p1a.pvalue<-numeric()
17 for (i in 1:dim(AML.feature)[2]){
18 fit<-coxph(Surv(Overall_Survival,delta)~AML.feature[,i])
19 #fit<-coxph(Surv(Overall_Survival)~AML.feature[,i])
20 p1a.pvalue[i]<-summary(fit)$waldtest["pvalue"]
21 }
22 sig.a<-colnames(AML.feature)[which(p1a.pvalue<=0.1)]
23
24
25
26
27 #Spearman rank test--------------------------------------
28 p1b.pvalue<-numeric()
29 for (i in 1:dim(AML.feature)[2]){
30 p1b.pvalue[i]<-cor.test(Overall_Survival,AML.feature[,i],method="
spearman")$p.value
31 }
32 sig.b<-colnames(AML.feature)[which(p1b.pvalue<=0.1)]
33
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34
35 #IC-------------------------------------------------------
36 AML.feature$AHD<-as.numeric(AML.feature$AHD)
37 var.class<-lapply(AML.feature,class)
38 cat.feature<-AML.feature[,var.class=="integer"]
39 numeric.feature<-AML.feature[,var.class=="numeric"]
40 kmean.feature<-data.frame(cat.feature,apply(numeric.feature,2,
function(x) kmeans(x,3)$cluster))
41
42 #function that caculates important score
43 Ic.fun<-function(var,surv){
44 Yk_hat<-aggregate(surv, by=list(var),FUN=mean)$x
45 n_k<-aggregate(surv, by=list(var),FUN=length)$x
46 Ic<-sum((n_k^2)*((Yk_hat-mean(surv))^2))/TSS
47 return(Ic)
48 }
49 TSS<-sum((Overall_Survival-mean(Overall_Survival))^2)
50
51 Ic.obs<-numeric()
52 for (i in 1:dim(kmean.feature)[2]){
53 Ic.obs[i]<-Ic.fun(kmean.feature[,i],surv=Overall_Survival)
54 }
55
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56 #bootstrap
57 subject<-1:dim(kmean.feature)[1]
58 Ic.matrix<-matrix(nr=dim(kmean.feature)[2],nc=1000)
59 for (i in 1:dim(kmean.feature)[2]){
60 var<-data.frame(Overall_Survival,kmean.feature[,i])
61 var2<-var[order(var[,2]),]
62 set.seed(1234)
63 for (b in 1:1000) {
64 bootsample<-sample(subject, replace=TRUE)
65 Surb<-var2[,1][bootsample]
66 #slope[b]<-lm(Surb ~ var2[,2])$coef[2] #mean=0 :)
67 #test.p[b]<-anova(lm(Surb ~ var2[,2]))[1,5] #uniform dist :)
68 Ic.matrix[i,b]<-Ic.fun(var2[,2],surv=Surb)
69 }
70 }
71
72
73 p1c.pvalue<-numeric()
74 for (i in 1:dim(kmean.feature)[2]){
75 Ic.ind<-ifelse(Ic.matrix[i,] > Ic.obs[i], 1, 0)
76 p1c.pvalue[i]<-sum(Ic.ind)/length(Ic.ind)
77 }
78 sig.c<-colnames(kmean.feature)[which(p1c.pvalue<=0.1)]
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79
80 hist(Ic.matrix[,2],breaks=100,main="Prior AML")
81 abline(v=Ic.obs[2],col="red")
82 kmean.feature[,1:5]
83
84 #Id---------------------------------------------------------------
85
86 #function that calculate Id
87 Id_fun<-function(surv,var){
88 y<-ifelse(surv<=52,1,ifelse(surv<=104,2,3))
89 k<-length(unique(var))
90 Fmatrix<-matrix(nr=k,nc=3)
91 sumG<-numeric()
92 for (i in 1:k){
93 Fmatrix[i,]<-cumsum(table(factor(y[var==i],levels = c(1:3))))/sum(
table(y[var==i]))
94 sumG[i]<-sum(Fmatrix[i,]*(1-Fmatrix[i,]))
95 }
96 sum(sumG)
97 }
98
99 #change binary variable from 0,1 to 1,2 to enable the function
100 kmean.feature2<-kmean.feature
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101 kmean.feature2[,1:6][kmean.feature2[,1:6]==1]<-2
102 kmean.feature2[,1:6][kmean.feature2[,1:6]==0]<-1
103
104 #observed Id for each x
105 Id.obs<-numeric()
106 for (i in 1:dim(kmean.feature2)[2]){
107 Id.obs[i]<-Id_fun(var=kmean.feature2[,i],surv=Overall_Survival)
108 }
109
110 #bootstrap
111 subject<-1:dim(kmean.feature2)[1]
112 Id.matrix<-matrix(nr=dim(kmean.feature2)[2],nc=1000)
113 for (i in 1:dim(kmean.feature2)[2]){
114 var<-data.frame(Overall_Survival,kmean.feature2[,i])
115 var2<-var[order(var[,2]),]
116 set.seed(1234)
117 for (b in 1:1000) {
118 bootsample<-sample(subject, replace=TRUE)
119 Surb<-var2[,1][bootsample]
120 Id.matrix[i,b]<-Id_fun(surv=Surb,var=var2[,2])
121 }
122 }
123
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124 p1d.pvalue<-numeric()
125 for (i in 1:dim(kmean.feature)[2]){
126 Id.ind<-ifelse(Id.matrix[i,] < Id.obs[i], 1 , 0)
127 p1d.pvalue[i]<-sum(Id.ind)/length(Id.ind)
128 }
129 sig.d<-colnames(kmean.feature2)[which(p1d.pvalue<=0.1)]
130
131 table(sig.c%in%sig.d)
132
133
134 #############---------------------------------------------
135 Multivariable predictive model using only significant features after
filtering
136 #############---------------------------------------------
137 y<-ifelse(Overall_Survival<=52,1,ifelse(Overall_Survival<=104,2,3))
138 method1.data<-data.frame(AML.feature[,which(p1a.pvalue<=0.1)])
139 method2.data<-data.frame(AML.feature[,which(p1b.pvalue<=0.1)])
140 method3.data<-data.frame(AML.feature[,colnames(AML.feature)%in%sig.c
==TRUE])
141 method4.data<-data.frame(AML.feature[,colnames(AML.feature)%in%sig.d
==TRUE])
142
143 #FCR------------------------------------------------------
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144 #forward continuation ratio model is used for prediction
145 fit.vglm1<-vglm(y~.,data=method1.data, family=sratio(parallel=T,
reverse=F),link=cloglog)
146 vglm.pi<-predict(fit.vglm1,type="response")
147 apply(vglm.pi,2,range)
148 vglm.class<-apply(vglm.pi,1,which.max)
149
150 #resubsitution error
151 out1<-table(factor(y,level=c(1:3)), factor(vglm.class,level=c(1:3)))
152 (sum(out1)-sum(diag(out1)))/sum(out1)
153
154 #leave one cross validation
155 #the function below taking predictors x data.frame, and will return
misclassification rate (CV_error)
156 LOOC.vglm<-function(x){
157 cv.fit<-function(x,y){vglm(y~.,data=data.frame(x), family=sratio(
parallel=T,reverse=F),link=cloglog)}
158 cv.predict<-function(fit,x){apply(predict(fit,newdata=x,type="
response"),1,which.max)}
159 u <- vector("list", length(y))
160 cv.result <- rep(NA,length(y) )
161 for (j in 1:length(y)) {
162 u <- cv.fit(x[-j, ], y[-j])
195
163 cv.result[j] <- cv.predict(u, x[j,])
164 }
165 out.cv<-table(factor(cv.result,level=c(1:3)),factor(y,level=c(1:3)))
166 (sum(out.cv)-sum(diag(out.cv)))/sum(out.cv)
167 }
168 LOOC.vglm(method1.data)
169
170 #
--------------------------------------------------------------------------------
171 fit.vglm2<-vglm(y~.,data=method2.data,family=sratio(parallel=T,
reverse=F),link=cloglog)
172 vglm.pi<-predict(fit.vglm2,type="response")
173 vglm.class<-apply(vglm.pi,1,which.max)
174
175 #resubsitution error
176 out2<-table(factor(y,level=c(1:3)), factor(vglm.class,level=c(1:3)))
177 (sum(out2)-sum(diag(out2)))/sum(out2)
178
179 #leave one cross validation
180 LOOC.vglm(method2.data)
181
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182 #
--------------------------------------------------------------------------------
183 fit.vglm3<-vglm(y~.,data=method3.data,family=sratio(parallel=T,
reverse=F),link=cloglog)
184 vglm.pi<-predict(fit.vglm3,type="response")
185 vglm.class<-apply(vglm.pi,1,which.max)
186
187 #resubsitution error
188 out3<-table(factor(y,level=c(1:3)), factor(vglm.class,level=c(1:3)))
189 (sum(out3)-sum(diag(out3)))/sum(out3)
190 #CV
191 LOOC.vglm(method3.data)
192
193 #
--------------------------------------------------------------------------------
194 fit.vglm4<-vglm(y~.,data=method4.data,family=sratio(parallel=T,
reverse=F),link=cloglog)
195 vglm.pi<-predict(fit.vglm4,type="response")
196 vglm.class<-apply(vglm.pi,1,which.max)
197
198 #resubsitution error
197
199 out4<-table(factor(y,level=c(1:3)), factor(vglm.class,level=c(1:3)))
200 (sum(out4)-sum(diag(out4)))/sum(out4)
201 #CV
202 LOOC.vglm(method4.data)
203
204
205 #Cox PH multivariable----------------------------------------
206 #Misclassification rate
207 #
-----------------------------------------------------------------------------------
208 #Fit cox model
209 fit.cox1<-coxph(Surv(Overall_Survival,delta)~.,data=method1.data,ties
="breslow")
210
211 #survival.rate is a matrix contains the probability of people die
within three intervals (<55, 55-144,>144)
212 # Col1=dealth rate for <=55, Col2=55-144, ...
213 # Row1=patient 1,...
214
215 survival.rate<-matrix(nc=3,nr=dim(method1.data)[1])
216 for (i in 1:dim(method1.data)[1]){
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217 summary.cox1<-summary(survfit(fit.cox1,newdata=method1.data[i,])) #
survfit function will create predicted survival curve for ith
observation
218 survival.rate[i,1]<-ifelse(length(summary.cox1$surv[summary.cox1$time
<=52])>0,diff(range(summary.cox1$surv[summary.cox1$time<=52])),0)
219 survival.rate[i,2]<-ifelse(length(summary.cox1$surv[summary.cox1$time
<=104 & summary.cox1$time >52])>0,diff(range(summary.cox1$surv[
summary.cox1$time<=104 & summary.cox1$time >52])),0)
220 survival.rate[i,3]<-1-survival.rate[i,1]-survival.rate[i,2]
221 }
222 cox.y1<-apply(survival.rate,1,which.max)
223 cox1.table<-table(factor(cox.y1,level=c(1,2,3)),factor(y,level=c
(1,2,3))) #nice
224 cox1.table
225 (sum(cox1.table)-sum(diag(cox1.table)))/sum(cox1.table)
226
227
228 fit.cox2<-coxph(Surv(Overall_Survival,delta)~.,data=method2.data,ties
="breslow")
229 survival.rate2<-matrix(nc=3,nr=dim(method1.data)[1])
230 for (i in 1:dim(method1.data)[1]){
231 summary.cox2<-summary(survfit(fit.cox2,newdata=method2.data[i,]))
199
232 survival.rate2[i,1]<-ifelse(length(summary.cox2$surv[summary.cox2$
time<=52])>0,diff(range(summary.cox2$surv[summary.cox2$time<=52]))
,0)
233 survival.rate2[i,2]<-ifelse(length(summary.cox2$surv[summary.cox2$
time<=104 & summary.cox2$time >52])>0,diff(range(summary.cox2$surv
[summary.cox2$time<=104 & summary.cox2$time >52])),0)
234 survival.rate2[i,3]<-1-survival.rate2[i,1]-survival.rate2[i,2]
235 }
236 cox.y2<-apply(survival.rate2,1,which.max)
237 cox2.table<-table(factor(cox.y2,level=c(1,2,3)),factor(y,level=c
(1,2,3)))
238 cox2.table
239 (sum(cox2.table)-sum(diag(cox2.table)))/sum(cox2.table)
240
241
242 fit.cox3<-coxph(Surv(Overall_Survival,delta)~.,data=method3.data,ties
="breslow")
243 survival.rate3<-matrix(nc=3,nr=dim(method1.data)[1])
244 for (i in 1:dim(method1.data)[1]){
245 summary.cox3<-summary(survfit(fit.cox3,newdata=method3.data[i,]))
246 survival.rate3[i,1]<-ifelse(length(summary.cox3$surv[summary.cox3$
time<=52])>0,diff(range(summary.cox3$surv[summary.cox3$time<=52]))
,0)
200
247 survival.rate3[i,2]<-ifelse(length(summary.cox3$surv[summary.cox3$
time<=104 & summary.cox3$time >52])>0,diff(range(summary.cox3$surv
[summary.cox3$time<=104 & summary.cox3$time >52])),0)
248 survival.rate3[i,3]<-1-survival.rate3[i,1]-survival.rate3[i,2]
249 }
250 cox.y3<-apply(survival.rate3,1,which.max)
251 cox3.table<-table(factor(cox.y3,level=c(1,2,3)),factor(y,level=c
(1,2,3)))
252 cox3.table
253 (sum(cox3.table)-sum(diag(cox3.table)))/sum(cox3.table)
254
255
256 fit.cox4<-coxph(Surv(Overall_Survival,delta)~.,data=method4.data,ties
="breslow")
257 survival.rate4<-matrix(nc=3,nr=dim(method1.data)[1])
258 for (i in 1:dim(method1.data)[1]){
259 summary.cox4<-summary(survfit(fit.cox4,newdata=method4.data[i,]))
260 survival.rate4[i,1]<-ifelse(length(summary.cox4$surv[summary.cox4$
time<=52])>0,diff(range(summary.cox4$surv[summary.cox4$time<=52]))
,0)
261 survival.rate4[i,2]<-ifelse(length(summary.cox4$surv[summary.cox4$
time<=104 & summary.cox4$time >52])>0,diff(range(summary.cox4$surv
[summary.cox4$time<=104 & summary.cox4$time >52])),0)
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262 survival.rate4[i,3]<-1-survival.rate4[i,1]-survival.rate4[i,2]
263 }
264 cox.y4<-apply(survival.rate4,1,which.max)
265 cox4.table<-table(factor(cox.y4,level=c(1,2,3)),factor(y,level=c
(1,2,3)))
266 cox4.table
267 (sum(cox4.table)-sum(diag(cox4.table)))/sum(cox4.table)
268
269 #cross validation
270 #
-------------------------------------------------------------------------------------------
271 #leave one cross validation
272 #the function below taking data need to be predicted, and will return
misclassification rate (CV_error)
273
274 LOOC.cox<-function(data){
275
276 #cox.pr function take x=coxph object, and y=new data and produce
predicted
277 cox.pr<-function(x,y){
278 summ.cox<-summary(survfit(x,newdata=y))
279 surv.vec<-numeric()
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280 surv.vec[1]<-ifelse(length(summ.cox$surv[summ.cox$time<=52])>0,diff(
range(summ.cox$surv[summ.cox$time<=52])),0)
281 surv.vec[2]<-ifelse(length(summ.cox$surv[summ.cox$time<=104 & summ.
cox$time >52])>0,diff(range(summ.cox$surv[summ.cox$time<=104 &
summ.cox$time >52])),0)
282 surv.vec[3]<-1-surv.vec[1]-surv.vec[2]
283 cox.y<-which.max(surv.vec)
284 cox.y
285 }
286
287 u<-numeric()
288 for (i in 1:dim(data)[1]){
289 fit.cox1<-coxph(Surv(Overall_Survival[-i],delta[-i])~.,data=data[-i
,])
290 u[i]<-cox.pr(fit.cox1,data[i,])
291 }
292
293 out.cv<-table(factor(u,level=c(1:3)),factor(y,level=c(1:3)))
294 (sum(out.cv)-sum(diag(out.cv)))/sum(out.cv)
295 }
296
297 LOOC.cox(method1.data)
298 LOOC.cox(method2.data)
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299 LOOC.cox(method3.data)
300 LOOC.cox(method4.data)
C.2 Coxpath and GMIFS-FCR code
1 ##########-------------------------------------------------
2 ##Coxpath
3 ##########--------------------------------------------
4 AML<-read.csv("AMLdata.csv")
5 attach(AML)
6 censor<-ifelse(vital.status=="A",1,0)
7 delta<-1-censor
8 AML.feature<-AML[,4:252]
9
10 ### RE-SUBSTITUTION ERROR
---------------------------------------------------------
11 #fit coxpath LASSO regression
12 library(glmpath)
13 fit.path1<-coxpath(list(x=as.matrix(AML.feature),time=Overall_
Survival,status=delta))
14 summary.coxpath1<-summary(fit.path1)
15 step1<-as.numeric(gsub("Step ","", rownames(summary.coxpath1)[which.
min(summary.coxpath1$AIC)] ) )
16 step1
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17 #obtain coefficient
18 #fit.path1$b.corrector will return the a matrix of coefficient
obtained in corrector step
19 #The coef obtained from $b.corrector is same as obtained from predict
.path
20 path.coef<-fit.path1$b.corrector[step1,]
21
22 #obtain cumulative hazards
23 #since predict.coxpath(type="coxph") did not converge, I hardcode
hazard function and predicted survival curve
24 #aalen will return Aalen’s estimates of the cumulative hazard
25
26 aalen <- function(x,time,delta,beta){
27 event <- delta == 1
28 new.x<-scale(x,center=TRUE,scale=FALSE)
29 path.coef<-beta
30 risk<-exp(new.x%*%path.coef)
31 dt <- unique(time[event])
32 ct <- unique(time[event==FALSE])
33 ct.dt<-data.frame()
34 for(i in 1:length(ct)){
35 ct.dt[i,1]<-ct[i]
36 diff<-ct[i]-dt
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37 ct.dt[i,2]<-(dt[diff>=0])[which.min(diff[diff>=0])]
38 }
39 colnames(ct.dt)<-c("cen.time","corres.time")
40 k <- length(dt)
41 lambda <- rep(0,k)
42 for(i in 1:k) {
43 lambda[i] <- sum(event[time==dt[i]])/sum(risk[time >= dt[i]])
44 }
45 result<-data.frame(time=dt, lambda=lambda)
46 result2<-result[order(result$time),]
47 new.result<-transform(result2,lambda.cum=cumsum(lambda))
48
49 #data.frame contained censored time and its lambda.cum
50 censor.haz<-merge(new.result,ct.dt,by.x="time",by.y="corres.time",all
.y=TRUE)
51 new.censor.haz<-transform(censor.haz,time=cen.time)
52 cum.haz<-rbind(new.result,new.censor.haz[,-4])
53 z0<-colMeans(x)
54 bz0<-sum(z0*path.coef)
55 cum.haz.data<-transform(cum.haz,lambda.cum.base=lambda.cum*exp(-bz0))
56 cum.haz.data[order(cum.haz$time),]
57 }
58
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59 x<-as.matrix(AML.feature)
60 cum.haz<-aalen(x,time=Overall_Survival,delta=delta,beta=path.coef)
61 exp.xb<-exp(as.matrix(AML.feature)%*%path.coef)
62 survival.rate.path<-matrix(nc=3,nr=dim(AML.feature)[1])
63 for(i in 1:length(exp.xb)){
64 pred.surv<-data.frame(surv=exp(-cum.haz$lambda.cum.base*exp.xb[i]),
time=cum.haz$time)
65 survival.rate.path[i,1]<-ifelse(length(pred.surv$surv[pred.surv$time
<=52])>0,diff(range(pred.surv$surv[pred.surv$time<=52])),0)
66 survival.rate.path[i,2]<-ifelse(length(pred.surv$surv[pred.surv$time
<=104 & pred.surv$time >52])>0,diff(range(pred.surv$surv[pred.surv
$time<=104 & pred.surv$time >52])),0)
67 survival.rate.path[i,3]<-1-survival.rate.path[i,1]-survival.rate.path
[i,2]
68 }
69
70 cox.path.y<-apply(survival.rate.path,1,which.max)
71 y<-ifelse(Overall_Survival<=52,1,ifelse(Overall_Survival<=104,2,3))
72 cox.path.table<-table(factor(cox.path.y,level=c(1,2,3)),factor(y,
level=c(1,2,3)))
73 (sum(cox.path.table)-sum(diag(cox.path.table)))/sum(cox.path.table)
74
207
75 ### CV ERROR
------------------------------------------------------------
76 ## Parallel coding was used to speed up the CV process
77 ## Parallel version using doSNOW, foreach, and itertools packages
78 library(doSNOW)
79 library(itertools)
80 machines <- rep("localhost", each=4)
81 cl <- makeCluster(machines, type="SOCK", outfile="test.txt")
82 registerDoSNOW(cl)
83
84 system.time({
85 iter <- isplitIndices(nrow(AML.feature), chunks=nrow(AML.feature))
86 nfold.class <- foreach(i=iter,
87 .combine=c, .packages="glmpath") %dopar% {
88 fit <- coxpath(list(x=as.matrix(AML.
feature[-i,]),time=AML$Overall_Survival
[-i],status=delta[-i]))
89 summary.fit<-summary(fit)
90 model.select<-as.numeric(gsub("Step ","",rownames(summary.
fit)[which.min(summary.fit$AIC)]))
91
92
93 path.coef.cv<-fit$b.corrector[model.select,]
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94 cum.haz<-aalen(x=as.matrix(AML.feature[-i,]),time=AML$
Overall_Survival[-i],delta=delta[-i],path.coef.cv)
95 exp.xb<-exp(sum(AML.feature[i,]*path.coef.
cv))
96 pred.surv<-data.frame(surv=exp(-cum.haz$
lambda.cum*exp.xb),time=cum.haz$time)
97
98 survival.rate.path<-numeric()
99 survival.rate.path[1]<-ifelse(length(pred.surv$surv[pred.
surv$time<=52])>0,diff(range(pred.surv$surv[pred.surv$
time<=52])),0)
100 survival.rate.path[2]<-ifelse(length(pred.surv$surv[pred.
surv$time<=104 & pred.surv$time >52])>0,diff(range(pred.
surv$surv[pred.surv$time<=104 & pred.surv$time >52])),0)
101 survival.rate.path[3]<-1-survival.rate.path[1]-survival.rate
.path[2]
102 cox.path.y<-which.max(survival.rate.path)
103 return(cox.path.y)
104 }
105 })
106
107 stopCluster(cl)
108 y<-ifelse(Overall_Survival<=52,1,ifelse(Overall_Survival<=104,2,3))
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109 cox.path.table<-table(factor(nfold.class,level=c(1,2,3)),factor(y,
level=c(1,2,3)))
110 (sum(cox.path.table)-sum(diag(cox.path.table)))/sum(cox.path.table) #
CV Error
111
112
113
114 ##############---------------------------------------
115 ##ordinalgmifs
116 ##############---------------------------------------
117 #Kyle Ferber codes for censoring------------------
118 G<-function(z){
119 1-exp(-exp(z))
120 }
121 ### Forward Continuation Ratio GMIFS function ###
122 forwardcr.stepwise<-function(x,y,censor=NULL,tol=1e-5, epsilon=0.001,
scale=FALSE) {
123 Detail content is written by Kyle Ferber, not disclosed in this
thesis
124 }
125
126 ### Function to update alpha ###
127 ForwardCR.fn<-function(par, x, y, censor=NULL, beta) {
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128 Detail content is written by Kyle Ferber, not disclosed in this
thesis
129 }
130
131 ### Function to predict class ###
132 predict.forwardCR<-function(fit,newx,model.select=NA) {
133 Detail content is written by Kyle Ferber, not disclosed in this
thesis
134 }
135
136
137 ### Function to predict cv class ###
138 predict.forwardCR.cv<-function(fit,newx,model.select=NA) {
139 x<-fit$x
140 y<-fit$y
141 if (is.na(model.select)) model.select=dim(fit$beta)[1]
142 beta<-fit$beta[model.select,]
143 alpha<-fit$alpha[model.select,]
144 k<-length(unique(y))
145 newx<-as.matrix(newx)
146 if (identical(newx,x)) {
147 if (fit$scale) {
148 newx<-scale(newx,center=TRUE,scale=TRUE)
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149 }
150 } else if (fit$scale) {
151 newx<-rbind(x,newx)
152 newx<-scale(newx,center=TRUE,scale=TRUE)
153 newx<-matrix(newx[-(1:dim(x)[1]),],ncol=dim(x)[2])
154 }
155 levels<-sort(unique(y))
156 Xb<-newx%*%beta
157 pi <- matrix(0, nrow = dim(newx)[1], ncol = k)
158 pi[,1]<-G(alpha[1]+Xb)
159 pi[,2]<-G(alpha[2]+Xb)*(1-pi[,1])
160 if (k>3) {
161 for (i in 3:(k-1)) {
162 pi[,i]<-G(alpha[i]+Xb)*(1-matrix(apply(pi[,1:(i-1)],1,sum),nrow=
nrow(pi),byrow=T))
163 }
164 }
165 pi[,k]<-1-matrix(sum(pi[,1:(k-1)]),nrow=nrow(pi),byrow=T)
166 class<-levels[apply(pi,1,which.max)]
167 list(predicted=pi,class=class)
168 }
169
212
170 #
----------------------------------------------------------------------------------------------------
171 y<-ifelse(Overall_Survival<=52,1,ifelse(Overall_Survival<=104,2,3))
172
173 fit.fcr.survival.over<-forwardcr.stepwise(x=AML.feature, censor=
censor, y=y, scale=TRUE, epsilon=0.01)
174 #fit.class.over<-predict.forwardCR(fit.fcr.survival.over,newx=AML.
feature)
175 fit.class.over<-predict.forwardCR(fit.fcr.survival.over,newx=AML.
feature,model.select=245)
176 censor.table.over<-table(factor(fit.class.over$class,level=c(1:3)),
factor(y,level=c(1:3)))
177 (sum(censor.table.over)-sum(diag(censor.table.over)))/sum(censor.
table.over)
178 AIC.model<-fit.fcr.survival.over$beta[fit.fcr.survival.over$model.
select,]
179 length(AIC.model[AIC.model!=0])
180 AIC.model[AIC.model!=0]
181
182 fit.class.cv<-numeric()
183 for (i in 1:dim(AML.feature)[1]){
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184 fit<-forwardcr.stepwise(x=AML.feature[-i,], censor=censor[-i], y=y[-i
], scale=TRUE, epsilon=0.01)
185 fit.class.cv[i]<-predict.forwardCR.cv(fit,newx=AML.feature[i,],model.
select=fit$model.select)$class
186 }
187
188 out.cv<-table(factor(fit.class.cv,level=c(1:3)),factor(y,level=c(1:3)
))
189 (sum(out.cv)-sum(diag(out.cv)))/sum(out.cv)
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